<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Implanted spinal neuromodulation interventions for chronic pain in adults - O'Connell, NE - 2021 | Cochrane Library</title> <meta content="Implanted spinal neuromodulation interventions for chronic pain in adults - O'Connell, NE - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013756.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Implanted spinal neuromodulation interventions for chronic pain in adults - O'Connell, NE - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013756.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013756.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Implanted spinal neuromodulation interventions for chronic pain in adults" name="citation_title"/> <meta content="Neil E O'Connell" name="citation_author"/> <meta content="Brunel University London" name="citation_author_institution"/> <meta content="neil.oconnell@brunel.ac.uk" name="citation_author_email"/> <meta content="Michael C Ferraro" name="citation_author"/> <meta content="William Gibson" name="citation_author"/> <meta content="The University of Notre Dame Australia" name="citation_author_institution"/> <meta content="Andrew SC Rice" name="citation_author"/> <meta content="Imperial College London" name="citation_author_institution"/> <meta content="Lene Vase" name="citation_author"/> <meta content="Aarhus University" name="citation_author_institution"/> <meta content="Doug Coyle" name="citation_author"/> <meta content="Christopher Eccleston" name="citation_author"/> <meta content="University of Bath" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD013756.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/12/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013756.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013756.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013756.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; *Chronic Pain [therapy]; Pain Measurement; Quality of Life; *Wound Infection" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013756.pub2&amp;doi=10.1002/14651858.CD013756.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="tIsQXAzh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013756\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013756\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","th","ko","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013756.pub2",title:"Implanted spinal neuromodulation interventions for chronic pain in adults",firstPublishedDate:"Dec 2, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tIsQXAzh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013756.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013756.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013756.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013756.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013756.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013756.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;riskOfBias2&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Risk of bias&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Risk of Bias&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013756.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013756.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013756.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013756.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12286 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013756.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0134"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-sec-0117"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/appendices#CD013756-sec-0146"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2"> Risk of bias </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/table_n/CD013756StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/table_n/CD013756StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Implanted spinal neuromodulation interventions for chronic pain in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Neil E O'Connell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0005">Michael C Ferraro</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0006">William Gibson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0007">Andrew SC Rice</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0008">Lene Vase</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0009">Doug Coyle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information#CD013756-cr-0010">Christopher Eccleston</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information/en#CD013756-sec-0153">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 December 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013756.pub2">https://doi.org/10.1002/14651858.CD013756.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013756-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013756-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013756-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013756-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013756-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013756-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD013756-abs-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013756-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013756-abs-0001" lang="en"> <section id="CD013756-sec-0001"> <h3 class="title" id="CD013756-sec-0001">Background</h3> <p>Implanted spinal neuromodulation (SNMD) techniques are used in the treatment of refractory chronic pain. They involve the implantation of electrodes around the spinal cord (spinal cord stimulation (SCS)) or dorsal root ganglion (dorsal root ganglion stimulation (DRGS)), and a pulse generator unit under the skin. Electrical stimulation is then used with the aim of reducing pain intensity. </p> </section> <section id="CD013756-sec-0002"> <h3 class="title" id="CD013756-sec-0002">Objectives</h3> <p>To evaluate the efficacy, effectiveness, adverse events, and cost‐effectiveness of implanted spinal neuromodulation interventions for people with chronic pain. </p> </section> <section id="CD013756-sec-0003"> <h3 class="title" id="CD013756-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE Ovid, Embase Ovid, Web of Science (ISI), Health Technology Assessments, ClinicalTrials.gov and World Health Organization International Clinical Trials Registry from inception to September 2021 without language restrictions, searched the reference lists of included studies and contacted experts in the field. </p> </section> <section id="CD013756-sec-0004"> <h3 class="title" id="CD013756-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) comparing SNMD interventions with placebo (sham) stimulation, no treatment or usual care; or comparing SNMD interventions + another treatment versus that treatment alone. We included participants ≥ 18 years old with non‐cancer and non‐ischaemic pain of longer than three months duration. Primary outcomes were pain intensity and adverse events. Secondary outcomes were disability, analgesic medication use, health‐related quality of life (HRQoL) and health economic outcomes. </p> </section> <section id="CD013756-sec-0005"> <h3 class="title" id="CD013756-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened database searches to determine inclusion, extracted data and evaluated risk of bias for prespecified results using the Risk of Bias 2.0 tool. Outcomes were evaluated at short‐ (≤ one month), medium‐ four to eight months) and long‐term (≥12 months). Where possible we conducted meta‐analyses. We used the GRADE system to assess the certainty of evidence. </p> </section> <section id="CD013756-sec-0006"> <h3 class="title" id="CD013756-sec-0006">Main results</h3> <p>We included 15 unique published studies that randomised 908 participants, and 20 unique ongoing studies. All studies evaluated SCS. We found no eligible published studies of DRGS and no studies comparing SCS with no treatment or usual care. We rated all results evaluated as being at high risk of bias overall. For all comparisons and outcomes where we found evidence, we graded the certainty of the evidence as low or very low, downgraded due to limitations of studies, imprecision and in some cases, inconsistency. </p> <p><b>Active stimulation versus placebo </b> </p> <p><b>SCS versus placebo (sham) </b> </p> <p>Results were only available at short‐term follow‐up for this comparison.</p> <p><b>Pain intensity</b> </p> <p>Six studies (N = 164) demonstrated a small effect in favour of SCS at short‐term follow‐up (0 to 100 scale, higher scores = worse pain, mean difference (MD) ‐8.73, 95% confidence interval (CI) ‐15.67 to ‐1.78, very low certainty). The point estimate falls below our predetermined threshold for a clinically important effect (≥10 points). No studies reported the proportion of participants experiencing 30% or 50% pain relief for this comparison. </p> <p><b>Adverse events (AEs)</b> </p> <p>The quality and inconsistency of adverse event reporting in these studies precluded formal analysis. </p> <p><b>Active stimulation + other intervention versus other intervention alone </b> </p> <p><b>SCS + other intervention versus other intervention alone (open‐label studies) </b> </p> <p><b>Pain intensity</b> </p> <p><b><i>Mean difference</i> </b> </p> <p>Three studies (N = 303) demonstrated a potentially clinically important mean difference in favour of SCS of ‐37.41 at short term (95% CI ‐46.39 to ‐28.42, very low certainty), and medium‐term follow‐up (5 studies, 635 participants, MD ‐31.22 95% CI ‐47.34 to ‐15.10 low‐certainty), and no clear evidence for an effect of SCS at long‐term follow‐up (1 study, 44 participants, MD ‐7 (95% CI ‐24.76 to 10.76, very low‐certainty). </p> <p><b><i>Proportion of participants reporting ≥50% pain relief</i> </b> </p> <p>We found an effect in favour of SCS at short‐term (2 studies, N = 249, RR 15.90, 95% CI 6.70 to 37.74, I<sup>2</sup> 0% ; risk difference (RD) 0.65 (95% CI 0.57 to 0.74, very low certainty), medium term (5 studies, N = 597, RR 7.08, 95 %CI 3.40 to 14.71, I<sup>2</sup> = 43%; RD 0.43, 95% CI 0.14 to 0.73, low‐certainty evidence), and long term (1 study, N = 87, RR 15.15, 95% CI 2.11 to 108.91 ; RD 0.35, 95% CI 0.2 to 0.49, very low certainty) follow‐up. </p> <p><b>Adverse events (AEs)</b> </p> <p><b><i>Device related</i> </b> </p> <p>No studies specifically reported  device‐related adverse events at short‐term follow‐up. At medium‐term follow‐up, the incidence of lead failure/displacement (3 studies N = 330) ranged from 0.9 to 14% (RD 0.04, 95% CI ‐0.04 to 0.11, I<sup>2</sup> 64%, very low certainty). The incidence of infection (4 studies, N = 548) ranged from 3 to 7% (RD 0.04, 95%CI 0.01, 0.07, I<sup>2</sup> 0%, very low certainty). The incidence of reoperation/reimplantation (4 studies, N =5 48) ranged from 2% to 31% (RD 0.11, 95% CI 0.02 to 0.21, I<sup>2</sup> 86%, very low certainty). One study (N = 44) reported a 55% incidence of lead failure/displacement (RD 0.55, 95% CI 0.35, 0 to 75, very low certainty), and a 94% incidence of reoperation/reimplantation (RD 0.94, 95% CI 0.80 to 1.07, very low certainty) at five‐year follow‐up. No studies provided data on infection rates at long‐term follow‐up. </p> <p>We found reports of some serious adverse events as a result of the intervention. These included autonomic neuropathy, prolonged hospitalisation, prolonged monoparesis, pulmonary oedema, wound infection, device extrusion and one death resulting from subdural haematoma. </p> <p><b><i>Other</i> </b> </p> <p>No studies reported the incidence of other adverse events at short‐term follow‐up. We found no clear evidence of a difference in otherAEs at medium‐term (2 studies, N = 278, RD ‐0.05, 95% CI ‐0.16 to 0.06, I<sup>2</sup> 0%) or long term (1 study, N = 100, RD ‐0.17, 95% CI ‐0.37 to 0.02) follow‐up. </p> <p>Very limited evidence suggested that SCS increases healthcare costs. It was not clear whether SCS was cost‐effective. </p> </section> <section id="CD013756-sec-0007"> <h3 class="title" id="CD013756-sec-0007">Authors' conclusions</h3> <p>We found very low‐certainty evidence that SCS may not provide clinically important benefits on pain intensity compared to placebo stimulation. We found low‐ to very low‐certainty evidence that SNMD interventions may provide clinically important benefits for pain intensity when added to conventional medical management or physical therapy. SCS is associated with complications including infection, electrode lead failure/migration and a need for reoperation/re‐implantation. The level of certainty regarding the size of those risks is very low. SNMD may lead to serious adverse events, including death. We found no evidence to support or refute the use of DRGS for chronic pain. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013756-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013756-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013756-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013756-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013756-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013756-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013756-abs-0010">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013756-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013756-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD013756-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013756-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013756-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013756-abs-0002" lang="en"> <h3>What are the benefits and risks of electrical spinal cord and dorsal root ganglion stimulation for the treatment of chronic pain in adults? </h3> <p><b>Why this question is important</b> </p> <p>Persistent (chronic) pain is a common problem that affects people from all walks of life. It can be the result of a wide range of different medical conditions and is sometimes unexplained, but it often causes substantial suffering, distress and disability and can have major impacts on a person's quality of life. </p> <p>Implanted spinal neuromodulation (SNMD) interventions involve surgically implanting wires (electrodes) into the space around nerves or the spinal cord that are connected to a "pulse generator" device which is usually implanted under the patient's skin. This delivers electrical stimulation to the nerves or spinal cord. It is thought that this stimulation interferes with danger messages being sent to the spinal cord and brain with the goal of reducing the perception of pain. Once implanted with a SNMD device people live with the device implanted, potentially on a permanent basis. We reviewed the evidence to find out whether these interventions were effective at reducing pain, disability and medication use, at improving quality of life and to find out the risk and type of complications they might cause. There are two broad types of SNMD: spinal cord stimulation (SCS), where electrodes are placed near the spinal cord and dorsal root ganglion stimulation (DRGS) where electrodes are placed near the nerve root, where the nerve branches off from the spinal cord. </p> <p><b>How we identified and assessed the evidence</b> </p> <p>First, we searched for all relevant studies in the medical literature. We then compared the results, and summarised the evidence from all the studies. Finally, we assessed the certainty of the evidence. We considered factors such as the way studies were conducted, study sizes, and consistency of findings across studies. Based on our assessments, we rated the evidence as being of very low, low, moderate or high certainty. </p> <p><b>What we found</b> </p> <p>We found 15 published studies that included 908 people with persistent pain due to a variety of causes including nerve disease, chronic low back pain, chronic neck pain and complex regional pain syndrome. All of these studies evaluated SCS; no studies evaluated DRGS. </p> <p>Eight studies (that included 205 people) compared SCS with a sham (placebo) stimulation, where the electrodes were implanted, but no stimulation was delivered. Six studies that included 684 people compared SCS added with either medical management or physical therapy with medical management or physical therapy on its own. We rated the evidence as being of low, or very low certainty. Limitations in how the studies were conducted and reported, the amount of evidence we found and inconsistency between studies in some instances means that our confidence in the results is limited. </p> <p>The evidence suggests the following.</p> <p>Compared to receiving medical management or physical therapy alone, people treated with the addition of SCS may experience less pain and higher quality of life after one month or six months of stimulation. There is limited evidence to draw conclusions in the long term of one year or more. It is unclear whether SCS reduces disability or medication use. </p> <p>Compared to a sham (placebo) stimulation, SCS may result in small reductions in pain intensity in the short term that may not be clinically important, but this is currently unclear. There is no evidence at medium or long‐term follow‐up points. </p> <p>SCS can result in complications. These include movement or malfunction of the electrode wires, wound infections and the need for further surgical procedures to fix issues with the implanted devices. We also found instances of serious complications that included one death, nerve damage, lasting muscle weakness, lung injury, serious infection, prolonged hospital stay and the extrusion of a stimulation device through the skin. </p> <p>Very limited evidence around the costs and economics of SCS suggested that SCS increases the costs of healthcare. It was not clear whether SCS was cost‐effective. </p> <p><b>What this means</b> </p> <p>SCS may reduce pain intensity in people with chronic pain. It is currently not clear how much of this effect is due to the SCS itself and how much is due to so‐called "placebo" effects, which are the result of the experience of undergoing the procedure and the person's expectations that it will help them. Receiving SCS does present a risk of relatively common complications and less common serious complications. We are currently unsure of the precise degree of this risk. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The evidence in this review is current to September 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013756-sec-0134" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013756-sec-0134"></div> <h3 class="title" id="CD013756-sec-0135">Implications for practice</h3> <section id="CD013756-sec-0135"> <section id="CD013756-sec-0136"> <h5 class="title">For people with chronic pain</h5> <p>There is low‐ to very low‐certainty evidence that implanted spinal cord stimulation (SCS) devices provide clinically important benefits for pain intensity and benefits on health‐related quality of life (HRQoL) when added to conventional medical management or physical therapy. However, we also found very low‐certainty evidence that SCS may not provide clinically important benefits on pain intensity or HRQoL when compared with placebo (sham) stimulation. These findings raise questions about how much of the observed benefits of SCS may result from the stimulation itself and how much may be the result of the contextual effects of receiving this complex, expensive and invasive intervention. SCS can result in relatively common complications such as infection, electrode lead failure or migration and a need for further surgical procedures. We found instances of serious adverse events (SAEs)resulting from unintended neurological injury including one death, but were not able to accurately estimate the risk of these. We found no clear evidence of benefit from SCS for disability or medication use. The low to very low certainty of our findings means that our confidence in them is limited. We found no evidence at all to support or refute the use of dorsal root ganglion stimulation (DRGS) for chronic pain. </p> </section> <section id="CD013756-sec-0137"> <h5 class="title">For clinicians</h5> <p>We found very low‐certainty evidence that SCS may not provide clinically important benefits on pain intensity when compared to a sham (placebo) stimulation and low‐ to very low‐certainty evidence that SCS when added to medical care or physical therapy may provide clinically important benefits for pain intensity and health‐related quality of life (HRQoL) for people with persistent pain, but no clear evidence for a beneficial effect for disability or medication use. SCS can result in complications such as infection, electrode lead failure or migration and a need for further surgical procedures. We found instances of SAEs resulting from unintended neurological injury including one death, but were not able to accurately estimate the risk of these. The low to very low certainty of our findings means that our confidence in them is limited. We found no evidence to support or refute the use of DRGS for chronic pain. </p> </section> <section id="CD013756-sec-0138"> <h5 class="title">For policymakers and funders of the intervention</h5> <p>We found very low‐certainty evidence that SCS may not provide clinically important benefits on pain intensity when compared to a sham (placebo) stimulation and low‐ to very low‐certainty evidence that SCS when added to medical care or physical therapy may provide clinically important benefits for pain intensity and HRQoL for people with persistent pain, but no clear evidence for a beneficial effect for disability or medication use. SCS can result in complications such as infection, electrode lead failure or migration and a need for further surgical procedures. We found instances of SAEs resulting from unintended neurological injury including one death, but were not able to accurately estimate the risk of these. The low to very low certainty of our findings means that our confidence in them is limited. We found limited economic evidence, but the included evidence suggests that SCS is associated with substantial additional healthcare costs, which are dominated by the costs of the device/apparatus and the implantation processes and the costs of managing complications. The only cost‐effectiveness analysis that we included suggested that the cost‐effectiveness of SCS was uncertain at willingness to pay thresholds of both 20,000 to 80,000 Euros perQuality Adjusted Life Years (QALY). We found no evidence at all to support or refute the use of DRGS for chronic pain. While some guidelines make recommendations for spinal neuromodulation (SNMD) interventions for selected participants with chronic pain, they do not specifically consider the uncertainty around clinical benefit compared to placebo stimulation based on current evidence (<a href="./references#CD013756-bbs2-0090" title="Medical Advisory Secretariat, Ministry of Health and Long-term Care (MoH-LTC).Spinal cord stimulation for neuropathic pain. An evidence based analysis. Ontario Health Technology Assessment Series2005;5(4):1-78.">MoH‐LTC 2005</a>; <a href="./references#CD013756-bbs2-0093" title="National Institute of Health and Care Excellence (NICE).Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. Technology appraisal guidance (TA159). www.nice.org.uk/guidance/ta1592008;(accessed 5 February 2020).">NICE 2008</a>; <a href="./references#CD013756-bbs2-0094" title="National Institute for Health and Care Excellence (NICE).Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. Medical technologies guidance (MTG41). www.nice.org.uk/guidance/mtg412019;(accessed 5 February 2020).">NICE 2019</a>). </p> </section> </section> <h3 class="title" id="CD013756-sec-0139">Implications for research</h3> <section id="CD013756-sec-0139"> <section id="CD013756-sec-0140"> <h5 class="title">General</h5> <p>We have identified that a key area of uncertainty is whether SCS provides clinically important benefits versus placebo. To reduce uncertainty around this question there is a need for larger studies. It can be argued that further small, short‐term cross‐over studies, of the type that dominate the ongoing studies we have identified for this comparison are unlikely to meaningfully improve certainty. Instead, larger parallel trials, that compare SNMD approaches with placebo for a more clinically relevant time period and that fully report both important efficacy outcomes and adverse effects are needed. In our search for ongoing studies we identified one trial with this type of design in people with chronic low back pain (<a href="./references#CD013756-bbs2-0050" title="Al-KaisyA , RoydsJ , PalmisaniS , PangD , WesleyS , TaylorR , et al.Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol. Trials2020;21:1-13. ">MODULATE‐ LBP</a>, N = 96) but arguably further such trials are needed, and in a broader range of conditions. While further open‐label studies of SNMD might improve the precision of our estimates of effectiveness they will not reduce the uncertainty around the important question of the mechanisms of observed effects. </p> <p>The field has generated and might continue to develop and promote novel forms of stimulation with claims of superior efficacy. There is currently uncertainty surrounding the efficacy of all existing forms of SNMD. There is a need to establish clear evidence of efficacy for all forms of SCS over placebo. Until there is compelling evidence for the efficacy of existing forms of SNMD any novel stimulation approach should also be validated by comparison with placebo. Future trials should include a formal analysis of healthcare and non‐healthcare costs with long‐term time horizons and conduct formal cost‐effectiveness analysis. Future studies should also be clear as to whether or not participants are recruited on the basis of pain of suspected neuropathic nature and clearly report the approaches used to establish that. If efficacy (versus placebo) is established with certainty then it would be valuable to study how SNMD interventions impact on supported self‐management of persistent pain. </p> <p>The evidence base is dominated by industry‐sponsored studies and there is a high rate of authors' declarations of industry relationships. Publicly‐funded trials, independent of industry involvement would improve confidence in this evidence base. There is an urgent need to improve the audit trail and transparency for trials in this field with pre‐registration and regular updating of trial status in the registries, routine availability of study protocols and statistical analysis plans, and posting results in the trials registries. Given the apparent trade‐off between clinical benefits and potentiallySAEs there would be value in further formal evaluation of patient preferences. These should be conducted independently of industry involvement. </p> </section> <section id="CD013756-sec-0141"> <h5 class="title">Design</h5> <p>Placebo‐controlled trials in this, as in all surgical fields, are challenging but can be feasible (<a href="./references#CD013756-bbs2-0111" title="WartolowskaK , CollinsGS , HopewellS , JudgeA , DeanBJ , RombachI , et al.Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review. BMJ Open2016;15(5 (3)):e010194.">Wartolowska 2016</a>). There are specific challenges for SNMD trials that require careful attention, relating to threats to participant blinding associated with the handheld programming units, battery recharging requirements and the presence of paraesthesias (the latter particularly with conventional stimulation). In a recent consensus exercise which aimed to identify important elements for successful sham controls for physical interventions, <a href="./references#CD013756-bbs2-0063" title="BraithwaiteFA , WaltersJL , MoseleyGL , WilliamsMT , McEvoyMP .Towards more credible shams for physical interventions: A Delphi survey. Clinical Trials2020;17(3):295-305.">Braithwaite 2020</a> found that essential strategies centred around maintaining the credibility of the sham by adhering to expectations and beliefs of participants using clinical interactions, professional behaviours, trial information and environmental setup, whereas exact replication of the intervention itself did not feature as strongly. This suggests that careful consideration needs to be given to the broader clinical interaction in sham‐controlled trials of SCS to maximise the credibility of the sham condition. For all sham‐controlled studies a formal assessment of the success of blinding and/or the credibility of sham controls should be considered essential. </p> <p>The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), the Institute of Neuromodulation (ION), and the International Neuromodulation Society (INS) have recently published recommendations (<a href="./references#CD013756-bbs2-0083" title="KatzN , DworkinRH , NorthR , ThomsonS , EldabeS , HayekSM , et al.Research design considerations for randomized controlled trials of spinal cord stimulation for pain: IMMPACT/ION/INS recommendations. Pain2021;162(7):1935-56.">Katz 2021</a>) on the design, conduct, analysis, and interpretation of RCTs of SCS for chronic pain and many of their recommendations are closely aligned with ours. Specifically, they recommend trials disclose all funding sources and potential conflicts; incorporate mechanistic objectives when possible; avoid non‐inferiority designs without internal demonstration of assay sensitivity; achieve and document double‐blinding whenever possible; document investigator and site experience; keep all information provided to patients balanced with respect to the expectation of benefit; disclose all information provided to patients, include verbal scripts; use placebo/sham controls when possible; account for ancillary pharmacologic and nonpharmacologic treatments in a clear manner; provide a complete description of intended and actual programming interactions; make a prospective ascertainment of SCS‐specific safety outcomes; train patients and researchers on appropriate expectations, outcome assessments, and other key aspects of study performance; and provide transparent and complete reporting of results according to applicable reporting guidelines. Future trial reports should fully comply with CONSORT (<a href="./references#CD013756-bbs2-0103" title="SchulzKF , AltmanDG , MoherD , for the CONSORT Group.CONSORT 2010 Statement: updated guidelinesfor reporting parallel group randomised trials. BMJ2010;340:c332.">Schulz 2010</a>). </p> </section> <section id="CD013756-sec-0142"> <h5 class="title">Outcome assessment</h5> <p>Future trials must include measurement of outcomes known to be important to people with chronic pain. <a href="./references#CD013756-bbs2-0083" title="KatzN , DworkinRH , NorthR , ThomsonS , EldabeS , HayekSM , et al.Research design considerations for randomized controlled trials of spinal cord stimulation for pain: IMMPACT/ION/INS recommendations. Pain2021;162(7):1935-56.">Katz 2021</a> recommend the following core domains: pain intensity, physical function, emotional functioning, global improvement or satisfaction, concomitant and rescue medications, patient disposition to treatment, sleep and fatigue, health‐related quality of life, costs and cost‐effectiveness. There is a need for improvement in the methodology and reporting of adverse events. Careful, long‐term active surveillance for known complications of SCS is essential and should include all cases of neurological injury and any resultant SAEs. The nature and incidence of all AEs should be reported in full. In addition to clinical trials, there would be value in the establishment of national and international clinical registries to allow more comprehensive surveillance of safety outcomes for these interventions. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013756-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013756-sec-0008"></div> <div class="table" id="CD013756-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Active stimulation vs placebo (sham)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Active Stimulation versus placebo for chronic pain in adults</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Patient or population:</b> adults with chronic pain </p> <p><b>Settings:</b> secondary care </p> <p><b>Intervention/comparison:</b> SCS vs placebo (sham stimulation) </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Probable outcome with SNMD</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with sham</b> </p> </td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of participants</b> <b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Short‐term follow‐up (reported within the first month )</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity continuous outcomes. (VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity was 8.73 points lower (95%CI ‐15.67, ‐1.78) than in the control group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean post‐intervention pain score in sham group. 55.8 (95%CI 43.3, 64.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Medium term follow‐up (reported between 3 and 6 months)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes(VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Long term follow‐up (reported at 1 year or longer greater than 1 year)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Need for reoperation/reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval; <b>SNMD:</b> Spinal neuromodulation<b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Lowcertainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1.</sup> downgraded twice for serious study limitations, once for imprecision, once for inconsistency and once for the potential for publication bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013756-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Active stimulation + other intervention vs other intervention alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Active stimulation + other intervention versus other intervention alone for chronic pain in adults (open label studies).</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Patient or population:</b> adults with chronic pain </p> <p><b>Settings:</b> secondary care </p> <p><b>Intervention/comparison:</b> SCS + other intervention (medical management or physical therapy) vs other intervention alone </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effects (Risk Ratio (RR) 95%CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Risk with SNMD + other interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Risk with other intervention alone</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Short‐term follow‐up (reported within the first month )</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity continuous outcomes. (VAS 0‐100, higher scores = worse pain)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 37.41 points lower (95% CI ‐46.39 to ‐28.42) than in the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean post‐intervention pain score in control group was 69.3 (95%CI 68‐72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 15.90 (95%CI 6.70, 37.74)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69.6%</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>249 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 65% more participants with SCS (95%CI 57, 74)</p> <p>NNTB 1.5 (95%CI 1.4, 1.8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Medium‐term follow‐up (reported between 4 and 8 months)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100, higher scores = worse pain)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 31.22 points lower (95% CI ‐47.34 to ‐15.10) than in the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean post‐intervention pain score in control group was 70.1 (95%CI 67, 73.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>635 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 7.08 (95%CI 3.40, 14.71)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>597 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 43% more participants with SCS (95%CI 14, 73)</p> <p>NNTB 2.3 (95%CI 1.4, 7.1)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse events:lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 3.02 (95%CI 0.52, 17.58)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>330 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 4% more participants with SCS (95%CI 4% fewer, 11% more)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events:infection</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 4.83 (95%CI 1.09, 21.40)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>548 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 4% more participants with SCS (95%CI 1, 7)</p> <p>NNTH 25 (95%CI 14, 100)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 9.79 (95%CI 2.35, 40.76)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>548 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 11% more participants with SCS (95%CI 2, 21)</p> <p>NNTH 9 (95%CI 4.8, 50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.87 (95%CI 0.64, 1.30)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>278 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 5% fewer participants with SCS (95%CI 16% fewer, 6% more)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Long‐term follow‐up (reported at 1 year or longer greater than 1 year)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100, higher scores = worse pain) (5 years follow‐up) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 7 points lower than in the control group (95% CI ‐‐24.76 to 10.76 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain intensity reduced from baseline in the control group by ‐10 (95%CI ‐18, 2) points.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief. (2‐year follow up)<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 15.15 (95%CI 2.11, 108.91)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>87 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 35% more participants with SCS (95%CI 20, 49)</p> <p>NNTB 2.9 (95%CI 2, 5)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 15.31 (95%CI 0.99, 237.16)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 55% more participants with SCS (95%CI 35, 75)</p> <p>NNTH 1.8 (95%CI 1.3, 2.9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: need for reoperation/reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 25.81 (95%CI 1.69, 393.31)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 94% more participants with SCS (95%CI 80, 107)</p> <p>NNTH 1.05 (95%CI 0.93, 1.25)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 0.66 (95%CI 0.42, 1.05)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 17% fewer participants with SCS (95%CI 37% fewer to 2% more)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>* Control group risk estimates come from pooled estimates of control groups.</p> <p><b>CI:</b> confidence interval; <b>SNMD:</b> Spinal neuromodulation<b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> downgraded once for study limitations, imprecision and inconsistency </p> <p><sup>2</sup> downgraded for twice for serious study limitations and once for imprecision </p> <p><sup>3</sup> downgraded once for study limitations and once for inconsistency </p> <p><sup>4</sup> downgraded once for study limitations and once for imprecision </p> <p><sup>5</sup> downgraded twice for serious study limitations, once for imprecision and once for inconsistency </p> <p><sup>6</sup> downgraded once for study limitations and twice for serious imprecision </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013756-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013756-sec-0009"></div> <section id="CD013756-sec-0010"> <h3 class="title" id="CD013756-sec-0010">Description of the condition</h3> <p>Chronic pain is a common problem. Global burden of disease data indicate that chronic pain is a leading cause of years lived with disability, with painful conditions comprising 4 of 10 leading causes of disability in both developed and developing countries (<a href="./references#CD013756-bbs2-0102" title="RiceAS , SmithBH , BlythFM .Pain and the global burden of disease. Pain2016;157(4):791-6.">Rice 2016</a>; <a href="./references#CD013756-bbs2-0110" title="VosT , BarberRM , BellB , Bertozzi-VillaA , BiryukovS , BolligerI , et al.Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet2015;386(9995):743-800.">Vos 2015</a>). Chronic pain impacts the physical and mental health and quality of life of those who experience it (<a href="./references#CD013756-bbs2-0092" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ .The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79-94.">Moore 2014</a>; <a href="./references#CD013756-bbs2-0108" title="SylwanderC , LarssonI , AnderssonM , BergmanS .The impact of chronic widespread pain on health status and long-term health predictors: a general population cohort study. BMC Musculoskeletal Disorders2020;6(21 (1)):36. [DOI: 10.1186/s12891-020-3039-5.]">Sylwander 2020</a>), but it also has a substantial economic impact on society, in terms of reduced productivity, participation, and healthcare utilisation (<a href="./references#CD013756-bbs2-0077" title="GaskinDJ , RichardP .The economic costs of pain in the United States. Journal of Pain2012;13(8):715-24.">Gaskin 2012</a>; <a href="./references#CD013756-bbs2-0079" title="GustavssonJ , BjorkmanJ , LjungcrantzC , RhodinA , Rivano-FischerM , SjolundKF , et al.Socio-economic burden of patients with a diagnosis related to chronic pain - register data of 840,000 Swedish patients. European Journal of Pain2012;16(2):289-99.">Gustavsson 2012</a>). </p> <p>Chronic pain is a heterogenous phenomenon with a wide variety of potential causes. These include nociceptive pain conditions, in which there is clear evidence of ongoing peripheral tissue pathology, such as rheumatoid arthritis; neuropathic pain, in which the pain arises as a result of identifiable nerve injury or disease, for example diabetic neuropathy; and many other chronic pain problems, such as fibromyalgia and chronic low back pain, in which the relationship between peripheral tissue pathology and clinical symptoms is less clear. In 2016, the term 'nociplastic pain' was added to the International Association for the Study of Pain (IASP) taxonomy of pain in an attempt to classify this latter group (<a href="./references#CD013756-bbs2-0085" title="KosekE , CohenM , BaronR , GebhartGF , MicoJA , RiceAS , et al.Do we need a third mechanistic descriptor for chronic pain states?Pain2016;157(7):1382-6. [DOI: 10.1097/j.pain.0000000000000507]">Kosek 2016</a>). It is likely that different mechanisms underpin these different types of chronic pain, though current understanding of those mechanisms is incomplete (<a href="./references#CD013756-bbs2-0098" title="OssipovMH , PoreccaF .Chronic pain: multiple manifestations, multiple mechanisms. Drug discovery today. Disease mechanisms2006;3(3):301-3.">Ossipov 2006</a>; <a href="./references#CD013756-bbs2-0109" title="VardehD , MannionR , WolffCJ .Toward a mechanism-based approach to pain diagnosis. Journal of Pain2016;17(9 Suppl 2):T50-69.">Vardeh 2016</a>). In 2019, chronic pain was formally classified in the International Classification of Diseases (ICD‐11) under the categories of 'chronic primary pain', characterised by disability or emotional distress not attributable to another diagnosis, and 'chronic secondary pain', when the pain is a symptom of an identifiable underlying condition (<a href="./references#CD013756-bbs2-0071" title="Detlef-TreedeR , RiefW , BarkeA , AzizQ , BennettMI , BenolielR , et al.Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). Pain2019;160(1):19-27.">Detlef‐Treede 2019</a>). </p> </section> <section id="CD013756-sec-0011"> <h3 class="title" id="CD013756-sec-0011">Description of the intervention</h3> <p>Electrical stimulation of neural structures, commonly labelled 'neuromodulation', is becoming an increasingly common intervention for the treatment of chronic pain. In this review, we will focus on neuromodulation procedures that stimulate the spinal cord or the nerve roots that arise directly from the spinal cord, which involve the implantation of electrodes into the epidural space around the spinal cord (spinal cord stimulation (SCS)) or dorsal root ganglion (dorsal root ganglion stimulation (DRGS)). Electrodes can be implanted either surgically or percutaneously. These electrodes remain <i>in situ</i>, and are connected to a portable battery‐powered stimulation unit 'pulse generator' that is either implanted under the skin or worn by the person, and delivers electrical stimulation to the neural structures. The procedure usually consists of a trial phase, with temporary electrode leads attached to an external wearable device, followed by the implantation of permanent electrode leads attached to a pulse generator that is implanted under the skin (<a href="./references#CD013756-bbs2-0099" title="PatelVB , WassermanR , ImaniF .Interventional therapies for chronic low back pain: a focused review (efficacy and outcomes). Anaesthesia and Pain Medicine2015;22(5):e29716.">Patel 2015</a>). </p> <p>There are various types of spinal neuromodulation devices (SNMDs), and approaches may differ in terms of the surgical approach taken, the neural structures targeted, the device and equipment, and the parameters of electrical stimulation delivered to the tissues. While novel approaches to stimulation continue to be reported, current stimulation parameters can be classified into the following broad categories (<a href="./references#CD013756-bbs2-0105" title="SdrullaAD , GuanY , RajaSN .Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Practice2018;18(8):1048-67.">Sdrulla 2018</a>). </p> <p> <ul id="CD013756-list-0001"> <li> <p>Conventional stimulation: involves the delivery of a tonic pulse, at a constant stimulation frequency between 40 Hz and 80 Hz, with a fixed pulse width. </p> </li> <li> <p>High frequency stimulation: involves the delivery of a tonic pulse, at a frequency between 1 kHz and 10 kHz, with a fixed pulse width. </p> </li> <li> <p>Burst stimulation: involves the delivery of intermittent trains of stimulation, though the stimulation parameters may vary. </p> </li> </ul> </p> <p>High frequency and burst stimulation approaches differ from conventional stimulation approaches, as they do not induce paraesthesia (tingling) sensations. This potentially improves the tolerability of the intervention, and offers the advantage of allowing the use of sham stimulation under blinded conditions as a comparator in clinical trials, to control for placebo effects (<a href="./references#CD013756-bbs2-0084" title="KjaerSW , RiceAS , WartolowskaK , VaseL .Neuromodulation: more than a placebo effect?Pain2019;161(3):491-5.">Kjaer 2019</a>). Spinal neuromodulation interventions are typically offered to people whose pain has been refractory to other interventions. They may include pharmacological, surgical, rehabilitation, or a combination of approaches. </p> </section> <section id="CD013756-sec-0012"> <h3 class="title" id="CD013756-sec-0012">How the intervention might work</h3> <p>The fundamental rationale common to all spinal neuromodulation approaches is that the stimulation of neural tissue may impact the processing of nociceptive input from nerve fibres from the painful body area, may alter the excitability (readiness to fire) of nerve cells in the target region, and may have upstream or downstream effects on neural activity in related structures in both the peripheral and central nervous system (<a href="./references#CD013756-bbs2-0082" title="JensenMP , BrownstoneRM .Mechanisms of spinal cord stimulation for the treatment of pain: still in the dark after 50 years. European Journal of Pain2019;23(4):652-9.">Jensen 2019</a>; <a href="./references#CD013756-bbs2-0105" title="SdrullaAD , GuanY , RajaSN .Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Practice2018;18(8):1048-67.">Sdrulla 2018</a>). It is proposed that neuromodulation techniques can reduce pain by altering the behaviour of the structures that are involved in the generation of the experience of pain. The precise mechanisms by which neuromodulation techniques might reduce pain are not known, and debate continues on which specific nerve structures are activated by SNMD, or which are optimal to achieve the greatest pain relief (<a href="./references#CD013756-bbs2-0066" title="CaylorJ , ReddyR , YinS , CuiC , HuangM , HuangC , et al.Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action. Bioelectronics in Medicine2019;5:12. [DOI: 10.1186%2Fs42234-019-0023-1]">Caylor 2019</a>; <a href="./references#CD013756-bbs2-0082" title="JensenMP , BrownstoneRM .Mechanisms of spinal cord stimulation for the treatment of pain: still in the dark after 50 years. European Journal of Pain2019;23(4):652-9.">Jensen 2019</a>; <a href="./references#CD013756-bbs2-0105" title="SdrullaAD , GuanY , RajaSN .Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Practice2018;18(8):1048-67.">Sdrulla 2018</a>). It is proposed that DRGS and SCS may have distinct analgesic effects due to their respective direct actions on DRG nerve cells, or those in the dorsal column of the spinal cord (<a href="./references#CD013756-bbs2-0069" title="DeerTR , LevyRM , KramercJ , PoreedL , AmirdelfaneK , GrigsbyE , et al.Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain2017;158(4):669-81.">Deer 2017</a>; <a href="./references#CD013756-bbs2-0075" title="EspositoMF , MalayilR , HanesM , DeerT .Unique characteristics of the dorsal root ganglion as a target for neuromodulation. Pain Medicine2019;20(Suppl 1):S23-30.">Esposito 2019</a>). While it is possible that different stimulation locations (SCS or DRGS) or parameters (conventional, high frequency, or burst stimulation) might elicit clinical effects through distinct mechanistic pathways, this is yet to be convincingly demonstrated in mechanistic studies (<a href="./references#CD013756-bbs2-0105" title="SdrullaAD , GuanY , RajaSN .Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Practice2018;18(8):1048-67.">Sdrulla 2018</a>). </p> </section> <section id="CD013756-sec-0013"> <h3 class="title" id="CD013756-sec-0013">Why it is important to do this review</h3> <p>Implanted spinal neuromodulation interventions are becoming a common option for the treatment of chronic pain, particularly for people who have not improved with drug or non‐invasive therapies (<a href="./references#CD013756-bbs2-0100" title="PragerJ .Estimates of annual spinal cord stimulator implant rises in the United States. Neuromodulation2010;13(1):68-9.">Prager 2010</a>). In the Cochrane Library, there are no up‐to‐date reviews specifically focusing on these interventions for non‐cancer and non‐ischaemic pain. A 2013 overview of reviews of interventions for complex regional pain syndrome concluded that there was only very low‐quality evidence that SCS was effective for that condition, and that adverse events appeared to be frequent (<a href="./references#CD013756-bbs2-0097" title="O'ConnellNE , WandBM , McAuleyJ , MarstonL , MoseleyGL .Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database of Systematic Reviews2013, Issue 4. Art. No: CD009416. [DOI: 10.1002/14651858.CD009416.pub2]">O'Connell 2013</a>). </p> <p>In 2005, a review of health technology appraisals from the Ontario Ministry of Health and Long‐term Care concluded that weak‐to moderate‐quality evidence supported the use of SCS to decrease pain in neuropathic pain conditions (<a href="./references#CD013756-bbs2-0090" title="Medical Advisory Secretariat, Ministry of Health and Long-term Care (MoH-LTC).Spinal cord stimulation for neuropathic pain. An evidence based analysis. Ontario Health Technology Assessment Series2005;5(4):1-78.">MoH‐LTC 2005</a>). In the UK, the National Institute for Health and Care Excellence (NICE) recommended SCS for people with chronic pain of neuropathic origin who had not responded to conventional medical management, based on a technology appraisal, the searches for which have not been updated since 2014 (<a href="./references#CD013756-bbs2-0093" title="National Institute of Health and Care Excellence (NICE).Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. Technology appraisal guidance (TA159). www.nice.org.uk/guidance/ta1592008;(accessed 5 February 2020).">NICE 2008</a>). That appraisal considered no placebo‐controlled studies, and only two small trials in populations with failed back surgery syndrome and complex regional pain syndrome. In 2019, a new technology appraisal from NICE focused specifically on a proprietary high‐frequency spinal cord neuromodulation device (SENZA), and recommended the system for chronic neuropathic back or leg pain after failed back surgery, despite conventional medical management, based on limited evidence from two small trials with contradictory findings (<a href="./references#CD013756-bbs2-0094" title="National Institute for Health and Care Excellence (NICE).Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. Medical technologies guidance (MTG41). www.nice.org.uk/guidance/mtg412019;(accessed 5 February 2020).">NICE 2019</a>). In 2016, the European Academy of Neurology (EAN) guidelines on central neurostimulation therapy in chronic pain conditions, made a weak recommendation to add SCS to medical management in painful diabetic neuropathy, chronic post‐surgical back and leg pain, and complex regional pain syndrome (CRPS) type I, and recommended offering SCS instead of reoperation in chronic low back pain (<a href="./references#CD013756-bbs2-0067" title="CruccuG , Garcia-LarreaL , HanssonP , KeindlM , LefaucheurJP , PaulusW .EAN guidelines on central neurostimulation therapy in chronic pain conditions. European Journal of Neurology2016;23:1489-99.">Cruccu 2016</a>). They highlighted the quality of the evidence as a key issue. </p> <p>While these guidance documents have made recommendations for the use of these interventions, they have done so from a limited evidence base. Given the relative costs of the treatment, and its invasive nature, there is need for a rigorous, and up‐to‐date review of the efficacy, effectiveness, cost‐effectiveness, and safety of the full range of these interventions, completed to Cochrane standards. This review aims to provide valuable information for people with chronic pain who have been offered, or who are considering these interventions, clinicians who work with people with chronic pain, clinical guideline organisations, and policy makers. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013756-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013756-sec-0014"></div> <p>To evaluate the efficacy, effectiveness, adverse events, and cost‐effectiveness of implanted spinal neuromodulation interventions for adults with chronic pain. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013756-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013756-sec-0015"></div> <section id="CD013756-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013756-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) comparing implanted spinal neuromodulation devices with placebo (sham) stimulation, no treatment or usual care; or comparing SNMDs + another treatment versus that treatment alone. We included RCTs of parallel, cross‐over, or cluster design, because RCTs are the best design to minimise bias when evaluating the effectiveness of an intervention. </p> <p>We did not include quasi‐randomised studies or non‐randomised studies, due to the risk of bias inherent in such designs. We excluded non‐randomised studies, studies of experimental pain, case reports, and clinical observations. </p> </section> <section id="CD013756-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included participants ≥ 18 years old who were identified as having non‐cancer and non‐ischaemic pain of longer than three months duration. We excluded studies of people with cancer, or ischaemic‐related pain, or headache of any origin. We excluded studies in which average baseline (pre‐intervention) pain intensity levels in participants were less than 4/10 or 40/100. For studies in which only some participants met these inclusion criteria, we included these studies if data from participants who met the criteria were presented separately. </p> </section> <section id="CD013756-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies that used any electrical spinal neuromodulation technique that involves the implanting of electrodes in the epidural space around the spinal cord (spinal cord stimulation (SCS)) or the dorsal root ganglion (dorsal root ganglion stimulation (DRGS)). We did not include interventions of peripheral nerve stimulation (of sites distal to the dorsal root) or transcutaneous stimulation procedures. </p> <p>Studies must have compared these procedures with either placebo (sham) stimulation, usual care, no treatment, or other treatments, or compared stimulation plus other treatments or usual care versus the same treatment or usual care alone. We did not include studies that compared one form of spinal neuromodulation with another, or compared different stimulation regimens using the same type of spinal neuromodulation. We considered the effectiveness of SCS and DRGS separately, because they differ by procedure, their proposed distinct analgesic effects, and mechanisms. </p> <p>The key comparisons of interests were:</p> <p> <ul id="CD013756-list-0002"> <li> <p>active stimulation versus placebo stimulation;</p> </li> <li> <p>active stimulation versus usual care or no treatment;</p> </li> <li> <p>active stimulation plus another intervention versus that intervention alone.</p> </li> </ul> </p> </section> <section id="CD013756-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD013756-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD013756-list-0003"> <li> <p>Pain intensity, measured using a visual analogue scale (VAS), numerical rating scale (NRS), verbal rating scale, or Likert scale. These must have been reported by the participant to be considered valid, and included. We presented and analysed primary outcomes as change on a continuous scale, or in a dichotomised format as the proportion of participants in each group who attained a predetermined threshold of improvement. For example, we judged cut‐points from which to interpret the likely clinical importance of (pooled) effect sizes according to criteria proposed in the IMMPACT consensus statement (<a href="./references#CD013756-bbs2-0073" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105-21.">Dworkin 2008</a>). Specifically, we judged reductions in pain intensity compared with baseline as follows: </p> <ol id="CD013756-list-0004"> <li> <p>≥ 30%: moderately important change;</p> </li> <li> <p>≥ 50%: substantially important change.</p> </li> </ol> </li> <li> <p>Adverse events (AEs; their nature, frequency, and the approach taken to record and classify them). Adverse events included, but were not limited to: electrode lead failure or displacement, infection, need for repeated implantation procedure(s). We treated them as separate outcomes, and included other AEs in an 'other' category. </p> </li> </ol> </p> </section> <section id="CD013756-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013756-list-0005"> <li> <p>Disability, measured by validated, self‐report questionnaires or scales, or functional testing protocols </p> </li> <li> <p>Analgesic medication use</p> </li> <li> <p>Health‐related quality of life, using any validated tool</p> </li> <li> <p>Health economic outcomes, including quality‐adjusted life‐years (QALYs), costs, health resource utilisation, and incremental cost‐effectiveness ratios (ICERS) </p> </li> </ol> </p> <p>The planned follow‐up time‐points were:</p> <p> <ul id="CD013756-list-0006"> <li> <p>during use: for trials that report during stimulation outcomes (most likely during the initial trial period of stimulation), we used the outcome reported closest to, but before the end of that period; </p> </li> <li> <p>short‐term: we used outcomes reported within the first month post permanent implantation. When multiple time points were reported in this timeframe, we took the closest to the implantation date; </p> </li> <li> <p>medium‐term: we used outcomes reported between four and eight months following permanent implantation. When multiple time points were reported in this timeframe, we took the latest date; </p> </li> <li> <p>long‐term: we used outcomes reported at one year or longer post‐implantation. When multiple time points were reported in this timeframe, we took the latest date. </p> </li> </ul> </p> <p>The distinction between "during use" and other time‐points was not possible to make and proved artificial in the context of the included studies, as outcomes were evaluated whilst stimulation was active at all time points. As a result, we restricted our analyses to short‐term, medium‐term and long‐term follow‐up. For cross‐over studies, follow‐up was measured from the point of the onset of stimulation. </p> </section> </section> </section> <section id="CD013756-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013756-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases from their inception, using a combination of controlled vocabulary, i.e. medical subject headings (MeSH), and free‐text terms to identify published articles: </p> <p> <ul id="CD013756-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library ‐Issue 10 of 12 2020; </p> </li> <li> <p>MEDLINE (Ovid) ‐1946 to21  Oct  2020;</p> </li> <li> <p>Embase (Ovid) ‐ 1980 to 2020 week 42;</p> </li> <li> <p>Web of Science (ISI) SCI‐EXPANDED, SSCI, CPCI‐S, CPCI‐SSH ‐1970 to 21‐10‐20;</p> </li> <li> <p>International HTA Database (<a href="https://database.inhata.org" target="_blank">https://database.inhata.org</a>) searched on 2/11/20; </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>). </p> </li> </ul> </p> <p>There were no language restrictions. All database searches were based on this strategy, but adapted to individual databases as necessary. We used medical subject headings (MeSH) or equivalent and text word terms. The search strategies can be found in <a href="./appendices#CD013756-sec-0147">Appendix 1</a>; <a href="./appendices#CD013756-sec-0148">Appendix 2</a>; <a href="./appendices#CD013756-sec-0149">Appendix 3</a>. </p> </section> <section id="CD013756-sec-0025"> <h4 class="title">Searching other resources</h4> <p>In addition, we checked reference lists of reviews and retrieved articles for additional studies. We contacted experts in the field for unpublished and ongoing trials. We contacted study authors for additional information when necessary. </p> </section> </section> <section id="CD013756-sec-0026"> <h3 class="title" id="CD013756-sec-0026">Data collection and analysis</h3> <section id="CD013756-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (NOC and WG) independently assessed the titles and abstracts of potential trials identified by the search strategy for their eligibility. We obtained the full text of studies we considered may be eligible, or if the eligibility of a study was unclear from the title and abstract. We excluded studies that did not match the inclusion criteria (see <a href="#CD013756-sec-0016">Criteria for considering studies for this review</a>). We resolved disagreements between review authors regarding a study's inclusion by discussion. If we could not reach agreement, we planned that a third review author would assess relevant studies, and a majority decision was made. This was not found to be necessary. We did not anonymise studies prior to assessment. We included a PRISMA study flow diagram to document the screening process (<a href="./references#CD013756-bbs2-0089" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine2009;6(7):e1000097.">Moher 2009</a>). </p> </section> <section id="CD013756-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (from NOC, MF, WG) independently extracted data from each included study using a standardised and piloted data extraction form. They resolved discrepancies and disagreements by consensus. In cases where consensus could not be achieved, we planned that a third review author assessed the trial for arbitration, and a majority decision was made. This was not found to be necessary. We extracted the following data from each study included in the review: </p> <p> <ul id="CD013756-list-0008"> <li> <p>country of origin;</p> </li> <li> <p>study design;</p> </li> <li> <p>study population (including diagnosis, diagnostic criteria used, symptom duration, age range, gender split, number, details of and reasons for participants excluded during the pre‐randomisation period, if used); </p> </li> <li> <p>concomitant treatments that may affect outcome: (medication, procedures, etc);</p> </li> <li> <p>sample size: active and control or comparator groups; loss to follow‐up, including number of people, characteristics, and reasons for withdrawal; </p> </li> <li> <p>intervention(s) (including type of spinal neuromodulation, device type and manufacturer, details of implantation methods and sites, including details of initial trial period (if any), stimulation parameters, e.g. frequency, intensity, duration, electrode type and position, clinical setting); </p> </li> <li> <p>type of placebo or comparator intervention;</p> </li> <li> <p>outcomes (primary and secondary) and time points assessed (only for the comparisons of interest to this review); </p> </li> <li> <p>declared industry sponsorship, study funding, author conflict of interest statements.</p> </li> </ul> </p> <p>We collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. We collected characteristics of the included studies in sufficient detail to populate a table of 'Characteristics of included studies'. </p> </section> <section id="CD013756-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (NOC and MF) independently assessed risk of bias for each study using the Cochrane risk of bias 2 (RoB 2) tool, using the criteria outlined in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, with any disagreements resolved by discussion (<a href="./references#CD013756-bbs2-0080" title="Higgins JP SavovićJ , PageMJ , ElbersRG , SterneJA .Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). In cases where consensus could not be achieved, we planned that a third review author would assess the trial for arbitration, and a majority decision made. This was not found to be necessary. </p> <p>We used the RoB 2 tool (<a href="./references#CD013756-bbs2-0107" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , Boutron I et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:I4898.">Sterne 2019</a>) to assess the risk of bias around the effect of assignment to the interventions (the intention‐to‐treat effect) for the following results, for DRGS and SCS separately. </p> <section id="CD013756-sec-0030"> <h5 class="title">Comparisons</h5> <p> <ul id="CD013756-list-0009"> <li> <p>Active stimulation versus placebo stimulation</p> </li> <li> <p>Active stimulation versus usual care or no treatment</p> </li> <li> <p>Active stimulation plus another intervention vs that intervention alone</p> </li> </ul> </p> </section> <section id="CD013756-sec-0031"> <h5 class="title">Outcomes</h5> <p> <ul id="CD013756-list-0010"> <li> <p>Pain intensity (continuous measures)</p> </li> <li> <p>Pain intensity (dichotomous measures)</p> </li> <li> <p>Adverse effects</p> </li> </ul> </p> </section> <section id="CD013756-sec-0032"> <h5 class="title">Time points</h5> <section id="CD013756-sec-0033"> <h6 class="title">For pain</h6> <p> <ul id="CD013756-list-0011"> <li> <p>Short term</p> </li> <li> <p>Mid term</p> </li> <li> <p>Long term</p> </li> </ul> </p> </section> <section id="CD013756-sec-0034"> <h6 class="title">For adverse events</h6> <p> <ul id="CD013756-list-0012"> <li> <p>Short term</p> </li> <li> <p>Medium term</p> </li> <li> <p>Long term</p> </li> </ul> </p> <p>The RoB 2 tool assesses the risk of bias in individual studies across the following domains: </p> <p> <ul id="CD013756-list-0013"> <li> <p>bias arising from the randomisation process;</p> </li> <li> <p>bias due to deviations from intended interventions;</p> </li> <li> <p>bias due to missing outcome data;</p> </li> <li> <p>bias in the measurement of the outcome; and</p> </li> <li> <p>bias in the selection of the reported results.</p> </li> </ul> </p> <p>For each domain, we followed the series of signalling questions outlined in the <i>Handbook</i>, and assigned a judgement of low risk of bias, some concerns, or high risk of bias. We planned to use interim guidance from the Cochrane Methods Support Unit to assess risk of bias for cluster‐RCTs but did not find any cluster trials. Since we planned to only take data from the first phase of cross‐over studies (see <a href="#CD013756-sec-0036">Unit of analysis issues</a>), we planned to assess them as though they were of parallel design. However, as first phase data were not available for any cross‐over studies we took the decision to analyse them as presented and used the ROB2 tool for cross‐over studies to assess this risk of bias. (<a href="https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2" target="_blank">https://www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2</a>). This tool adds a supplementary domain "Risk of bias arising from period and carryover effects" with its own set of signalling questions. </p> <p>When studies used a sham stimulation control as the comparator, as part of the RoB 2 domain 'bias due to deviations from intended interventions', we assessed the credibility of the sham condition, in terms of the likelihood that it was indistinguishable from the active stimulation condition and successfully blinded participants to the treatment condition. We rated the credibility of the sham used in sham‐ or placebo‐controlled studies as follows. </p> <p> <ul id="CD013756-list-0014"> <li> <p>Optimal: high frequency or burst (sub‐perceptual) stimulation is delivered, which would not be expected to induce sensation, and sham stimulation involves implantation of electrodes and the use of a stimulator device that is identical, and appears to be active, but does not induce stimulation. Formal evaluation should indicate that blinding was likely to have been successful. </p> </li> <li> <p>Suboptimal: stimulation occurs at a frequency that elicits sensation (e.g. paraesthesia), or is compared to a sham condition that is materially distinguishable from the active stimulation condition, or both. Stimulation for which aspects of the intervention other than sensations might compromise blinding, for example, if battery recharging requirements differ substantially between conditions, or sham stimulation for which a formal assessment or explicit report suggests that blinding was likely unsuccessful. </p> </li> </ul> </p> <p>We used these judgements to inform the judgements made on participant blinding. When we made a judgement of suboptimal, we subsequently made a judgement of yes or probably yes for the signalling question 2.1. Were participants aware of their assigned intervention during the trial? </p> <p>When evaluating the signalling question 2.2. Were carers and people delivering the interventions aware of participants' assigned intervention during the trial?, we considered whether the clinicians implanting the electrodes, involved in the perioperative process, or both, and follow‐up care of the participants were blind to the programmed stimulation parameters. </p> <p>We reached overall judgements of risk of bias as outlined in Chapter 8 of the <i>Handbook</i> (<a href="./references#CD013756-bbs2-0080" title="Higgins JP SavovićJ , PageMJ , ElbersRG , SterneJA .Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>): </p> <p> <ul id="CD013756-list-0015"> <li> <p>low risk of bias: the trial is judged to be at low risk of bias for all domains;</p> </li> <li> <p>some concerns: the trial is judged to raise some concerns for at least one domain, but not to be at high risk of bias for any domain; </p> </li> <li> <p>high risk of bias: the trial is judged to be at high risk of bias for at least one domain, or the trial is judged to have some concerns for multiple domains, in a way that substantially lowers confidence in the results. </p> </li> </ul> </p> <p>We used the 'RoB Excel' tool and word templates (available at <a href="http://riskofbias.info" target="_blank">riskofbias.info</a>) to record and manage RoB 2 assessments and processes, and we made available the full data related to this process on Figshare (DOI: 10.17633/rd.brunel.14838678). </p> </section> </section> </section> <section id="CD013756-sec-0035"> <h4 class="title">Measures of treatment effect</h4> <p>When data were available, we presented outcomes in a dichotomised format. For dichotomised data (responder analyses), we considered analyses based on a 30% or greater reduction in pain intensity to represent a moderately important benefit, and a 50% or greater reduction in pain intensity to represent a substantially important benefit, as suggested by the IMMPACT guidelines (<a href="./references#CD013756-bbs2-0073" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105-21.">Dworkin 2008</a>). When possible, we calculated risk ratio (RR) and risk difference (RD) with 95% confidence intervals (CIs) for dichotomised outcome measures. For device/procedure‐related adverse events, we prioritised the risk difference as there were zero events in the control arm. We calculated the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH) as an absolute measure of treatment effect. </p> <p>We planned to express the size of the treatment effect for pain intensity, measured with a Visual Analogue Scale (VAS) or = Numerical Rating Scale (NRS), using the mean difference (MD) when all studies utilised the same measurement scale. As all studies measured pain intensity on a 0 to 10 or 0 to 100 VAS or NRS, we normalised all scales to a 0 to 100 scale and expressed the effect size as the mean difference to aid interpretability. We planned to use the standardised mean difference (SMD) when studies used substantially different scales. When we pooled data from different scales for which the direction of interpretation varies, we normalised the direction of the scales to a common direction. </p> <p>The OMERACT 12 group has developed recommendations for establishing the minimal clinically important difference for pain outcomes (<a href="./references#CD013756-bbs2-0065" title="BusseJW , BartlettSJ , DougadosM , JohnstonBC , GuyattGH , KirwanJR , et al.Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 Workshop. Journal of Rheumatology2015;42(10):1962-70.">Busse 2015</a>). They recommend 10 mm on a 0 to 100 mm VAS as the threshold for minimal clinical importance for the mean between‐group difference. They advise this should be interpreted with caution, as it remains possible that estimates that fall just below this point may still reflect a treatment that benefits an appreciable number of people. We used this threshold, but interpret it in light of the certainty of the included evidence. </p> </section> <section id="CD013756-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>For studies with more than two eligible comparisons in a single meta‐analysis, we divided the number of participants in each arm by the number of comparisons included from that study to avoid double‐counting. For cluster‐RCTs, we planned to seek direct estimates of the effect from an analysis that accounted for the cluster design. When the analysis in a cluster trial did not account for the cluster design, we planned to use the approximately correct analysis approach, presented in the <i>Handbook</i> (<a href="./references#CD013756-bbs2-0080" title="Higgins JP SavovićJ , PageMJ , ElbersRG , SterneJA .Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). For cross‐over studies, we planned to only include data from the first phase of the study, when they were available. This is because it is theorised that spinal cord stimulation may elicit lasting effects beyond the period of stimulation, raising a high risk of carry‐over effects (<a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a>). As first‐phase, or phase‐by‐phase data were not available for any of the included cross‐over studies we took the decision to analyse these studies as presented. As we did not have access to individual patient data from any of these studies, we were unable to adjust for the paired nature of the data from these trials as recommended in the <i>Cochrane Handbook</i> (<a href="./references#CD013756-bbs2-0081" title="Higgins JPT EldridgeS , Li T (editors).Chapter 23: Including variants on randomized trials.. In: Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane, 2021.">Higgins 2021</a>). As such, while point estimates in this analysis should be accurate representations of the data it is possible that these analyses may be conservative, in terms of overestimating imprecision. </p> </section> <section id="CD013756-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>When there were insufficient data presented in the study report to enter into a meta‐analysis, we requested the missing data from the study authors. We preferentially calculated effect sizes derived from intention‐to‐treat analyses. We had planned to exclude studies rated at high risk of bias from the primary meta‐analyses, including those at risk of bias due to missing outcome data. However, all included studies were rated at high risk of bias on one or more domain of the ROB2 tool. </p> </section> <section id="CD013756-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We attempted to deal with clinical heterogeneity by combining studies that examined similar interventions. We did not combine studies that compared spinal neuromodulation techniques to usual care with studies that compared spinal neuromodulation techniques to sham within the same analysis. We assessed heterogeneity using the Chi² test to investigate the statistical significance of such heterogeneity, and the I² statistic to estimate the amount of heterogeneity. When significant heterogeneity (I² ≥ 50%, P &lt; 0.10) was present, we explored subgroup analyses, described in the section <a href="#CD013756-sec-0041">Subgroup analysis and investigation of heterogeneity</a>. </p> </section> <section id="CD013756-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>We considered the possible influence of small‐study biases on review findings. When possible, for studies that reported dichotomised outcomes, we tested for the possible influence of publication bias on each outcome, by estimating the number of participants in studies with no effect required to change the NNTB to an unacceptably high level (defined as an NNTB of 10), as outlined in <a href="./references#CD013756-bbs2-0091" title="MooreRA , BardenJ , DerryS , McQuayHJ .Managing potential publication bias. In: Systematic Reviews in Pain Research: Methodology Refined. Vol. 1. Seattle: IASP Press, 2008:1:15-23.">Moore 2008</a>. When continuous outcomes were reported, we planned to use funnel plots to visually explore small‐study biases when there were at least 10 studies in a meta‐analysis, and the included studies differed substantially in size. However, no analysis contained this number of unique studies. </p> <p>We identified the number of registered trials that have not been published or had results made available for this review, and report the number of participants that this represents. When results data were available in the trials registers, but there was no study report (published or made available by study authors upon request), we planned to exclude those data in the primary analyses, but conduct sensitivity analyses to evaluate how the inclusion of these data impacted our results and conclusions. </p> </section> <section id="CD013756-sec-0040"> <h4 class="title">Data synthesis</h4> <p>We pooled the results of included studies using Review Manager 5 (<a href="./references#CD013756-bbs2-0101" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5.Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We planned to conduct separate meta‐analyses for SCS and DRGS interventions using a random‐effects model, as there are likely to be a number of sources of clinical heterogeneity between the included studies. However, we identified no studies of DRGS that met our inclusion criteria. We performed analyses at the following follow‐up points: </p> <p> <ul id="CD013756-list-0016"> <li> <p>short term</p> </li> <li> <p>medium term</p> </li> <li> <p>long term</p> </li> </ul> </p> <p>In the primary analysis, we pooled data from studies regardless of the specific diagnosis, stimulation site, or parameters. When inadequate data were found to support statistical pooling, we conducted narrative synthesis of the evidence, based upon the same key comparisons. </p> </section> <section id="CD013756-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>When there was significant heterogeneity (I² ≥ 50%, P &lt; 0.10), we explored subgroup analyses by clinical population, stimulation site, and stimulation parameters. </p> <p>We planned to explore the effect of clinical condition, using the following distinct subgroups: </p> <p> <ul id="CD013756-list-0017"> <li> <p>neuropathic pain: studies that exclusively include participants with confirmed pain of neuropathic origin; </p> </li> <li> <p>non‐neuropathic pain: studies that exclusively include participants with pain of non‐neuropathic origin (including conditions that are not clearly neuropathic in origin); </p> </li> <li> <p>mixed populations: studies that include participants with both neuropathic and non‐neuropathic pain (including conditions that are not clearly neuropathic in origin). </p> </li> </ul> </p> <p>We planned to explore the effect of stimulation parameters, using the following distinct subgroups: </p> <p> <ul id="CD013756-list-0018"> <li> <p>conventional stimulation: the delivery of a tonic pulse, at a constant stimulation frequency between 40 Hz and 80 Hz, with a fixed pulse width; </p> </li> <li> <p>high‐frequency stimulation: the delivery of a tonic pulse, at a frequency between 1 kHz and 10 kHz, with a fixed pulse width; </p> </li> <li> <p>burst stimulation: the delivery of intermittent trains of stimulation.</p> </li> </ul> </p> <p>To explore whether there is a difference in mean effects between subgroups, we used the test for subgroup differences (<a href="./references#CD013756-bbs2-0068" title="DeeksJJ , HigginsJP , AltmanDG .Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Deeks 2020</a>). We were only able to do this for one comparison (<a href="./references#CD013756-fig-0002" title="">Analysis 1.1</a>) due to a lack of adequate data. </p> </section> <section id="CD013756-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>When sufficient data were available, we planned to conduct the following sensitivity analyses. </p> <p> <ul id="CD013756-list-0019"> <li> <p>Choice of meta‐analysis model: random‐effects models can produce inflated effect sizes in circumstances when many of the included studies are small. We explored this by repeating our analyses using a fixed‐effect model. </p> </li> <li> <p>Risk of bias: based on the overall ROB 2 judgement for studies, we planned to explore the impact of risk of bias for the primary analyses, by repeating the analyses and excluding studies rated at high risk of bias. As all studies were rated at high risk of bias for one or more domains we were not able to conduct this analysis. </p> </li> <li> <p>When results data are available in the trials registers, but there was no study report (published or made available by study authors upon request), we planned not include those data in the primary analyses, but to conduct sensitivity analyses to evaluate how the inclusion of these data impacts our results and conclusions. As we did not find any studies with data reported in the trial registry with no published study report we were unable to conduct this analysis. </p> </li> </ul> </p> <section id="CD013756-sec-0043"> <h5 class="title">Incorporating economic evidence</h5> <p>We developed a brief economic commentary based on current methods guidelines, to summarise the availability and principal findings of formal cost‐effectiveness analyses that were conducted as part of the identified RCTs (<a href="./references#CD013756-bbs2-0106" title="ShemiltI , AlukoP , GraybillE , CraigD , HendersonC , DrummondM , et al.Chapter 20: Economic evidence. In: JHiggins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Shemilt 2019</a>). This included reviewing the methods used, reporting data on costs per quality‐adjusted life‐year (QALY) for each treatment group, and reporting the incremental cost‐effectiveness ratio (ICER) for our comparisons of interest, when reported. We did not develop a new health economic model as part of this review. </p> </section> </section> <section id="CD013756-sec-0044"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>Two review authors (NOC<i>,</i> MF) independently used the GRADE system to rate the level of certainty of the evidence (<a href="./references#CD013756-bbs2-0104" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al, on behalf of the Cochrane GRADEing Methods Group (formerly Applicability and Recommendations Methods Group) and the Cochrane Statistical Methods Group.Chapter 14. 'Summary of findings’ tables and grading the certainty of the evidence. In: JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schünemann 2020</a>). </p> <p>The GRADE approach uses five considerations (limitations of studies, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence for each outcome, and uses the following criteria to describe the confidence in the evidence: </p> <p> <ul id="CD013756-list-0020"> <li> <p>high: we are very confident that the true effect lies close to that of the estimate of the effect; </p> </li> <li> <p>moderate: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different; </p> </li> <li> <p>low: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect; </p> </li> <li> <p>very low: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>We decreased the grade rating by one (‐ 1), two (‐ 2), or three (‐ 3) levels, up to a maximum of ‐ 3, (or very low) for any criteria, based on the level of concern it raises. </p> <section id="CD013756-sec-0045"> <h5 class="title">Summary of findings table</h5> <p>We planned to include Summary of findings tables to present the findings for the following comparisons: </p> <p> <ul id="CD013756-list-0021"> <li> <p>spinal cord stimulation versus placebo stimulation;</p> </li> <li> <p>spinal cord stimulation versus usual care or no treatment;</p> </li> <li> <p>dorsal root ganglion stimulation versus placebo stimulation;</p> </li> <li> <p>dorsal root ganglion stimulation versus usual care or no treatment.</p> </li> </ul> </p> <p>We included key information concerning the sum of available data on the following outcomes at short‐, medium‐and long‐term follow‐up, the magnitude of effect of the interventions examined, and the certainty of the evidence. </p> <p> <ul id="CD013756-list-0022"> <li> <p>Pain intensity (continuous measures)</p> </li> <li> <p>Pain intensity (dichotomous measures)</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> <p>For continuous outcomes, we presented the mean difference; for dichotomous outcomes, we presented the risk ratio, risk difference, and the NNTB or NNTH (where the 95% confidence intervals did not include' no effect'), with 95% confidence intervals. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013756-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013756-sec-0046"></div> <section id="CD013756-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD013756-sec-0048"> <h4 class="title">Results of the search</h4> <p>For a full description of our screening process, see the study flow diagram (<a href="#CD013756-fig-0001">Figure 1</a>). For a summary of the search results for this review see <a href="./appendices#CD013756-sec-0148">Appendix 2</a> and <a href="./appendices#CD013756-sec-0149">Appendix 3</a>. </p> <div class="figure" id="CD013756-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD013756-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <p>The main database searches were conducted in October 2020 and updated in September 2021 (see <a href="#CD013756-sec-0024">Electronic searches</a>) and retrieved 3553 records after de‐duplication. We excluded 3454 of those at the title and abstract screening stage. After full‐text screening of the remaining 99 records we excluded 21 records of 21 studies (see <a href="./references#CD013756-sec-0160" title="">Characteristics of excluded studies</a> and <a href="#CD013756-sec-0062">Excluded studies</a> for details). Two studies (<a href="./references#CD013756-bbs2-0038" title="MillerN , SebaharM , VallejoR , BinyaminR , LinS , Mekel-BobrovN .Optimization of stimulation location is essential to sub-perception SCS: results of a double-blind randomized placebo-controlled trial. In: Neuromodulation. Vol. 18. 2015:e99. ">Miller 2015</a>; <a href="./references#CD013756-bbs2-0039" title="MillerJ , SweetJA , BadjatiyaA , TanD .Paresthesia-free high-density SCS for postlaminectomy syndrome in a pre-screened population: A prospective, randomized, placebo-controlled study. In: Neuromodulation. Vol. 19 (3). 2016:e29. ">Miller 2016</a>) were awaiting classification as were only available as conference abstracts. This left 58 records describing 15 unique studies and 18 records of ongoing studies. </p> <p>We searched the trials registries in October 2020 and September 2021. Due to decreased functionality of the WHO registry related to the COVID pandemic we conducted a simplified search strategy of that registry. After deduplication our searches identified 930 records of which 889 were excluded on screening. This left 41 records, 11 of which were of published studies already identified and included, 20 were of ongoing studies, six were of studies identified as being terminated or withdrawn, and four studies were awaiting classification. </p> <p>The final review includes 15 unique published studies that randomised 908 participants in total, and 20 unique ongoing studies. </p> </section> <section id="CD013756-sec-0049"> <h4 class="title">Included studies</h4> <section id="CD013756-sec-0050"> <h5 class="title">Country of origin and number of sites</h5> <p>Studies were conducted in the UK (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>), Belgium (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>), the Netherlands (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>), Germany (<a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>), Poland (<a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>), Sweden (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>), and the USA (<a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>). There were four international studies. <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a> was conducted in centres in the Netherlands, Denmark, Belgium and Germany, <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> was conducted in Switzerland and the UK, <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> in Australia, Belgium, Canada, Italy, Israel, Spain and the UK and <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> in Belgium, Canada, Colombia, France, Germany, the Netherlands, Spain, the UK and the USA. </p> <p>Six studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) were conducted in a single centre. The number of centres in the remaining studies ranged from 2 (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) to 28 (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>). </p> </section> <section id="CD013756-sec-0051"> <h5 class="title">Study funding and author declarations of interest</h5> <p>Of the 15 included trials 11 declared some form of industry funding (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>). One study was funded by the Dutch Health Insurance council (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>), one by the host hospital (<a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>), one declared no external funding (<a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>), and one provided no information (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>). </p> <p>Ten studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) reported one or more authors with relationships with industry involved in SNMD technology. These took the form of non‐financial support, research funding, consultancies, stock options, honoraria, speakers fees and travel grants. <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> declared that the first author had obtained a patent for burst stimulation, which was being evaluated in that study. <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a> reported that authors had no financial interest to declare and <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> reported no information relating to author conflicts of interest. </p> </section> <section id="CD013756-sec-0052"> <h5 class="title">Study designs</h5> <p>We included nine cross‐over studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) with a total of 224 participants randomised. Study size ranged from 10 to 41 participants. Eight of these studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) compared various types of SCS (high‐frequency, burst, conventional stimulation) to a placebo stimulation condition and one study (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>) compared conventional stimulation with the stimulator switched off. Seven cross‐over studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) reported no washout period between stimulation conditions, while <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> reported a two‐day washout period and <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a> reported a nine‐day washout period. </p> <p>We included six parallel studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) with a total of 684 participants randomised. Study size ranged from 36 to 218 participants. Of these, five studies compared conventional SCS in addition to other forms of management with the other management alone, and one study (<a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>) compared high‐frequency SCS + conventional medical management with conventional medical management alone. </p> </section> <section id="CD013756-sec-0053"> <h5 class="title">Participants</h5> <p>All studies included both male and female participants. Across all trials 50% of participants were female. Across studies that reported the range, the age of participants ranged from 25 to 74 years. In studies that reported the mean or median age of participants, the age ranged from 37 to 61 years. </p> <p>Studies included participants with a range of painful conditions. Four studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>) included participants with failed back surgery syndrome (FBSS), and one study included participants with chronic low back pain with or without leg pain (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>). Of these one study (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>) mandated that leg pain was dominant over back pain in their inclusion criteria and two studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>, <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) required participants' back pain intensity to be greater than their leg pain intensity. Three studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) included participants with painful diabetic neuropathy, and two studies (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>) included participants with complex regional pain syndrome<b>(</b>CRPS) (though <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> used the older diagnostic label "reflex sympathetic dystrophy"). Three studies included participants with various diagnoses. Of these <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> included participants with FBSS, failed neck surgery syndrome (FNSS), myelopathy and myelomalacia, <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> included participants with CRPS and FBSS and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> included people with FBSS, peripheral neuropathy, diabetic neuropathic pain, multiple sclerosis (MS), and CRPS. One study (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>) included participants with irritable bowel syndrome. </p> <p>Four studies included participants on the basis of a diagnosis of neuropathic pain. These included the three studies in painful diabetic neuropathy (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) and two studies in FBSS (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>) which specified that participants suffered from neuropathic pain of radicular origin. In the <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> study, the neuropathic nature was checked clinically by investigation of the pain distribution, examination of sensory, motor and reflex changes with supporting clinical tests such as electromyography (EMG). One study (<a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>), included a mixed population of participants (CRPS, FBSS with predominant leg pain) with pain of neuropathic and non‐neuropathic origin, although did not describe how that distinction was made. One study in FBSS (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) reported that pain seemed to be neuropathic in nature in 84.4% of cases as indicated by the Neuropathic Pain questionnaire, Douleur Neuropathique 4 [DN4]. Two studies alluded to the neuropathic nature of the presenting pain in their reports but included conditions that are not necessarily neuropathic in nature such as CRPS, FBSS and FNSS (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>). These studies did not report any criteria or process for confirming a neuropathic mechanism. Three studies did not report or discuss the possible neuropathic nature of participants' pain (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>). </p> <p>The majority of studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) stated in their inclusion criteria that participant's pain must be refractory to previous treatments, though the details of those treatments varied. <a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> all included a minimum level of pain at baseline of at least the equivalent of between 4/10 and 6/10 on a visual analogue scale (VAS) in their inclusion criteria. Four studies included people already implanted with, and receiving SCS at the point of recruitment (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>;n<a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>). </p> <p>Across studies that reported baseline average pain levels for the pain that was the target of the intervention, these ranged from the equivalent of 4/10 to 8.2/10. Only three studies reported average baseline pain levels below 6/10 (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>). In these studies, participants were implanted with a spinal cord stimulator and were receiving conventional stimulation prior to enrolment in the study. Of those studies that reported the average duration of participants' painful symptoms (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) values ranged from 3 to 8.3 years, indicating longstanding pain. </p> </section> <section id="CD013756-sec-0054"> <h5 class="title">Interventions and comparisons</h5> <p>All the included trials investigated SCS. We found no eligible completed trials of dorsal root ganglion stimulation(DRGs). </p> <p>Of the cross‐over studies that compared different simulation parameters with placebo stimulation, five studies (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) compared conventional stimulation with sham, four studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>, <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>, <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>, <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) included a high‐frequency (HF) condition, allowing for a comparison of HF versus sham. Four studies (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) included a burst stimulation condition, allowing for a comparison of burst stimulation versus sham. Three studies (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>) included a stimulation condition (500 Hz) that did not fit into either our predefined categories for conventional or HF stimulation. Data from that condition were not included in this review. In these studies, the intervention period (first phase) for each stimulation condition ranged from one to six weeks per condition. All of these studies provided outcome data for short‐term follow‐up only. </p> <p>Of the five parallel studies that compared conventional SCS in addition to other forms of management with the other management alone, four studies compared the addition of SCS with medical management labelled as "conventional medical therapy" (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>), "best medical treatment (BMT)" (<a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), "optimal medical treatment (OMT)" (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) and "conventional medical management (CMM)" (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>) with medical management alone. In these studies, the duration of the spinal neuromodulation device (SNMD) intervention mirrored the maximum length of follow‐up, notwithstanding treatment discontinuations; as once implanted these interventions are intended to be used long term. The length of the follow‐up period in these studies ranged from six months to five years. </p> <p>The details of medical management were reported as follows. In the study by <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>, medication adjustments and other conventional pain treatments, such as physical therapy, were allowed at any time if required. The <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> study reported that OMM was individualised for each patient and optimised at each visit and could include a range of treatments including acupuncture, psychological/behavioural therapies, physiotherapy as well as invasive treatments such as spinal injection, nerve blocks, epidural adhesiolysis and neurotomies. The <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> study similarly reported that CMM could include a range of physical, psychological and drug treatments but not spinal surgery or intrathecal drug delivery. Drug therapies included opioids, non‐steroidal anti‐inflammatory drugs (NSAIDs), antidepressants, anticonvulsants/antiepileptics and other analgesic therapies (not defined). <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> reported that CMM may include a variety of non‐invasive or minimally‐invasive treatments that comprise the standard of care for neuropathic limb pain, including, but are not limited to, pharmacological agents, physical therapy, cognitive therapy, chiropractic care, nerve blocks, and other non‐invasive or minimally invasive therapies. <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> reported that BMT was based on international guidelines for the treatment of peripheral neuropathic pain but did not offer further detail. In the registry record for that study, the comparator was labelled "treatment as usual". </p> <p>One study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>) compared SCS in addition to physical therapy versus physical therapy alone. Physical therapy was administered for 30 minutes twice weekly and lasted for six months and consisted of a standardised programme of graded exercises designed to improve strength, mobility and function of the affected hand or foot. </p> <section id="CD013756-sec-0055"> <h6 class="title">Study blinding</h6> <p>All of the parallel studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) evaluated open‐label comparisons of SCS + another therapy versus the other therapy alone. As such, neither participants nor clinicians/providers were blinded to the interventions allocated. </p> <p>Eight of the cross‐over studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) employed a sham control during which no stimulation was delivered from the stimulator. <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> employed a low‐amplitude burst paradigm where standard stimulation with 0.1 mA bursts was used as this was expected to be subtherapeutic. This was labelled as a sham in the trial registry record, however, in the final published report was labelled as an active stimulation condition "low amplitude burst stimulation." In their discussion, <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> stated that the difference in amplitude between low (0.1 mA for every participant) and high amplitude (individually adjusted) burst stimulation was less than expected and only minimal in some participants. For this reason, they considered that low amplitude burst was most likely not subtherapeutic in all participants and it is more appropriate to call this form of stimulation low amplitude burst stimulation instead of sham. We have included this study as the sham condition was intended as a sham <i>a priori</i> and an alternative explanation for the lack of contrast in stimulation amplitude may be a lack of efficacy. </p> <p>For comparisons between conventional stimulation and sham (included by <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>), we rated blinding as suboptimal since conventional stimulation is associated with paraesthesia sensations and is thus distinguishable from sham. <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> compared HF stimulation to sham, reported equivalent battery recharging requirements and a formal assessment of blinding was not indicative of problems and so blinding was rated as optimal for this study/comparison. For the comparisons of HF or Burst stimulation to sham, included by <a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>, we rated blinding as suboptimal. While these stimulation frequencies are generally sub‐perceptual, no formal evaluation of the success of blinding was reported. </p> </section> <section id="CD013756-sec-0056"> <h6 class="title">Pre‐implantation trial periods</h6> <p>It is common clinical practice for participants to undergo a trial period of stimulation, in which electrodes are implanted and attached to an external stimulator. If a successful clinical response to trial stimulation is considered to have been established then participants usually proceed to full implantation of the final stimulator device. The timing and details of this trial period with regards to its relationship to the time of recruitment and randomisation varied across studies. </p> <p>Three cross‐over studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) included a trial period of conventional stimulation of between one and two weeks prior to full implantation which was completed after recruitment and prior to randomisation. Those considered to achieve a successful clinical response were subsequently implanted with a permanent stimulator. Four cross‐over studies (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) recruited participants who had been previously implanted were currently being treated with conventional SCS. One cross‐over study (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>) was conducted within the pre‐implantation trial period (that is, participants were randomised to different stimulation parameters during this period before the stimulation device had been permanently implanted), and one study did not report a pre‐implantation trial period (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>). As a result, it is important to note that in all cross‐over studies except <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> and <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>, participants were pre‐selected on the basis of a positive response to a trial period of conventional stimulation. </p> <p>All six parallel studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) included a pre‐implantation trial period in the SCS arm as part of the study intervention. In these studies the pre‐implantation trial period occurred after randomisation had occurred. </p> <p>Pre‐implantation trial periods ranged from 5 to 28 days in those studies that reported the duration. Not all studies reported criteria for determining the success of these trial periods. Of those that did an average reduction on pain of ≥ 50% was commonly used (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>). One study (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>) additionally required at least 80% overlap of participant's pain with stimulation‐induced paraesthesia, and one study (<a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) also considered a score of six or higher on the participant global impression of change (PGIC) scale for pain or sleep as a successful trial. One trial (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) required "adequate LBP relief with usual activity and appropriate analgesia in the context of post‐operative pain...as assessed by the investigator". </p> <p>In the parallel design trials (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), the proportion of participants randomised to SCS who received trial stimulation ranged from 92% to 100% (median 100%). The proportion of participants who received trial stimulation and were judged to have had a successful trial ranged from 67% to 94% (median 85.5%). The proportion of participants who received a trial period of stimulation and who were subsequently permanently implanted ranged from 67% to 93% (median 83.5%). As a proportion of the total number of participants randomised to SCS between 67% and 93% were received a permanent SCS implant (median 80.7%). </p> </section> </section> <section id="CD013756-sec-0057"> <h5 class="title">Primary outcomes</h5> <p>None of the cross‐over studies reported data for pain for each phase of the cross‐over study. Therefore, separate first‐phase data were not available in the study reports. For all studies we contacted the authors to request some data that could not be found in the published reports. The authors of three studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>) provided data upon request. </p> <section id="CD013756-sec-0058"> <h6 class="title">Pain intensity</h6> <p>All the included studies included pain intensity as an outcome. Pain intensity was measured using 0 to 10 or 0 to100 NRS or VAS in all studies. There was variation across studies in the reported anchors of the scales and in the level of detail provided regarding the precise question asked of participants. Five studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) reported the numbers of people who achieved ≥ 50% pain relief and presented responder analyses based on that outcome. Thirteen studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) reported the post‐intervention mean pain score, the average pain score over a period of two to five days at the end of an intervention period, or the average (mean) change from baseline in the pain score. One study (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>) did not report pain scores in a numeric form in their results. </p> </section> <section id="CD013756-sec-0059"> <h6 class="title">Adverse events</h6> <p>Adverse events (AEs) were reported in 14 studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>). While the level of detail regarding the methods used for monitoring and reporting adverse events varied, for most studies limited information on methods was reported. In five studies (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>), no methods were described for measuring, classifying or reporting AEs. In two studies (<a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), only serious adverse events (SAEs)were reported, though the definition used for classifying SAEs was not described. For studies with medium‐ to long‐term follow‐up, AEs were generally reported for the full follow‐up period rather than at each follow‐up time point. In one study (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>), the report did not provide any details for measuring AEs and did not report any data on AEs. In one study (<a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>), only SCS‐related adverse events were reported. </p> </section> </section> <section id="CD013756-sec-0060"> <h5 class="title">Secondary outcomes</h5> <p>Five studies (<a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) reported measuring disability as an outcome. Of these, four studies used the Oswestry Disability Index (ODI) and one study in CRPS used the Disabilities of Arm Shoulder and Hand Questionnaire (DASH) when the upper extremity was affected, and the Walking Ability Questionnaire when the lower extremity was affected. </p> <p>Eleven studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>;  <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) reported measuring health‐related quality of life (HRQoL). The EuroQoL 5D (EQ‐5D) was used in eight studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), theShort Form 36 (SF‐36) was used in four studies (<a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), and the Nottingham Health profile was also used in one study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>). <a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a> and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> used a 0‐10 VAS to measure HRQoL without reporting the anchors of the scale or the specific question. We did not consider this a valid form of measurement and did not include these data in any analyses. <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> also measured the McGill Pain Questionnaire QoL scale. </p> <p>Six studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) reported medication use as an outcome. <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> and <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> reported measuring all medication consumption in the trial period. <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a> used the Medication Quantification Scale III (MQS). <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> did not report the methods used to measure this outcome. <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> reported measuring medication use in the published protocol but did not report these data. </p> <p>Two studies (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) reported data on economic aspects of the intervention. The <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> study performed an economic evaluation with cost‐effectiveness analysis with long‐term modelling. <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> performed an economic evaluation with a 12‐month time horizon. <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> reported a cost analysis of SCS in the study protocol but these results were not reported in the published paper. </p> </section> </section> <section id="CD013756-sec-0061"> <h4 class="title">Ongoing studies</h4> <p>We have identified 20 unique ongoing studies that may be included in future updates of this review. In terms of our comparison "SCS versus placebo" these include eight more cross‐over studies (<a href="./references#CD013756-bbs2-0043" title="An evaluation of spinal cord stimulation for the treatment of chronic pain, also its effect on mood, sleep, physical activity and analgesic medicine requirements.. Ongoing study. 03/08/20. Contact author for more information.">ACTRN12620000720910</a>; <a href="./references#CD013756-bbs2-0044" title="Burst Spinal Cord Stimulation (Burst-SCS) study. Ongoing study. 12/03/2019. Contact author for more information.">Burst SCS</a>;  <a href="./references#CD013756-bbs2-0051" title="Spinal cord Burst stimulation for chronic radicular pain following lumbar spine surgery: a randomized double-blind sham-controlled crossover trial. Ongoing study. 05/09/2018. Contact author for more information.">NCT03546738</a>; <a href="./references#CD013756-bbs2-0052" title="A randomised sham-controlled double-blinded study of burst spinal cord stimulation for chronic peripheral neuropathic pain. Ongoing study. 07/11/2018. Contact author for more information.">NCT03733886</a>; <a href="./references#CD013756-bbs2-0053" title="Spinal cord stimulation for refractory pain in erythromelalgia. Ongoing study. 26/09/2019. Contact author for more information.">NCT04039633</a>; <a href="./references#CD013756-bbs2-0055" title="Spinal cord stimulation (SCS) forsSpinal cord injury (SCI) . Ongoing study. 31/05/2021. Contact author for more information.">NCT04894734</a>; <a href="./references#CD013756-bbs2-0056" title="Prospective, randomised, crossover, controlled, feasibility study to assess the efficacy of BurstDR spinal cord stimulation (SCS) as a treatment for persistent abdominal refractory visceral pain secondary to chronic pancreatitis:  trial. Ongoing study. 09/07/2018. Contact author for more information.">PANACEA</a>; <a href="./references#CD013756-bbs2-0059" title="PET patterns, biomarkers and outcome in  treated FBSS patients (). Ongoing study. 11/02/2018. Contact author for more information.">PET‐SCS</a>) with a median N of 22 participants(range 10 to 60, total N 246), all of which compare <a href="./references#CD013756-bbs2-0044" title="Burst Spinal Cord Stimulation (Burst-SCS) study. Ongoing study. 12/03/2019. Contact author for more information.">Burst SCS</a> with sham. There are also two parallel design studies, one of which is of high‐frequency SCS (<a href="./references#CD013756-bbs2-0050" title="Al-KaisyA , RoydsJ , PalmisaniS , PangD , WesleyS , TaylorR , et al.Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol. Trials2020;21:1-13. ">MODULATE‐ LBP</a>, N = 96) and the other is unclear (<a href="./references#CD013756-bbs2-0046" title="LuY , MaoP , WangG , TaoW , XiongD , MaK , et al.Spinal cord stimulation for chronic intractable trunk or limb pain: study protocol for a Chinese multicenter randomized withdrawal trial (CITRIP study). Trials2020;21(1):834. ">CITRIP</a> N = 54).  </p> <p>For our comparison SCS + other intervention versus other intervention alone, we have identified six ongoing studies (<a href="./references#CD013756-bbs2-0045" title="A randomized controlled study of spinal cord electrical stimulation in the treatment of pain in patients with diabetic foot. Ongoing study. 03/08/2020. Contact author for more information.">ChiCTR‐IOR‐17012289</a>; <a href="./references#CD013756-bbs2-0047" title="MoeschlerS , YueJ , SchultzD , DeerT , DesaiM , FalowskiS , et al.DISTINCT: RCT toevaluate BurstDRTM vs medical management for low back pain. In: Neuromodulation. Vol. 24. 2021:e155. ">DISTINCT</a>; <a href="./references#CD013756-bbs2-0049" title="Comparison of spinal cord stimulation in combination with standard pain treatment versus standard pain treatment only in patients with intractable chronic back pain without previous history of spine surgery. Ongoing study. 01/01/2020. Contact author for more information.">ISRCTN10663814</a>; <a href="./references#CD013756-bbs2-0054" title="SCS as an option for chronic low back and/or leg pain instead of surgery (SOLIS). Ongoing study. 26/03/2021. Contact author for more information.">NCT04676022</a>;  <a href="./references#CD013756-bbs2-0060" title="Treatment of neuropathic pain with spinal cord stimulation and physiotherapy for more effective pain relief, increased physical activity and improved health related quality of life. Ongoing study. 109/05/2018. Contact author for more information.">SCS‐PHYSIO</a>; <a href="./references#CD013756-bbs2-0061" title="Al-KaisyA , EldridgeP , CrossmanJ , KallewaardJW , ElzingaL , ShibanE , et al.Medical management versus 10 khz spinal cord stimulation and medical management for the treatment of non-surgical back pain. In: Pain physician. Vol. 21. 2018:E229. Al-KaisyA , EldridgePR , CrossmanJ , KallewaardJW , ElzingaLL , ShibanEES , et al.Medical management and 10 kHz spinal cord stimulation for the treatment of non-surgical back pain. In: Neuromodulation. Vol. 21. 2018:3: E138. PatelN , CalodneyA , KapuralL , Province-AzaldeR , LadSP , PilitsisJ , et al.high-frequency spinal cord stimulation at 10 kHz for the treatment of nonsurgical refractory back pain: design of a pragmatic, multicenter, randomized controlled trial. Pain Practice2021;21(2):171-83. ReitersP , Al-KaisyA , EldridgeP , ShibanE , CrossmanJ , Fritz AK , et al.High Frequency Spinal Cord Stimulation (HFSCS) at 10 kHz plus Conventional Medical Management (CMM) versus conventional medical management alone for the treatment of non-surgical back pain. In: Neuromodulation. Vol. 22. 2019:e8. ">SENZA‐NSRBP</a>) with a median N of 200 participants (range 30 to 300, total N 1100), three of which are of conventional SCS, two of high‐frequency SCS and one of <a href="./references#CD013756-bbs2-0044" title="Burst Spinal Cord Stimulation (Burst-SCS) study. Ongoing study. 12/03/2019. Contact author for more information.">Burst SCS</a>. Three ongoing studies are investigating DRGs, one of which is a cross‐over study (<a href="./references#CD013756-bbs2-0048" title="Effect of stimulation frequency in dorsal root ganglion stimulation (DRG Stimulation). Ongoing study. 01/04/2021. Contact author for more information.">DRKS00022557</a>, N = 50) and two use a parallel design of which one  (<a href="./references#CD013756-bbs2-0062" title="A European, prospective, multi-center, double-blind, randomized, controlled, clinical trial investigating the effects of high frequency wireless spinal cord stimulation (SCS) over exiting nerve roots in the treatment of chronic back pain. Ongoing study. 01/03/2018. Contact author for more information.">TSUNAMI DRG</a>, N = 38) is testing high‐frequency DRGs and one (<a href="./references#CD013756-bbs2-0058" title="Diabetic peripheral neuropathy treatment with dorsal root ganglion stimulation – the trial. Ongoing study. 13/06/2018. Contact author for more information.">PENTAGONS</a>, N = 56) is unclear. Nine out of 20 of these ongoing studies are reported as industry‐sponsored. </p> </section> <section id="CD013756-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded 21 studies at the full‐text screening stage. Nine were not RCTs (<a href="./references#CD013756-bbs2-0016" title="AloKM .Prospective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Neuromodulation2016;19(1):99-100. ">Alo 2016</a>; <a href="./references#CD013756-bbs2-0018" title="DonesI , BroggiG , LoeserJD , PennRD , HendersonJM , SagherO .The effects of spinal cord stimulation in neuropathic pain are sustained: A 24 month follow-up of the prospective randomized controlled multi-center trial of the effectiveness of spinal cord stimulation. Comments. Neurosurgery2008;63(4):768-70. ">Dones 2008</a>; <a href="./references#CD013756-bbs2-0024" title="LiemL , RussoM , HuygenFJP , Van BuytenJP , SmetI , VerrillsP , et al.A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic pain. Neuromodulation2013;16(5):471-82. ">Liem 2013</a>; <a href="./references#CD013756-bbs2-0027" title="MarchandS , Bushnell MC , MolinanegroP , Martinez SN , Duncan GH .The effects of dorsal column stimulation on measures of clinical and experimental pain in man. Pain1991;45(3):249257. ">Marchand 1991</a>; <a href="./references#CD013756-bbs2-0029" title="RigoardP , JacquesL , MonlezunO , DelmotteA , PoonK , MunsonR .Treatment of the back pain component of failed back surgery syndrome (FBSS) by multi-column spinal cord stimulation: a multicentre prospective study. Neuromodulation2013;Conference: 11th World Congress of the International Neuromodulation Society Berlin Germany. Conference Start: 20130608 Conference End: 20130613. Conference Publication::e218. ">Rigoard 2013</a>; <a href="./references#CD013756-bbs2-0030" title="SagherO .The effects of spinal cord stimulation in neuropathic pain are sustained: A 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation: Commentary. Neurosurgery2008;63(4):770. ">Sagher 2008</a>; <a href="./references#CD013756-bbs2-0031" title="SteinbachK , BettstetterH , LinkC .High-frequency spinal cord stimulation at 10 kHz for the treatment of chronic neuropathic pain after a II-III degree burn. Pain Medicine2017;18(9):1826-8. ">Steinbach 2017</a>; <a href="./references#CD013756-bbs2-0033" title="TesfayeS , BenbowSJ , WattJ , PangKA , MilesJ , MacfarlaneIA .Electrical spinal cord stimulator: a new and effective treatment for chronic peripheral neuropathic pain. Diabetologia1995;38:A7. ">Tesfaye 1995</a>; <a href="./references#CD013756-bbs2-0035" title="WinfreeCJ .Spinal cord stimulation for the relief of chronic pain. Current Surgery2005;62(5):476‐81. ">Winfree 2005</a>), five did not include a comparison of interest to this review (<a href="./references#CD013756-bbs2-0019" title="FalowskiSM , SharanA , McInerneyJ , JacobsD , VenkatesanL , AgnesiF .Nonawake vs awake placement of spinal cord stimulators: a prospective, multicenter study comparing safety and efficacy. Neurosurgery2019;84(1):198-205. ">Falowski 2019</a>; <a href="./references#CD013756-bbs2-0023" title="KufakwaroN , KothariS , ReddyR , PetrovicZ , ShettyA .Neuromodulation of dorsal root ganglion: a comparative study to assess efficacy of pulsed-radiofrequency and neurostimulation in treatment of neuropathic pain. Pain Practice2012;12:174. ">Kufakwaro 2012</a>; <a href="./references#CD013756-bbs2-0025" title="LiuB , YangY , ZhangZ , WangH , FanB , SimaL .Clinical study of spinal cord stimulation and pulsed radiofrequency for management of herpes zoster-related pain persisting beyond acute phase in elderly patients. Pain Physician2020;23(3):263‐70. ">Liu 2020</a>; <a href="./references#CD013756-bbs2-0020" title="GilliganC .Restorative neurostimulation for refractory mecjhanical chronic low back pain- results of a randomized active sham-controlled trial. In: Pain Practice. Vol. 20. 2020:71, ID242. ">Gilligan 2020</a>; <a href="./references#CD013756-bbs2-0026" title="LiuJ , ZhangA , YeX , HuX , HeR , JiangZ .The effect of short-term spinal cord electrical stimulation on patients with postherpetic neuralgiaand its effect on sleep quality. Neuroendocrinology Letters2021;42(2):81-6. ">Liu 2021</a>), three were reports of economic models that were not directly developed as part of the included RCTs (<a href="./references#CD013756-bbs2-0017" title="AnnemansL , Van BuytenJP , SmithT , Al-KaisyA .Cost effectiveness of a novel 10 kHz high-frequency spinal cord stimulation system in patients with failed back surgery syndrome (FBSS). Journal of Long term Effects of Medical Implants2014;24(2-3):173-83. ">Annemans 2014</a>; <a href="./references#CD013756-bbs2-0022" title="KemlerMA , RaphaelJH , BentleyA , TaylorRS .The cost-effectiveness of spinal cord stimulation for complex regional pain syndrome. Value in Health2010;13(6):735-42. ">Kemler 2010</a>; <a href="./references#CD013756-bbs2-0032" title="TaylorRJ , TaylorRS .Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. International Journal of Technology Assessment in Health Care2005;21(3):351-8. ">Taylor 2005</a>), one presented no outcomes of interest (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>), one was a report of uncontrolled within‐group follow‐up data (<a href="./references#CD013756-bbs2-0034" title="vanBeekM , SlangenR , SchaperNC , Faber CG , Joosten EA , DirksenCD , vanDongenRT ,  et al.Sustained treatment effect of spinal cord stimulation in painful diabetic peripheral neuropathy: 24-month follow-up of a prospective two-center randomized controlled trial. Diabetes Care2015;38(9):e132‐4. ">van Beek 2015</a>), and one included participants with average baseline pain levels of &lt; 4/10 on a 0 to 10 Numerical Rating Scale (NRS) (<a href="./references#CD013756-bbs2-0036" title="WolterT , KiemenA , PorzeliusC , KaubeH .Effects of sub-perception threshold spinal cord stimulation in neuropathic pain: a randomized controlled double-blind crossover study. European Journal of Pain2012;16(5):648‐55. ">Wolter 2012</a>). In one study (<a href="./references#CD013756-bbs2-0028" title="MeierK , NikolajsenL , SørensenJC , Jensen TS.Effect of spinal cord stimulation on sensory characteristics: a randomized, blinded crossover study. Clinical Journal of Pain2015;31(5):384-92. ">Meier 2015</a>), the clinical stimulation periods were only 12 hours in duration and not considered clinically applicable. </p> </section> </section> <section id="CD013756-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>A summary of the risks of bias of studies included in each analysis can be found in forest plots of each outcome and in the risk of bias tables (<a href="./references#CD013756-tblf-0049" title="">Risk of bias table for Analysis 2.1</a>; <a href="./references#CD013756-tblf-0050" title="">Risk of bias table for Analysis 2.2</a>; <a href="./references#CD013756-tblf-0051" title="">Risk of bias table for Analysis 2.3</a>; <a href="./references#CD013756-tblf-0052" title="">Risk of bias table for Analysis 2.4</a>; <a href="./references#CD013756-tblf-0053" title="">Risk of bias table for Analysis 2.5</a>; <a href="./references#CD013756-tblf-0054" title="">Risk of bias table for Analysis 2.6</a>; <a href="./references#CD013756-tblf-0057" title="">Risk of bias table for Analysis 2.9</a>; <a href="./references#CD013756-tblf-0055" title="">Risk of bias table for Analysis 2.7</a>; <a href="./references#CD013756-tblf-0056" title="">Risk of bias table for Analysis 2.8</a>; <a href="./references#CD013756-tblf-0058" title="">Risk of bias table for Analysis 2.10</a>; <a href="./references#CD013756-tblf-0059" title="">Risk of bias table for Analysis 2.11</a>; <a href="./references#CD013756-tblf-0060" title="">Risk of bias table for Analysis 2.12</a>; <a href="./references#CD013756-tblf-0061" title="">Risk of bias table for Analysis 2.13</a>). Risk of bias assessments for each outcome, including all domain judgements and support for judgements, are located in the risk of bias section (located after the <a href="./references#CD013756-sec-0159" title="">Characteristics of included studies</a>). Additional details on how we applied the Risk of Bias‐2 tool for each trial for each outcome can be found in the supplemental data file available in Figshare (DOI: 10.17633/rd.brunel.14838678). </p> <p>We rated all results that we evaluated as being at high risk of bias overall.</p> <p>For the comparison of spinal cord stimulation (SCS) versus sham, we judged all results to be at high risk of bias on more than one domain. All results where there were data available used continuous self‐reported outcome measures in the short term and so risk of bias issues were generally consistent across results. Common issues were the lack of washout periods employed to minimise potential carry‐over effects, the likelihood of inadequate blinding compounded by the infrequent use of formal assessment of blinding success and the presence of post‐randomisation exclusions with per‐protocol type analyses. With regard to bias in the measurement of the outcome, we rated comparisons of conventional stimulation versus sham as being at high risk of bias as they involve suprathreshold, perceptible sensations. For high‐frequency and burst stimulations which may be expected to be sub‐perceptual, we rated results as causing"some concerns" unless a formal evaluation of blinding was presented and demonstrated success. As RevMan Web does not currently have the function to present distinct risk of bias (ROB) judgements for different comparisons from the same study, the ROB figures and tables presented in this review give a default "high" risk judgement for all studies unless the stimulation was sub‐perceptual and successful blinding was formally demonstrated. Importantly, this does not impact any overall risk of bias judgments for any studies, or any related GRADE ratings. </p> <p>For the comparisons SCS + other intervention versus other intervention alone, we rated all results to cause "some concerns" for bias due to deviations from the intended intervention for the outcome pain intensity, on the basis that these were open‐label studies and minimal detail was provided regarding how non‐SCS management was delivered throughout the studies. For device‐related adverse events (AEs), we considered this risk to be low, as any potential deviations in physical therapy or medical management are unlikely to impact the incidence of device‐related adverse events. We judged all of these results to be at high risk of bias in the measurement of the outcome as they are all derived from open‐label studies of the addition of a complex and invasive intervention, with mainly subjective self‐reported outcomes. For adverse events, the included studies presented minimal information on how AEs were classified and the approach taken to surveillance which we considered may have impacted on the reported values. </p> </section> <section id="CD013756-sec-0064"> <h3 class="title" id="CD013756-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD013756-tbl-0001"><b>Summary of findings 1</b> Active stimulation vs placebo (sham)</a>; <a href="./full#CD013756-tbl-0002"><b>Summary of findings 2</b> Active stimulation + other intervention vs other intervention alone</a> </p> <p>We found no eligible published studies of DRGS and no studies comparing SCS to no treatment or usual care.  </p> <section id="CD013756-sec-0065"> <h4 class="title">Active Stimulation versus placebo</h4> <section id="CD013756-sec-0066"> <h5 class="title">SCS versus placebo (sham)</h5> <p>See <a href="./full#CD013756-tbl-0001">summary of findings Table 1</a> for a summary of the primary outcomes for= spinal cord stimulation (SCS) versus sham. </p> <section id="CD013756-sec-0067"> <h6 class="title">Pain intensity</h6> <section id="CD013756-sec-0068"> <p><b>Short‐term follow‐up</b></p> <p>Six studies contributed to this analysis (<a href="./references#CD013756-fig-0002" title="">Analysis 1.1</a>, <a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>, N = 164), most of which compared two or more stimulation types with sham and were entered into the analysis more than once. For studies that contributed multiple comparisons, we divided the number of participants in each arm by the number of comparisons included from that study to avoid double counting. We were unable to include data from three eligible studies in this analysis (combined N = 44)  due to a lack of reporting of necessary measures of variance (<a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a>; <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>) or both point estimates and measures of variance (<a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a>). </p> <p>We found evidence of a small effect in favour of SCS (mean difference (MD) ‐8.73, 95% confidence interval (CI) ‐15.67 to 1.78, P = 0.005, I<sup>2</sup> = 58%, very low‐certainty evidence, downgraded twice for serious limitations of studies, once for imprecision and once due to the potential for publication bias). The point estimate falls below our threshold of a clinically important effect, though the upper confidence interval exceeds it. Pre‐planned subgroup analysis by stimulation parameters (conventional, high‐frequency and burst) reduced heterogeneity in the high‐frequency group (I<sup>2</sup> 0%) but not in the conventional (I<sup>2</sup> 77%) or the burst (I<sup>2</sup> 76%) group. The test for subgroup differences did not provide evidence for differences (Chi<sup>2</sup> 1.06, P = 0.59). </p> <p>Planned sensitivity analysis using a fixed‐effect model resulted in a smaller effect in favour of SCS (MD ‐6.58, 95% CI ‐10.84 to ‐2.32). </p> <p>No studies reported data for the proportion of participants experiencing 30% or 50% pain relief for this comparison. </p> </section> <section id="CD013756-sec-0069"> <p><b>Reporting bias</b></p> <p>We identified potential studies that were either recorded in the trial registry (<a href="./references#CD013756-bbs2-0037" title="">ISRCTN33292457</a>; <a href="./references#CD013756-bbs2-0041" title="">NCT00351208</a>; <a href="./references#CD013756-bbs2-0042" title="">NCT03462147</a>) or published as a conference abstract (<a href="./references#CD013756-bbs2-0038" title="MillerN , SebaharM , VallejoR , BinyaminR , LinS , Mekel-BobrovN .Optimization of stimulation location is essential to sub-perception SCS: results of a double-blind randomized placebo-controlled trial. In: Neuromodulation. Vol. 18. 2015:e99. ">Miller 2015</a>; <a href="./references#CD013756-bbs2-0039" title="MillerJ , SweetJA , BadjatiyaA , TanD .Paresthesia-free high-density SCS for postlaminectomy syndrome in a pre-screened population: A prospective, randomized, placebo-controlled study. In: Neuromodulation. Vol. 19 (3). 2016:e29. ">Miller 2016</a>), but where we did not find a published study report. Combined, these studies may have contributed data from 74 more participants to these comparisons, which in light of the number of participants in this comparison may impact our estimate of effect. </p> </section> </section> <section id="CD013756-sec-0070"> <h6 class="title">Adverse events (AEs)</h6> <section id="CD013756-sec-0071"> <p><b>Short‐term follow‐up</b></p> <p>All studies comparing SCS versus sham stimulation were cross‐over studies.  In these trials, all participants were surgically implanted with electrodes for all stimulation conditions. We graded the evidence for all adverse effects as very low certainty, downgraded twice for serious limitations of studies, once for imprecision and once for inconsistency. </p> <p>There were important differences between the trials that might impact the reported incidence of adverse events. <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>, <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>, <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> recruited participants who were already implanted successfully with a device and had been receiving SCS for their pain at the point for recruitment, thus reducing the probability of identifying perioperative adverse events. <a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a> reported all AEs during the course of the study including the pre‐implantation trial period, <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> reported AEs occurring during the pre‐implementation trial period, cross‐over period and up to 17 months of follow‐up after that. <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>, <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>, <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> and <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> reported AEs that occurred during the cross‐over period and <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a> continued to follow up participants for any serious adverse events (SAEs) for a further six months. <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> only reported SAEs though did not provide a clear definition for those. <a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> reported no data for AEs. Cross‐over periods ranged in duration from 3 to 24 weeks. We have summarised the reported AEs in <a href="#CD013756-tbl-0003">Table 1</a>. </p> <div class="table" id="CD013756-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS versus sham</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Period of measurement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Lead failure/ displacement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Infection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Need for reop</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other* AEs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks cross‐over period + 17 days pre‐implementation trial period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (during pre‐implentation trial period)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in pre‐implementation trial period, not defined.</p> <p>Pain at the IPG site 3 (1 required re‐operation)</p> <p>Skin heating during recharging 1</p> <p>Intercostal pain 1</p> <p>3 additional "minor lead migrations"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐week cross‐over period plus 6 months post study surveillance for SAEs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased pain 15</p> <p>Cramp in foot 2</p> <p>Pain over device 1</p> <p>Intermittent jolts of stimulation 2</p> <p>Loss of adaptive stimulator function 1</p> <p>Discomfort in neck 1</p> <p>Paraesthesia 1</p> <p>Bilateral foot pain 1</p> <p>Numbness in leg 1</p> <p>Left hip pain 1</p> <p>Uncomfortable sensations 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1‐ week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Device/ stim output issues 68,</p> <p>Itching rash 2,</p> <p>Axial paraesthesia 1,</p> <p>Headache 4, converted to standard stimulation 2, Discontinued stimulation 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2‐ week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feeling of tiredness during stimulation periods 2,</p> <p>sensations of unsteady gait during stimulation probably related to paresthesia in the legs 2 </p> <p>Uncomfortably high‐intensity stimulation in her legs 1,</p> <p>pain at the implantation site of the stimulator 1, transient headache upon removal of the SCS system 1. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malaise that was attributed to a vasovagal attack at the programming session of one of the treatment periods. This patient subsequently withdrew consent to the study and was excluded. 1<br/>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only SAEs measured and none reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2‐week pre‐trial implementation period, 8‐week cross‐over period, up to 17 months follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Device/ electrodes removed due to inadequate pain relief 2</p> <p>Removal of IPG 3,</p> <p>Allergic reaction at implant site 1,</p> <p>Replacement due to battery issues 1</p> <p>Electrode replacement due to electrode dysfunction 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heavy feeling or pressure in their legs or feet 3</p> <p>Increased sensation of local stimulation around IPG 1</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><i>Footnotes:</i><b><i>AEs</i> </b><i>= adverse events;</i><b><i>IPG</i> </b><i>=  implanted pulse generator.</i><b><i>N</i> </b><i>I= No Information reported; *as defined and reported in original studies;</i><b><i>SAEs</i> </b><i>serious adverse events</i> </p> </div> </div> <p>Only <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a> (N = 19) reported the incidence ofAEs by stimulation condition to allow comparisons of SCS versus sham at any pre‐specified time point. They reported no cases of infection, lead failure or re‐operation in any condition, though it is important to recognise that participants in that trial were recruited on the basis of experiencing stable pain relief from an existing implanted stimulator. Of otherAEs they reported 14 participants with 15 events in the 500 Hz condition, 11 participants with 11 events in the Burst condition and 12 participants with 12 events in the sham condition. Details of these are summarised in <a href="#CD013756-tbl-0003">Table 1</a> </p> <p>Four studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) reported incidences of lead failure. These ranged from 1 event in 41 participants (2%) (<a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) to 4 events in 30 participants (13%) (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>). Three studies (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>; <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) reported the incidence of infection of which <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> ranging from no events to 1 event in 33 participants (3%). In these three studies, re‐operation rates ranged from 1 event in 30 participants (3%) (<a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a>) to 7 events in 18 participants (39%) (<a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>). </p> <p>In studies where some data were available the rate of other AEs ranged from 1 event in 33 participants to 78 events in 33 participants. Details are reported in <a href="#CD013756-tbl-0003">Table 1</a>. These results are highly likely to have been substantially affected by variation in the methods and reporting approach taken to AEs, of which there was little detail in the original papers. </p> </section> </section> <section id="CD013756-sec-0072"> <h6 class="title">Disability</h6> <section id="CD013756-sec-0073"> <p><b>Short‐term follow‐up</b></p> <p>Three studies (<a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) measured disability for this comparison. However, only <a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> reported this outcome in adequate detail to allow analysis. <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> reported in their protocol measuring the Disabilities of Arm Shoulder and Hand Questionnaire (DASH) when the upper extremity was affected, and the Walking Ability Questionnaire when the lower extremity was affected, but did not present results in the published study report. <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> measured disability using the Oswestry Disability Index (ODI), but did not report point estimates or measures of variance in the published report. </p> <p><a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> measured disability using the ODI (0 to 100 scale, higher scores reflect higher levels of disability). Analysis of data from this study (<a href="./references#CD013756-fig-0003" title="">Analysis 1.2</a>), including conventional stimulation and burst stimulation demonstrated a small effect of SCS vs sham (N = 20, MD ‐7.48, 95% CI ‐13.13 to ‐1.82, P = 0.01, I<sup>2</sup> 0%, very low‐certainty evidence, downgraded twice for serious limitations, once for imprecision and once for inconsistency). </p> </section> </section> <section id="CD013756-sec-0074"> <h6 class="title">Health‐related quality of life (HRQoL)</h6> <section id="CD013756-sec-0075"> <p><b>Short‐term follow‐up</b></p> <p>Three studies (<a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> pooled N = 73) reported HR‐QoL at short‐term follow‐up. <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> used EQ‐5D utility index values and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> used the McGill Pain Questionnaire QoL scale. As a result, we used the standardised mean difference (SMD) as our effect measure. We were unable to include data from <a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a>  in this analysis (N = 19) due to a lack of reporting of necessary measures of variance. We found no evidence for an effect of SCS vs sham on HRQoL (<a href="./references#CD013756-fig-0004" title="">Analysis 1.3</a>, SMD 0.03, 95% CI ‐0.30 to 0.35, P = 0.88, I<sup>2</sup> = 0%, very low‐certainty evidence, downgraded twice for serious limitations and once for imprecision). </p> </section> </section> <section id="CD013756-sec-0076"> <h6 class="title">Medication use</h6> <section id="CD013756-sec-0077"> <p><b>Short‐term follow‐up</b></p> <p>Three studies (<a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a>; <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>; <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>) reported measuring medication use. None of these studies reported results in adequate detail to allow analysis or pooling of data. <a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> (N = 33) did not report medication use in the published study report, although it was reported to be measured in the study protocol. <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> (N = 23) did not report data in an extractable format but reported that the total number of medications taken did not differ across conditions. <a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> (N = 40) similarly reported that medication use was unchanged in all but one patient who increased their dose of oral morphine. We graded the evidence as very low certainty, downgraded twice for serious limitations, once for imprecision and once for inconsistency. </p> </section> </section> </section> </section> <section id="CD013756-sec-0078"> <h4 class="title">Active stimulation plus another intervention versus that intervention alone</h4> <section id="CD013756-sec-0079"> <h5 class="title">SCS + other intervention versus other intervention only</h5> <p>See <a href="./full#CD013756-tbl-0002">summary of findings Table 2</a> for a summary of the primary outcomes for SCS + other intervention versus other intervention only. We included outcomes at medium‐term follow‐up in this table, though this was not prespecified in our protocol. The reason for this was that for all included studies the specified primary endpoint was at medium‐term follow‐up. </p> <section id="CD013756-sec-0080"> <h6 class="title">Pain intensity</h6> <section id="CD013756-sec-0081"> <p><b>Mean difference (MD)</b></p> <p>Three studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> combined N = 303, <a href="./references#CD013756-fig-0005" title="">Analysis 2.1</a>) provided data after one month of stimulation. Pooling of these studies demonstrated a potentially clinically important mean difference in favour of SCS of ‐37.41 (95% CI ‐46.39 to ‐28.42, P &lt; 0.001, I<sup>2</sup> 65%) with substantial heterogeneity. The evidence was rated as very low certainty, downgraded once for limitations, once for imprecision and once for inconsistency. Sensitivity analysis using a fixed‐effect model did not substantially impact the estimate of effect. We were unable to include data from one study (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, N = 218) in this analysis as, although their methods reported that this outcome was evaluated at this time point, the data were not reported. </p> </section> <section id="CD013756-sec-0082"> <p><b>Proportion of participants reporting ≥ 50% pain relief</b></p> <p>Two studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> combined N= 249; <a href="./references#CD013756-fig-0006" title="">Analysis 2.2</a>) provided data for this outcome. The analysis demonstrated an effect in favour of SCS (RR 15.90 (95% CI 6.70 to, 37.74, P&lt;0.001, I<sup>2</sup> 0% ; RD 0.65 (95% CI 0.57 to 0.74). This equates to an NNTB of 1.5 (95% CI 1.4 to 1.8). We graded the evidence as very low certainty, downgraded twice for serious limitations and once for imprecision. Sensitivity analysis using a fixed‐effect model did not impact the estimate of effect. We were unable to include data from one study (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, N=218) in this analysis as, although this outcome was reported to have been evaluated at this time point, the data were not reported. </p> </section> <section id="CD013756-sec-0083"> <p><b>Mean difference (MD)</b></p> <p>Five studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>, combined N = 635, <a href="./references#CD013756-fig-0007" title="">Analysis 2.3</a>) provided data aftersix months of stimulation. Pooling of these studies demonstrated a potentially clinically important mean difference in favour of SCS of ‐31.22 (95% CI ‐47 to 34 to ‐15.10, P &lt; 0.001, I<sup>2</sup> = 95%) with substantial heterogeneity. We graded the evidence as low certainty, downgraded once for limitations of studies, and once for inconsistency. Sensitivity analysis using a fixed‐effect model slightly reduced the estimate of effect (MD ‐27.76, 95% CI ‐31.26 to ‐24.26). </p> </section> <section id="CD013756-sec-0084"> <p><b>Proportion of participants reporting ≥ 50% pain relief</b></p> <p>Five studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>, combined n = 597, <a href="./references#CD013756-fig-0008" title="">Analysis 2.4</a>) provided data for this outcome after six months of stimulation. Pooling of these studies demonstrated an effect in favour of SCS (RR 7.08, 95% CI 3.40 to 14.71, P &lt; 0.001, I<sup>2</sup> = 43%; RD 0.43, 95% CI 0.14 to 0.73). This equates to an NNTB of 2.3 (1.4 to 7.7). We graded the evidence as as low certainty, downgraded once for limitations of studies and once for imprecision. Sensitivity analysis using a fixed‐effect model resulted in a larger effect size for this comparison (RR 8.24, 95% CI 4.99 to 13.62). </p> </section> <section id="CD013756-sec-0085"> <p><b>Mean difference (MD)</b></p> <p>One study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, N = 44 for this comparison, <a href="./references#CD013756-fig-0009" title="">Analysis 2.5</a>) provided data for this outcome after 5 years of stimulation. There was no clear evidence for an effect of SCS (MD ‐7, 95%  CI ‐24.76 to 10.76, P = 0.44). We graded the evidence as very low certainty, downgraded twice for serious limitations of studies, once for imprecision and once for inconsistency. We were unable to include data from two studies (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, combined N = 318) in this analysis as, although the methods suggested this outcome was evaluated at this time point, the data were not reported for all participants randomised. </p> </section> <section id="CD013756-sec-0086"> <p><b>Proportion of participants reporting ≥50% pain relief</b></p> <p>One study (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>, N=87 for this comparison, <a href="./references#CD013756-fig-0010" title="">Analysis 2.6</a>) provided data for this outcome after 24 months of stimulation. The study reported a benefit of SCS (RR 15.15, 95% CI 2.11 to 108.91, P = 0.007; RD 0.35, 95% CI 0.2 to 0.49). This equates to an NNTB of 2.86 (95% CI 2.04 to 5). We graded the evidence as very low certainty, downgraded twice for serious limitations of studies, once for imprecision and once for inconsistency). We were unable to include data from one study (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, N = 218) in this analysis as, although the methods suggested this outcome was evaluated at this time point, the data were not reported for all participants randomised. </p> </section> <section id="CD013756-sec-0087"> <p><b>Reporting biases</b></p> <p>We identified one study (<a href="./references#CD013756-bbs2-0040" title="">NCT00200122</a>) that was recorded in a trial registry but where we did not identify a full published study report. This study may have contributed data from a further 100 participants to our analyses. We estimated the number of participants in studies with no effect required to change the NNTB to an unacceptably high level (defined as an NNTB of 10), as outlined in <a href="./references#CD013756-bbs2-0091" title="MooreRA , BardenJ , DerryS , McQuayHJ .Managing potential publication bias. In: Systematic Reviews in Pain Research: Methodology Refined. Vol. 1. Seattle: IASP Press, 2008:1:15-23.">Moore 2008</a> for each time point. This value was 297 (95% CI 210 to 420) at short term, 2033 (95% CI 179 to 3892) at medium‐term and 1490 (95%CI 597 to 2329) at long‐term follow‐up. </p> </section> </section> <section id="CD013756-sec-0088"> <h6 class="title">Adverse events: device/procedure‐related</h6> <p><a href="#CD013756-tbl-0004">Table 2</a> summarises the detail of other adverse events related to the device/ procedure. </p> <div class="table" id="CD013756-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS + other interventions vs other interventions alone</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N randomised to stimulation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N implanted with electrodes in SCS group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N who received full device implantation in SCS group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Period of measurement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Lead failure/ displacement</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Infection</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Need for reop</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other AEs*</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other AE details</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Medium Term reporting</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 participant with coagulopathy, which complicated the implantation procedure and prolonged hospitalisation. </p> <p>2 pain due to IPG</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemler 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 dural puncture (1 with headache)</p> <p>Six of the 24 patients treated with spinal cord stimulation (25%) had a total of 11 other complications during the six months after implantation. Four patients had long‐term complications. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Back pain</p> <p>Device stimulation issues</p> <p>2 Device deployment issues</p> <p>1 Device Battery issue</p> <p>1 Implant site cellulitis</p> <p>1 Implant site pain</p> <p>2 Paraesthesia</p> <p>1 Pelvic pain</p> <p>1 Pulmonary oedema</p> <p>1 Urinary tract infection</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 wound dehiscence</p> <p>1 impaired healing</p> <p>1 device extrusion</p> <p>1 incision site pain</p> <p>1 IPG site discomfort</p> <p>1 contact dermatitis</p> <p>1 urticaria</p> <p>1 radiculopathy</p> <p>1 uncomfortable stimulation</p> <p>1 Gastrooesophageal reflux</p> <p>1 myalgia</p> <p>1 arthralgia</p> <p>1 hyporeflexia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Dural puncture leading to headache. Subsequent large subdural haematoma leading to death. </p> <p>1 infection leading to device removal</p> <p>Participant did not fully recover and developed autonomic neuropathy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Long term reporting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67****</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19, Change of amplitude with bodily movements.</p> <p>13 Paraesthesia over other body parts</p> <p>11 Pain/irritation from IPG</p> <p>7 More pain in other body parts</p> <p>4 Disturbed urination</p> <p>3 Movements or cramps resulting from elevated amplitude</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>*** </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> <p>(78 implanted after cross‐over from control group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 (+1 device migration)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 "Technique" issues**</p> <p>5 Pain at IPG site</p> <p>4 Fluid collection in neurostimulator pocket</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>*** </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> <p>(174 implanted overall after cross‐over from control group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 Device stimulation issues</p> <p>6 implant site pain</p> <p>5 Back pain</p> <p>4 Paraesthesia</p> <p>3 Device dislocation</p> <p>2 Device deployment issue</p> <p>2 Procedural pain</p> <p>2 Product ineffective</p> <p>2 Therapeutic response decreased</p> <p>2 Abdominal pain</p> <p>1 Burning sensation</p> <p>1 Dermatitis contact</p> <p>1 Device battery issue</p> <p>1 Extradural abscess</p> <p>1 Extradural haematoma</p> <p>1 Hypoaethesia</p> <p>1 Implant site cellulitis</p> <p>1 Implant site swelling</p> <p>1 Monoparesis</p> <p>1 Musculoskeletal pain</p> <p>1 Pelvic pain</p> <p>1 Postprocedural complication</p> <p>1 Pulmonary oedema</p> <p>1 Urinary tract infection</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><i>* Other AEs reported here if there is a high likelihood of being directly related to the device/ procedure.</i> </p> <p><i>** "Technique" issues (1) Cap not installed on IPG when only one lead was implanted: (2) suboptimal connection of extension to IPG led to intermittent stimulation; (3) anteriorly implanted electrode caused shocks; (4) lead cut during implant; (5) dural tear during implant</i> </p> <p>*** Numbers of events for these studies reflects those randomised to SCS and those who crossed over from the control group after 6 months. </p> <p>**** other device‐related AEs from <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> reported a 2 year follow‐up. </p> </div> </div> <p>All six trials for this comparison (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>) reported some information regarding AEs though there was variation in the detail reported in terms of the methods used and in the completeness of reporting. In all of these trials the implantation process, including the pre‐implantation trial period occurred post‐randomisation. At long‐term follow‐up, two studies (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) only reported device/procedure‐related complications for the group randomised to SCS combined and any participants who crossed over to receive SCS from the control group. As a result these data could not be used in our analyses. We describe the number and nature of AEs at this time point for all participants implanted in <a href="#CD013756-tbl-0004">Table 2</a>. Details of the number and nature of procedure‐ and device‐related adverse events for all studies are presented in <a href="#CD013756-tbl-0004">Table 2</a>. It is difficult to estimate how many studies measured but failed to report each of these outcomes due to the lack of detail regarding the methods of AE measurement reported in the included studies. </p> </section> <section id="CD013756-sec-0089"> <h6 class="title">Lead failure or displacement</h6> <p>Incidence of lead failure or displacement was inconsistently reported, and it is likely that for some trials this was reported under the umbrella of device‐related issues. As such it is likely that the data for these comparisons is an incomplete reflection of the true number of events. </p> <section id="CD013756-sec-0090"> <p><b>Short‐term follow‐up</b></p> <p>No studies reported the incidence of lead failure or displacement at short‐term follow‐up.</p> </section> <section id="CD013756-sec-0091"> <p><b>Medium‐term follow‐up</b></p> <p>Three studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>, pooled N = 330, <a href="./references#CD013756-fig-0011" title="">Analysis 2.7</a>) reported the number of instances of lead failure or displacement after six months of stimulation. The incidence of these events ranged from 1/113 (0.9%) to 5/36 participants (14%). Pooling these studies did not demonstrate clear evidence of an increased risk of lead failure/ displacement with SCS with uncertainty and heterogeneity (RD 0.04, 95% CI ‐0.04 to 0.11, P = 0.31, I<sup>2</sup> = 64%). Sensitivity analysis using a fixed‐effect model did not substantially impact the estimate of effect. The evidence was graded to be of very low certainty, downgraded once for limitations of studies, and twice for serious imprecision. </p> </section> <section id="CD013756-sec-0092"> <p><b>Long‐term follow‐up</b></p> <p>One study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, N = 44, <a href="./references#CD013756-fig-0012" title="">Analysis 2.8</a>) reported the number of cases of lead repositioning or replacement events at five‐year follow‐up. This study reported 17 events in the SCS group (RD 0.55, 95% CI 0.35 to 0.75, P &lt; 0.001) equating to an NNTH of 1.8 (95% CI 1.3 to 2.9). We graded the evidence as very low certainty, downgraded once for limitations of studies, and once for inconsistency and once for imprecision. </p> </section> </section> <section id="CD013756-sec-0093"> <h6 class="title">Infection</h6> <section id="CD013756-sec-0094"> <p><b>Short‐term follow‐up</b></p> <p>No studies reported the incidence of infection for the short term follow‐up period.</p> </section> <section id="CD013756-sec-0095"> <p><b>Medium‐term follow‐up</b></p> <p>Four studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>, pooled N = 548, <a href="./references#CD013756-fig-0013" title="">Analysis 2.9</a>) reported the number of infections after six months of stimulation. Rates ranged from 2.5% to 8% of those implanted with electrodes (including those who did and did not have a successful pre‐implantation trial period). Pooling these studies demonstrates an increased risk of infection (RD 0.04, 95% CI 0.01, 0.07, P   =0.003, I<sup>2</sup> 0%) equating to an NNTH of 25 (95% CI 14.29 to 100). We graded the evidence as low certainty, downgraded once for limitations of studies, and once for imprecision. Sensitivity analysis using a fixed‐effect model did not substantially impact the estimate of effect. </p> </section> <section id="CD013756-sec-0096"> <p><b>Long‐term follow‐up</b></p> <p>No studies reported the incidence of infection by group allocation for the long‐term follow‐up period. </p> </section> </section> <section id="CD013756-sec-0097"> <h6 class="title">Need for reoperation, repeated implantation procedure(s)</h6> <p>All trials that reported on these outcomes reported either lead or device‐related issues some of which required reoperation. </p> <section id="CD013756-sec-0098"> <p><b>Short‐term follow‐up</b></p> <p>No studies reported this outcome for the short term follow‐up period.</p> </section> <section id="CD013756-sec-0099"> <p><b>Medium‐term follow‐up</b></p> <p>Four studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>, pooled N = 548, <a href="./references#CD013756-fig-0014" title="">Analysis 2.10</a>) reported on the need for repeated implantation/reoperation at this time point. As a percentage of the total number of participants randomised to stimulation, rates of reoperation at medium‐term follow‐up ranged from 2% to 30.5% (4 studies, <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> 299 participants randomised to stimulation). The pooled analysis indicates an increased risk of repeated procedures with heterogeneity (RD 0.11, 95% CI 0.02 to 0.21, P = 0.02, I<sup>2</sup> = 86%). This equates to an NNTH of 9.1 (95% CI 4.8 to 50). We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. Sensitivity analysis using a fixed‐effect model did not meaningfully impact the estimate of effect. </p> </section> <section id="CD013756-sec-0100"> <p><b>Long‐term follow‐up</b></p> <p>One study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, N = 44, <a href="./references#CD013756-fig-0015" title="">Analysis 2.11</a>) provided data for this outcome after five years of stimulation and reported 29 reoperation events, (risk difference (RD) of 0.94, 95% CI 0.80 to 1.07, P &lt; 0.001) equating to an NNTH of 1.05 (95% CI 0.93 to 1.25). We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. </p> </section> </section> <section id="CD013756-sec-0101"> <h6 class="title">Serious and other adverse events related to procedure/device</h6> <p>There were some notable cases of SAEs or potential SAEs reported. <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> (22 participants randomised to stimulation) reported that one participant experienced a dural puncture headache in the immediate pos‐operative period and a subsequent large subdural haematoma which, despite surgery, led to death. In the same study one participant contracted an infection of the SCS system leading to its removal. Despite antibiotic treatment the study reported that the participant did not fully recover and developed autonomic neuropathy. Dural puncture was also reported by <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> (2 cases in 36 participants). <a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a> (40 participants randomised to stimulation) reported one participant who had a coagulopathy leading to procedural complications and prolonged hospitalisation. Both the <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> and <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> studies (52 and 110 participants randomised to stimulation, respectively) reported one case of pulmonary oedema and urinary tract infection. The <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> study also reported a single case of an extradural abscess and an extradural haematoma with that participant experiencing resultant monoparesis at the time of study exit. <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> reported one case of disturbed urination. <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> reported two SAEs, on request the authors clarified that one was a wound infection and one was a case of device extrusion. </p> </section> <section id="CD013756-sec-0102"> <h6 class="title">Adverse events: other</h6> <p>For the analysis of "other adverse events" it was not possible to extract the average number of events per participant in order to treat these as continuous data. We analysed the number of participants who experienced one or more adverse events in each group. Adverse events included non‐SCS‐related AEs as reported in each paper and were reported to broadly consist of adverse drug reactions, new illnesses or injuries. </p> <section id="CD013756-sec-0103"> <p><b>Short‐term follow‐up</b></p> <p>No studies reported this outcome specifically at short‐term follow‐up.</p> </section> <section id="CD013756-sec-0104"> <p><b>Medium‐term follow‐up</b></p> <p>Two studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, pooled N = 278; <a href="./references#CD013756-fig-0016" title="">Analysis 2.12</a>) reported on other AEs after six months of stimulation. Pooling these studies found no evidence for a difference in other adverse events (RD ‐0.05, 95% CI ‐0.16 to 0.06, P = 0.82, I<sup>2</sup> = 0%). We graded the evidence as low certainty, downgraded once for limitations of studies and once for imprecision. Sensitivity analysis using a fixed‐effect model did not impact the estimate of effect. </p> </section> <section id="CD013756-sec-0105"> <p><b>Long‐term follow‐up</b></p> <p>One study (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>, N = 100, <a href="./references#CD013756-fig-0017" title="">Analysis 2.13</a>) reported other adverse events after 12 months of stimulation. There was no clear evidence for a difference between groups (RD ‐0.17, 95% CI ‐0.37 to 0.02, P = 0.07). We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. Adverse events were reported as being mainly due to drug adverse events or the development of a new injury, illness or condition. </p> </section> </section> <section id="CD013756-sec-0106"> <h6 class="title">Disability</h6> <p>Two studies (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>) measured and reported disability as an outcome, both using the ODI. </p> <section id="CD013756-sec-0107"> <p><b>Short‐term follow‐up</b></p> <p>Neither study reported data on disability at short‐term follow‐up.</p> </section> <section id="CD013756-sec-0108"> <p><b>Medium‐term follow up</b></p> <p>Pooling data from two studies (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, N = 312, <a href="./references#CD013756-fig-0018" title="">Analysis 2.14</a>) found no clear evidence for an effect of SCS on disability (MD ‐15.93, 95% CI ‐35.99 to  4.13, P = 0.12, I<sup>2</sup> 92%), but there was substantial heterogeneity. We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. Sensitivity analysis using a fixed‐effect model substantially decreased the point estimate of effect and demonstrated an effect in favour of SCS (MD ‐9.74, 95% CI ‐13.97 to ‐5.51). </p> </section> <section id="CD013756-sec-0109"> <p><b>Long‐term follow‐up</b></p> <p>Neither study reported data on disability at long‐term follow‐up.</p> </section> </section> <section id="CD013756-sec-0110"> <h6 class="title">Health‐related quality of life</h6> <section id="CD013756-sec-0111"> <p><b>Short‐term follow‐up</b></p> <p>One study (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>, <a href="./references#CD013756-fig-0019" title="">Analysis 2.15</a>) shared data on request for this outcome in the short term. Using the EQ‐5D self‐reported perception of health scale (0 to100 with higher scores reflecting better health), the data suggest a positive effect on HR‐QoL (N = 55, MD 17, 95% CI 5.74 to  28.26). We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. We were unable to include data from two studies (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, combined N = 272) in this analysis as, although the methods suggested this outcome was evaluated at this time point, the data were not reported. </p> </section> <section id="CD013756-sec-0112"> <p><b>Medium‐term follow‐up</b></p> <p>Five studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>; <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> N=595, <a href="./references#CD013756-fig-0020" title="">Analysis 2.16</a>) contributed to this analysis. We were unable to include data from <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> as HRQoL data, measured using the Nottingham Health Profile were only presented as percentage change rather than absolute values. Three studies presented EQ‐5D utility index values, one presented the EQ‐5D 0‐100 VAS scale and one the SF‐36 Physical Component Score. As a result, we pooled results using the SMD. The analysis showed a positive effect of SCS on HR‐QoL with heterogeneity (SMD 0.73, 95% CI 0.46 to  0.99, P &lt; 0.001, I<sup>2</sup> = 54%). We graded the evidence as low certainty, downgraded once for limitations of studies and once for inconsistency. It is notable that heterogeneity was largely due to the inclusion of the <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> study. Removal of this study results in an I<sup>2</sup> of 0%. That was the only study in this comparison that delivered HF SCS but was also the study rated at high risk of bias on the highest number of domains. Sensitivity analysis using a fixed‐effect model did not meaningfully impact the estimate of effect. </p> </section> <section id="CD013756-sec-0113"> <p><b>Long‐term follow‐up</b></p> <p>Only one study (<a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a>, N = 44, <a href="./references#CD013756-fig-0021" title="">Analysis 2.17</a>) reported HRQoL results at long‐term follow‐up. This study reported no evidence for a difference in EQ‐5D visual analogue scale scores at five5‐year follow‐up (N = 44, MD ‐0.09, 95% CI ‐0.74 to 0.56). We graded the evidence as very low certainty, downgraded once for limitations of studies, once for imprecision and once for inconsistency. We were unable to include data from two studies (<a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>, <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>, combined N = 318) in this analysis as, although the methods suggested this outcome was evaluated at this time‐point, the data were not reported for all participants as randomised. </p> </section> </section> <section id="CD013756-sec-0114"> <h6 class="title">Medication use</h6> <p>No studies reported medication use at short‐ or long‐term follow‐up.</p> <section id="CD013756-sec-0115"> <p><b>Medium‐term follow‐up</b></p> <p>Two studies (<a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a>; <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>, pooled N = 154, <a href="./references#CD013756-fig-0022" title="">Analysis 2.18</a>) reported the number of participants using different classes of analgesics at six months follow‐up. Pooling these studies demonstrated no strong evidence for a difference in the number of participants using of opioids (RR 0.77, 95% CI 0.58 to  1.01, P = 0.06, I<sup>2</sup> 0%, low‐certainty evidence, downgraded for limitations of studies and imprecision), NSAIDS (RR 0.69, 95% CI 0.43 to  1.09, P = 0.11, I<sup>2</sup> 0%, low‐certainty evidence, downgraded for limitations of studies and imprecision), antidepressants (RR 0.68, 95% CI 0.46 to 1.00, P = 0.05, I<sup>2</sup> 0%, lo‐ certainty evidence, downgraded for limitations of studies and imprecision), anticonvulsants (RR 0.80, 95% CI 0.33 to  1.94, P = 0.62, I<sup>2</sup> 75%, very low‐certainty evidence, downgraded for limitations of studies, imprecision and inconsistency) or paracetamol (acetaminophen) (1 study n = 60; RR 0.58, 95% CI 0.23 to  1.51, P = 0.27, low‐certainty evidence, downgraded for limitations of studies, inconsistency and imprecision). Though it is noted that the point estimates all indicated a possible reduction in the number of participants using these medications in the SCS group. Sensitivity analysis using a fixed‐effect model did not impact these estimates of effect. </p> <p>One study (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>, N = 100, <a href="./references#CD013756-fig-0023" title="">Analysis 2.19</a>) measured daily doses of opioids and converted them to a morphine equivalent dose using "routine conversion tables". These were presented as a low and high range equivalent daily mg as for some drugs a range of values was provided. There was no clear evidence of a difference in morphine consumption in either the low range (MD mg, ‐28.60, 95% CI ‐102.65 to 45.45) or high range (MD mg, ‐48.20, 95% CI ‐140.57 to 44.17) values. We graded the evidence as very low certainty, downgraded for limitations of studies, imprecision and inconsistency. </p> <p>The <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> study reported that at six months follow‐up 8/52 participants in the SCS group and 1/48 participants in the control group ceased opioids. <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> did not report changes in medication use consistently between groups making interpretation difficult. </p> <p>We were unable to include data from <a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a>, (N = 226) in this analysis as, although the methods suggested this outcome was evaluated at this time‐point, the data were not reported. </p> </section> </section> </section> <section id="CD013756-sec-0116"> <h5 class="title">Brief economic commentary</h5> <p>With two of the published RCTs (<a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>; <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a>), additional publications reported the results of economic evaluations that were planned and conducted as part of the original RCTs. Both compared SCS + medical management with medical management alone. <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> included participants with FBSS and <a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> with painful diabetic neuropathy. </p> <p>In the <a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a> study, healthcare consumption data related to screening, the use of implantable SCS generators, hospital stays, drug and non‐drug‐related treatments were collected and used to estimate resource consumption and costs for participants using UK and Canadian national figures (from 2005 to 2006). This study was conducted across 12 centres in Europe, Canada, Australia and Israel between 2003 and 2005 and randomised 100 participants. HRQoL was measured using the EQ‐5D. The study reported unadjusted costs at six‐month follow‐up in the SCS group of 12,653 Euros (SD 2756) per participant compared to costs of EUR 2594 (SD 2939) in the CMM group (MD 10059, 95% CI 8742.39 to 11375.61). Improvements in HRQoL at this point were reported as a mean difference, in favour of SCS of 0.23 (95% CI 0.12 to 0.35) on the EQ‐5D index score. After adjustment for participant baseline characteristics, the authors report that SCS increased HRQoL by 0.21 (95% CI 0.00 to 0.33) points at an additional cost of EUR 9997 (95% CI 8435 to 11577). A full cost‐effectiveness analysis, including Quality Adjusted Life Years (QALYs) or incremental cost‐effectiveness ratios (ICERs), was not reported as the authors argued that this would require consideration of costs and quality of life effects beyond the six‐month trial time horizon. </p> <p><a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> conducted an economic evaluation from a societal and healthcare perspective. This study was conducted in two academic hospitals in the Netherlands and randomised 36 participants. EQ‐5D scores were used to calculate QALYs. Cost analysis included all healthcare costs according to Dutch guidelines, inclusive of costs relating to the intervention, costs incurred for other reasons attributable to PDN and its treatment, other healthcare costs and non‐healthcare costs derived by a questionnaire administered to participants. Incremental cost‐effectiveness ratios (ICERs) were derived for full societal costs. From a healthcare perspective costs were calculated based on successfully treated patients, defined as a patient experiencing ≥ 50% relief of pain intensity on a weighted numeric rating scale, for four days during daytime or nighttime, or a score of ≥ 6 on a 7‐point Likert scale (6 = much improved; 7 = very much improved) of the Patient Global Impression of Change (PIC) scale for pain and sleep at 12 months. Cost‐effectiveness was judged using maximum willingness to pay thresholds of EUR 20,000 and 80,000 per QALY gain. The evaluation had a 12‐month time horizon. </p> <p>Total societal costs amounted to EUR 26,539.20 in the SCS group and EUR 5,313.45 in the medical management group. Intervention costs amounted to EUR 16,579.82 in the SCS group and EUR 341.97 in the medical management group. Implanted/ device materials accounted for 58% of intervention costs, while complications related to SCS resulted in costs of EUR 2388. Non‐healthcare costs were also higher in the SCS group than the medical management group (EUR 7797 and 3140, respectively) and included differences in costs due to informal care, productivity loss and loss of daily activities. </p> <p>In terms of cost‐effectiveness from a societal perspective, SCS provided the most QALYs with an ICER of EUR 94,159.65 per QALY for SCS versus medical management. Using a range of willingness to pay threshold of EUR 20,000 to 80,000 per QALY, the probability that SCS was cost‐effective ranged between 0 and 46%. From a healthcare perspective, the ICER was EUR 34,518.85 per successfully treated patient. </p> <p>We did not subject either of the economic evaluations to critical appraisal, and we do not attempt to draw any firm or general conclusions regarding the relative costs or efficiency of SCS + medical management compared with medical management alone. However, very limited evidence demonstrates that adding SCS to medical management to medical management alone is associated with substantial increases in healthcare costs and may be associated with increases in non‐healthcare costs. One small cost‐effectiveness model did not clearly demonstrate cost‐effectiveness. The relatively short‐time horizons of the available studies limit their applicability in assessing cost‐effectiveness. Thus, the included studies are not sufficient to confidently draw conclusions regarding the cost‐effectiveness of SCS. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013756-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013756-sec-0117"></div> <section id="CD013756-sec-0118"> <h3 class="title" id="CD013756-sec-0118">Summary of main results</h3> <p>We included 15 published studies in this review that randomised 908 participants. All the included evidence in this review relates to spinal cord stimulation(SCS). We identified no studies of dorsal root ganglion stimulation (DRGS) and thus have found no evidence to support or refute the use of DRGS for the treatment of chronic pain. We found no studies that compared spinal neuromodulation S(NMD)interventions with no treatment or usual care. </p> <section id="CD013756-sec-0119"> <h4 class="title">Pain</h4> <section id="CD013756-sec-0120"> <h5 class="title">Active stimulation versus placebo</h5> <section id="CD013756-sec-0121"> <h6 class="title">Spinal cord stimulation (SCS) versus placebo</h6> <p>We included nine studies that randomised 224 participants in total that compared SCS using a variety of stimulation parameters with some form of sham stimulation, in which a potentially therapeutic dose was not delivered to participants. We found very low‐certainty evidence of small short‐term effects of SCS versus sham on pain intensity that may not be clinically important. Heterogeneity of treatment effects was moderate and was not explained by stimulation parameters. These studies did not provide data at medium‐ or long‐term follow‐up. </p> </section> </section> <section id="CD013756-sec-0122"> <h5 class="title">Active stimulation versus other intervention versus other intervention alone</h5> <section id="CD013756-sec-0123"> <h6 class="title">SCS + other intervention versus other intervention alone</h6> <p>We included six studies that randomised 684 participants in total that evaluated the addition of SCS versus either medical management or physical therapy versus medical management or physical therapy alone. We found evidence that SCS had large effects on pain intensity at both short‐term (very low‐certainty evidence) and medium‐term follow‐up (low‐certainty evidence), both in terms of average pain scores and the proportion of participants experiencing ≥ 50% pain relief. At long‐term follow‐up we found no clear evidence for a benefit of SCS on average pain scores (very low certainty), and evidence of a large effect on the proportion of participants experiencing ≥ 50% pain relief (very low certainty). </p> </section> </section> </section> <section id="CD013756-sec-0124"> <h4 class="title">Adverse events</h4> <p>SCS is associated with a reasonably common incidence of procedure and device‐related complications including infection, lead failure or displacement, and the need for further surgical procedures. For example, at six months follow‐up our estimates suggest a 4% risk of infection, a 4% risk of lead failure/ displacement and an 11% risk of requiring reoperation/reimplantation. However, the certainty around our estimates of the risk of these events is low to very low. Studies also reported other procedure‐ and device‐related complications. </p> <p>In the included studies we found reports of some serious adverse events that were highly likely to be associated with the intervention. These included one death resulting from a subdural haematoma following a dural puncture, autonomic neuropathy resulting from a procedure‐related infection, prolonged hospitalisation due to a coagulopathy that resulted in procedural complications, an extradural abscess leading to prolonged monoparesis, a case of pulmonary oedema, wound infection, and an incident of device extrusion. </p> </section> <section id="CD013756-sec-0125"> <h4 class="title">Secondary outcomes</h4> <section id="CD013756-sec-0126"> <h5 class="title">SCS versus placebo</h5> <p>We found limited data for our secondary outcomes for this comparison. There was insufficient evidence to draw conclusions regarding disability or medication use. We found no evidence for an effect of SCS versus sham on health‐related quality of life (HRQoL) (very low‐certainty evidence). </p> </section> <section id="CD013756-sec-0127"> <h5 class="title">SCS + other intervention versus other intervention alone</h5> <p>We found no clear evidence for an effect of SCS on disability (very low‐certainty evidence). For HRQoL we found evidence for positive effects of SCS in the short and medium‐term (low certainty evidence) and no evidence for an effect at long‐term follow‐up (very low‐certainty evidence). We found no clear evidence for an effect of SCS on medication use at medium‐term follow‐up (low‐ to very low‐certainty evidence). </p> <p>We found limited economic evidence. The available evidence indicates that SCS is associated with substantial increases in costs that are dominated by the costs of the device/apparatus and procedure, and the costs of managing complications. The only cost‐effectiveness analysis we included suggested that the cost‐effectiveness of SCS was uncertain at willingness to pay thresholds of both EUR 20,000 to 80,000 per Quality Adjusted Life Years (QALY). </p> </section> </section> </section> <section id="CD013756-sec-0128"> <h3 class="title" id="CD013756-sec-0128">Overall completeness and applicability of evidence</h3> <p>The absence of evidence relating to dorsal root ganglion stimulation (DRGS) prevents us from drawing any conclusions regarding the efficacy, effectiveness or safety of that intervention. </p> <p>The included studies were conducted across a range of countries and, while limited information was provided on settings, all appeared to be conducted in specialist secondary care. We identified no studies that were conducted in lower‐ to middle‐income countries. Studies included participants with a range of painful conditions, many of which might be classified as neuropathic in nature, or are proposed to be potentially neuropathic e.g. failed back surgery syndrome (FBSS) or complex regional pain syndrome (CRPS). However, few studies in those latter conditions used formal assessments or criteria to determine the presence or absence of neuropathic mechanisms. We did not find adequate data to formally evaluate whether treatment effects differed by clinical condition, but the frequent lack of formal approaches to establishing pain of a likely neuropathic nature (e.g. <a href="./references#CD013756-bbs2-0076" title="FinnerupN , HaroutounianS , KamermanP , BaronR , BennettDL , Bouhassira D et al.Neuropathic pain: an updated grading system for research and clinical practice. Pain2016;157:1599-606.">Finnerup 2016</a>) would have presented a further challenge to that process. The balance across sex of participants was even overall, but almost all studies offered no information on other demographic characteristics of participants such as ethnicity or socioeconomic status. Studies mainly recruited participants whose pain was refractory to prior clinical management and baseline levels of pain were uniformly high across all studies except those where participants were already receiving SCS prior to randomisation. </p> <p>For the comparison SCS versus sham, three studies randomised participants after they had been considered to demonstrate a positive clinical response to a trial period of stimulation and three studies recruited participants who were already implanted with and were receiving SCS. As a result, these studies might be considered to be of an enriched enrolment design as participants were pre‐selected on the basis of their outcomes following SCS. </p> <p>Studies comparing SCS versus sham were all small, with short‐term follow‐up and all employed a cross‐over design. We found no studies to inform a comparison of SCS versus placebo in the medium or long term. Some trials failed to report on our outcomes of interest at specific time points despite designating those outcomes in the trial registry record or trial protocol. We needed to request data from the authors of all the included studies, but we only received requested data from the authors of three studies. It is possible that these missing data may not be missing completely at random. We identified a small number of unpublished studies from conference abstracts and trial registry records. However, it is important to consider that this likely underestimates the true number of unpublished studies of SNMD as it cannot include studies that were not pre‐registered or presented at conferences. </p> <p>While all trials reported adverse events in some form, there was a frequent lack of detail regarding the methods used to measure and classify adverse events (AEs). Reporting of both device‐/procedure‐related and other AEs varied substantially across studies. It is possible that AEs may be underreported in the included trials. In addition, the included trials may not be of adequate size to capture rare adverse events. </p> <p>There were no adequate data to formally explore the potential differential effectiveness of different stimulation parameters (conventional, high frequency or burst). Preliminary data from our SCS versus sham comparison was not suggestive of marked differences, but this is based on very little data. In our comparisons of SCS + other versus other alone, all but one of the included studies used conventional SCS and one study used high‐frequency spinal cord stimulation(HF‐SCS). </p> <p>The limited availability of cost‐effectiveness analyses embedded within the included studies substantially limits our ability to draw conclusions. Those data did not clearly demonstrate cost‐effectiveness and should be considered against a historic trend of increasing costs per surgery of SCS (<a href="./references#CD013756-bbs2-0086" title="LadSP , KalanithiPS , ArrigoRT , PatilCG , NathanJK , BoakyeM , et a[.A socioeconomic survey of spinal cord stimulation (SCS) surgery.. Neuromodulation2010;13:265-8.">Lad 2010</a>). Similarly, we found little data to inform our analyses for the outcomes of disability and medication use. </p> <p>Reviewing the ongoing studies that we identified, the majority are similar to included published studies. Most are either small, short‐term cross‐over studies, the majority of which evaluate burst SCS versus sham, or open‐label studies of SCS + medical management versus medical management alone, and vary between evaluating conventional, HF or burst SCS. We found only one parallel sham‐controlled study of SCS (HF) (<a href="./references#CD013756-bbs2-0050" title="Al-KaisyA , RoydsJ , PalmisaniS , PangD , WesleyS , TaylorR , et al.Multicentre, double-blind, randomised, sham-controlled trial of 10 khz high-frequency spinal cord stimulation for chronic neuropathic low back pain (MODULATE-LBP): a trial protocol. Trials2020;21:1-13. ">MODULATE‐ LBP</a>, N = 96), which proposed follow‐up beyond the short term (six months) and only three small studies of DRGS, two where the comparator was sham stimulation (<a href="./references#CD013756-bbs2-0048" title="Effect of stimulation frequency in dorsal root ganglion stimulation (DRG Stimulation). Ongoing study. 01/04/2021. Contact author for more information.">DRKS00022557</a> N = 50; <a href="./references#CD013756-bbs2-0062" title="A European, prospective, multi-center, double-blind, randomized, controlled, clinical trial investigating the effects of high frequency wireless spinal cord stimulation (SCS) over exiting nerve roots in the treatment of chronic back pain. Ongoing study. 01/03/2018. Contact author for more information.">TSUNAMI DRG</a>, N = 38), and the other medical management (<a href="./references#CD013756-bbs2-0058" title="Diabetic peripheral neuropathy treatment with dorsal root ganglion stimulation – the trial. Ongoing study. 13/06/2018. Contact author for more information.">PENTAGONS</a>, N = 56). </p> </section> <section id="CD013756-sec-0129"> <h3 class="title" id="CD013756-sec-0129">Quality of the evidence</h3> <section id="CD013756-sec-0130"> <h4 class="title">SCS versus placebo</h4> <p>All the assessed study results were at high risk of bias overall and were rated to be either at high risk or to present some concerns for multiple domains on the ROB2 tool for all comparisons where we made judgments. For sham‐controlled studies the lack of formal assessment of blinding success, the common use of per‐protocol analyses and the lack of washout periods seriously impact our confidence in those results. That we found only small effects of SCS versus sham despite these biases further reinforces the lack of compelling evidence to support the efficacy of SCS. It is notable that the one study in this comparison that we rated at low risk of bias relating to outcome measurement (blinding) found no evidence for an effect of SCS (<a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a>). </p> <p>Studies included in this comparison were all relatively small, delivered short‐term interventions with only short‐term follow‐up, and were essentially exploratory in nature. To reduce the uncertainty there is a need for larger studies comparing SCS with sham over longer, more clinically‐relevant time periods with full reporting of both efficacy outcomes and adverse events. There is evidence that the size of the included studies may lead to an overly positive picture for some interventions (<a href="./references#CD013756-bbs2-0070" title="DechartresA , TrinquartL , BoutronI , RavaudP .Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ2013;346:f2304.">Deschartres 2013</a>; <a href="./references#CD013756-bbs2-0096" title="NüeschE , TrelleS , Reichenbach S, RutjesAW , TschannenB, AltmanDG , et al.Small study effects in meta-analysesof osteoarthritis trials: meta-epidemiological study. BMJ2010;341(7766):241.">Nuesch 2010</a>). In a review of meta‐analyses, <a href="./references#CD013756-bbs2-0070" title="DechartresA , TrinquartL , BoutronI , RavaudP .Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ2013;346:f2304.">Deschartres 2013</a> demonstrated that trials with fewer than 50 participants, which reflects all the studies included in this comparison, returned effect estimates that were on average 48% larger than the largest trials and 23% larger than estimates from studies with sample sizes of more than 50. While there were no adequate data to formally explore publication bias, the identification of five potential unpublished studies with a total of 74 participants raises the possibility of such a bias in this evidence base. </p> <section id="CD013756-sec-0131"> <h5 class="title">SCS + other intervention versus other intervention alone</h5> <p>Open‐label comparisons resulted in much larger effect sizes at short‐ and medium‐term follow‐up. Study results in these comparisons were rated to be at high risk of bias overall and as such the resultant effect sizes may be exaggerated. The finding of large, clinically‐important effects in open‐label studies and a lack of compelling evidence for important effects from sham‐controlled studies raises questions regarding the mechanisms of SCS and how much of the observed effect might be explained by the contextual effects of undergoing this complex and invasive clinical procedure, rather than the specific effects of SCS. It might be argued that contextual (placebo) effects are unlikely to account for such large and sustained effects. However, the use of sophisticated technology, the invasive nature of the procedure, the need for frequent clinical interactions and treatment‐related sensory experiences and, in some cases, the costs of SNMD all have the potential to drive non‐specific effects. </p> <p>There are parallels from other clinical interventions. <a href="./references#CD013756-bbs2-0064" title="BuchbinderR , JohnstonRV , RischinKJ , HomikJ , JonesCA , GolmohammadiK , et al.Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD006349. [DOI: 10.1002/14651858.CD006349.pub4]">Buchbinder 2018</a> reviewed the evidence for percutaneous vertebroplasty for osteoporotic vertebral compression fractures. Like SNMD, vertebroplasty is an invasive intervention with persistent pain a key outcome and where participants typically report high levels of baseline pain intensity. They found large effects on pain (mean difference ranged from the equivalent of 16 to 33 points on a 0 to 100 pain scale) in usual care comparisons at short‐, medium‐ and long‐term follow‐up, but evidence of no clinically important effects of vertebroplasty versus placebo (moderate to high‐certainty evidence). In contrast, in our review that evidence is of very low certainty. The rating of the results in these comparisons as being at high risk of bias or presenting “some concerns” across ROB2 domains that are not solely related to blinding further increases the risk that the observed effect sizes may be inflated. </p> <p>There was insufficient evidence to explore small‐study/potential publication biases through the use of funnel plots or associated tests. Using the method outlined by <a href="./references#CD013756-bbs2-0091" title="MooreRA , BardenJ , DerryS , McQuayHJ .Managing potential publication bias. In: Systematic Reviews in Pain Research: Methodology Refined. Vol. 1. Seattle: IASP Press, 2008:1:15-23.">Moore 2008</a>, we estimated the number of participants in studies with no effect required to change the number needed to treat for an additional beneficial outcome (NNTB) to an unacceptably high level (defined as an NNTB of 10) and found that in general, large numbers of participants in negative studies would be needed for that outcome. This is a function of the consistently large effect sizes observed in included studies and subsequent low NNTBs, which, as discussed above, may to some extent reflect a number of study‐level biases. </p> <p>The evidence for adverse events was of poorer quality than for pain. This was largely due to substantial variation and frequent lack of detail in the detail of reporting of the methods used to record and classify adverse events, and inconsistency in the level of reporting of adverse events. </p> <p>Eleven of the 15 included studies declared some funding or sponsorship from industry entities with an interest in the manufacture and sale of SCS equipment and the sponsor's role in the study was not always made clear. Ten studies reported one, or commonly, more authors with declared relationships with industry related to SNMD technology. These took the form of non‐financial support, consultancies, stock options, honoraria, speakers fees and travel grants. Another study reported that an author had obtained a patent for the intervention under investigation. <a href="./references#CD013756-bbs2-0087" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL .Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [CENTRAL: MR000033] [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a> found moderate‐ to low‐certainty evidence that industry‐sponsored studies of drugs or medical devices more often report more favourable efficacy results and conclusions, though similar harms results compared to non‐industry sponsored studies. While we provide no direct evidence in this review, this potential for bias should be considered when interpreting these results. </p> </section> </section> </section> <section id="CD013756-sec-0132"> <h3 class="title" id="CD013756-sec-0132">Potential biases in the review process</h3> <p>We have conducted searches across a range of databases, included studies regardless of language, searched for unpublished completed studies and contacted study authors to ensure our review is as inclusive of the available evidence as is possible. </p> <p>Due to the lack of necessary phase‐by‐phase data we deviated from our protocol plan for analysing cross‐over studies, but did not have the required data to make adjustments for the paired nature of these studies. This presents a potential unit of analysis issue. As such, while point estimates in this analysis should be accurate representations of the data it is likely that these analyses may be conservative, specifically in terms of overestimating imprecision. The effect size for the SCS versus sham comparison on pain intensity is slightly more conservative than that seen in a recent review by <a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a> who were able to make adjustments for the paired nature of the data and reported a mean difference equivalent to ‐11.5 (95% CI ‐17.5 to ‐5.5) on a 0 to 100 visual analogue scale (VAS). However, this might better be explained by differences in the studies and data included between the two reviews. We included an additional trial arm from one study (<a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a>) and three comparisons from another study (<a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a>), and excluded a study (<a href="./references#CD013756-bbs2-0036" title="WolterT , KiemenA , PorzeliusC , KaubeH .Effects of sub-perception threshold spinal cord stimulation in neuropathic pain: a randomized controlled double-blind crossover study. European Journal of Pain2012;16(5):648‐55. ">Wolter 2012</a>) that was included by <a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a>. The exclusion of those data from <a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> and <a href="./references#CD013756-bbs2-0015" title="Tjepkema-CloostermansMC , deVosCC , WoltersR , Dijkstra-ScholtenC , LendersMW .Effect of burst stimulation evaluated in patients familiar With spinal cord stimulation. Neuromodulation2016;19(5):492-7. ">Tjepkema‐Cloostermans 2016</a> from our analysis results in an effect size very similar to that reported by <a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a> (‐11.1 (95% CI ‐17.4 to ‐4.70), suggesting that our analysis approach may have had minimal impact on our findings. </p> <p>We planned to analyse on an intention‐to‐treat basis. In many trials, where the pre‐implantation trial period occurred post‐randomisation a proportion of participants (median 19%, range (7% to 33 %) did not receive permanent implantation. In terms of adverse events, our analysis includes all available participants randomised to SCS regardless of whether permanent implantation followed. As a result, these data may underestimate the rate of AEs in those receiving permanent implantation. </p> <p>We only included economic evaluations that were conducted as part of the included randomised controlled trials (RCTs.) This has limited the amount of health economic evidence from which we can draw conclusions. </p> </section> <section id="CD013756-sec-0133"> <h3 class="title" id="CD013756-sec-0133">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a> conducted a systematic review of placebo‐controlled SCS studies. Despite minor differences in inclusion and analytical approach discussed above they found similar results to ours, with modest effects of SCS versus sham, though our analysis is more conservative. <a href="./references#CD013756-bbs2-0072" title="DuarteRV , NevittS , McNicolE , TaylorRS , BuchserE , NorthRB , et al.Systematic review and meta-analysis of placebo/sham controlled randomised trials of spinal cord stimulation for neuropathic pain. Pain2020;161(1):24-35.">Duarte 2020</a> investigated the potential influence of blinding and found much smaller effects when their analysis was limited to studies they assessed as more likely to be effectively blinded, though that included studies that did not formally evaluate the success of blinding. </p> <p>In a review of SCS for chronic spinal pain, <a href="./references#CD013756-bbs2-0078" title="GriderJS , ManchikantiL , CarayannopoulosA , SharmaML , BalogCC , HarnedME , et al.Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Physician2016;19(1):E33-54.">Grider 2016</a> concluded that there misquote:  "significant level I to II evidence" of the efficacy of SCS in lumbar failed back surgery syndrome (FBSS), moderate evidence for high‐frequency stimulation, and limited evidence for burst stimulation. While the conclusions of that review are nominally more positive than our review, it is important to note that our review is more current, includes more studies and a wider range of conditions, and has arguably taken a more robust approach to assess risk of bias and the certainty of the evidence. It is also noteworthy that <a href="./references#CD013756-bbs2-0078" title="GriderJS , ManchikantiL , CarayannopoulosA , SharmaML , BalogCC , HarnedME , et al.Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Physician2016;19(1):E33-54.">Grider 2016</a> did not evaluate the potential harms of SCS. </p> <p><a href="./references#CD013756-bbs2-0074" title="EldabeS , BuchserE , DuarteRV .Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Medicine2016;17(2):325-36.">Eldabe 2016</a> conducted a review of the literature relating to the complications of SCS. The authors included a range of study designs including RCTs, systematic reviews and retrospective studies. They reported an overall incidence of complications of 30% to 40%. Mean rates were reported for lead failure (fracture of malfunction) 6% (95% CI 2% to 10%, lead migration 15.5% (95% CI 9% to 22%, infection (4.8% (95% CI 3.4% to 6.4%). These rates are broadly similar to those in this review. Also similar to our findings serious adverse events (SAEs) were generally the result of neurological injury and also included a case of paraplegia as a result of SCS implantation. <a href="./references#CD013756-bbs2-0074" title="EldabeS , BuchserE , DuarteRV .Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Medicine2016;17(2):325-36.">Eldabe 2016</a> noted, as we have, that the reporting of complications of SCS is variable in the literature and makes recommendations for more consistent, clearer reporting. </p> <p>With regards cost‐effectiveness, <a href="./references#CD013756-bbs2-0095" title="NiyomsriS , DuarteRV , EldabeS , FioreG , KopellBH , McNicolE , et al.A systematic review of economic evaluations reporting the cost-effectiveness of spinal cord stimulation. Value in Health2020;23(5):656-65.">Niyomsri 2020</a> reviewed evidence of economic evaluations from controlled studies of SCS or DRGS.  Based on 14 studies, the authors concluded that when considering a long‐term time horizon SCS is cost‐effective particularly for the management of FBSS and CRPS. In contrast to our review, there was no requirement for the economic evaluations to have been planned and conducted as part of the original RCTs and the inclusion criteria did not exclude non‐randomised studies. </p> <p>A recent systematic review (<a href="./references#CD013756-bbs2-0088" title="McNicolE , FergusonM , BungayK , RoweEL , EldabeS , GewandterJS , HayekSM , et al.Systematic review of research methods and reporting quality of randomized clinical trials of spinal cord stimulation for pain. Journal of Pain2021;22(2):127-42.">McNicol 2021</a>) scrutinised the design characteristics and quality of reporting of RCTs of SCS for the treatment of pain, in children and adults. Using broader inclusion criteria than our review, <a href="./references#CD013756-bbs2-0088" title="McNicolE , FergusonM , BungayK , RoweEL , EldabeS , GewandterJS , HayekSM , et al.Systematic review of research methods and reporting quality of randomized clinical trials of spinal cord stimulation for pain. Journal of Pain2021;22(2):127-42.">McNicol 2021</a> identified substantial deficiencies in the reporting and methodology of SCS trials, including issues with inadequate study size, the use and adequacy of blinding, clear and appropriate use and reporting of intention‐to=treat analysis, clarity over the sponsor's role and the methods for collecting and the reporting of adverse events. These issues were all present and identified as issues in our review. </p> <p>Health technology appraisals (HTA) from Canada (<a href="./references#CD013756-bbs2-0090" title="Medical Advisory Secretariat, Ministry of Health and Long-term Care (MoH-LTC).Spinal cord stimulation for neuropathic pain. An evidence based analysis. Ontario Health Technology Assessment Series2005;5(4):1-78.">MoH‐LTC 2005</a>) and the UK (<a href="./references#CD013756-bbs2-0093" title="National Institute of Health and Care Excellence (NICE).Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. Technology appraisal guidance (TA159). www.nice.org.uk/guidance/ta1592008;(accessed 5 February 2020).">NICE 2008</a>) have recommended SCS for people with chronic pain of neuropathic origin who had not responded to conventional medical management. These appraisals are not based on the most recent evidence and do not reflect the uncertainty arising from subsequent sham‐controlled studies, regarding the clinical benefit of SNMD over placebo stimulation. A more recent HTA in the UK (<a href="./references#CD013756-bbs2-0094" title="National Institute for Health and Care Excellence (NICE).Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. Medical technologies guidance (MTG41). www.nice.org.uk/guidance/mtg412019;(accessed 5 February 2020).">NICE 2019</a>), focused on the SENZA high‐frequency spinal cord neuromodulation device, recommended the system for chronic neuropathic back or leg pain after failed back surgery based on limited evidence from two small trials comparing high‐frequency stimulation with conventional stimulation, but did not include any comparison with sham stimulation. The European Academy of Neurology (EAN) guidelines on central neurostimulation therapy in chronic pain conditions (<a href="./references#CD013756-bbs2-0067" title="CruccuG , Garcia-LarreaL , HanssonP , KeindlM , LefaucheurJP , PaulusW .EAN guidelines on central neurostimulation therapy in chronic pain conditions. European Journal of Neurology2016;23:1489-99.">Cruccu 2016</a>) made a "weak recommendation" to add SCS to medical management in painful diabetic neuropathy, chronic post‐surgical back and leg pain, and complex regional pain syndrome (CRPS) type I. Similar to our review, the authors highlighted the quality of the evidence as a key issue in this evidence base. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013756-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD013756-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SCS vs sham, Outcome 1: Pain Intensity: average post‐intervention. Short‐term follow up. Mean difference" data-id="CD013756-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: SCS vs sham, Outcome 1: Pain Intensity: average post‐intervention. Short‐term follow up. Mean difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SCS vs sham, Outcome 2: Disability: short‐term follow‐up" data-id="CD013756-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: SCS vs sham, Outcome 2: Disability: short‐term follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SCS vs sham, Outcome 3: HR‐QoL: short‐term follow‐up" data-id="CD013756-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: SCS vs sham, Outcome 3: HR‐QoL: short‐term follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 1: Pain intensity: average post‐intervention. Short‐term follow‐up. Mean Difference" data-id="CD013756-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 1: Pain intensity: average post‐intervention. Short‐term follow‐up. Mean Difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 2: Pain: participants with ≥50% pain relief. Short‐term follow‐up. Risk Ratio" data-id="CD013756-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 2: Pain: participants with ≥50% pain relief. Short‐term follow‐up. Risk Ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 3: Pain intensity: average post‐intervention. Medium‐term follow‐up. Mean difference" data-id="CD013756-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 3: Pain intensity: average post‐intervention. Medium‐term follow‐up. Mean difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 4: Pain: participants with ≥50% pain relief. Medium‐term follow‐up. Risk Ratio" data-id="CD013756-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 4: Pain: participants with ≥50% pain relief. Medium‐term follow‐up. Risk Ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 5: Pain intensity: average post‐intervention. Long‐term follow‐up. Mean difference" data-id="CD013756-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 5: Pain intensity: average post‐intervention. Long‐term follow‐up. Mean difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 6: Pain: participants with ≥50% pain relief. Long‐term follow‐up. Risk Ratio" data-id="CD013756-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 6: Pain: participants with ≥50% pain relief. Long‐term follow‐up. Risk Ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 7: Adverse events: electrode/lead failure or displacement. Medium‐term follow‐up" data-id="CD013756-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 7: Adverse events: electrode/lead failure or displacement. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 8: Adverse events: electrode/lead failure or displacement. Long‐term follow‐up" data-id="CD013756-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 8: Adverse events: electrode/lead failure or displacement. Long‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 9: Adverse events: infection. Medium‐term follow‐up" data-id="CD013756-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 9: Adverse events: infection. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 10: Adverse events: need for repeated implantation procedures. Medium‐term follow‐up" data-id="CD013756-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 10: Adverse events: need for repeated implantation procedures. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 11: Adverse events: need for repeated implantation procedures. Long‐term follow‐up" data-id="CD013756-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 11: Adverse events: need for repeated implantation procedures. Long‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 12: Adverse events: other. Medium‐term follow‐up" data-id="CD013756-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 12: Adverse events: other. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 13: Adverse events: other. Long‐term follow‐up" data-id="CD013756-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 13: Adverse events: other. Long‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 14: Disability (Oswestry Disabiility Index). Medium‐term follow‐up" data-id="CD013756-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 14: Disability (Oswestry Disabiility Index). Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 15: Health‐Related Quality of Life. Short‐term follow‐up" data-id="CD013756-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 15: Health‐Related Quality of Life. Short‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 16: Health‐Related Quality of Life. Medium‐term follow‐up" data-id="CD013756-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 16: Health‐Related Quality of Life. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 17: Health‐Related Quality of Life. Long‐term follow‐up" data-id="CD013756-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 17: Health‐Related Quality of Life. Long‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 18: Medication use: participants using medication. Medium‐term follow‐up" data-id="CD013756-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 18: Medication use: participants using medication. Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013756-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/urn:x-wiley:14651858:media:CD013756:CD013756-CMP-002.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SCS + other intervention vs other intervention, Outcome 19: Medication use: morphine oral equivalent daily (mg). Medium‐term follow‐up" data-id="CD013756-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_t/tCD013756-CMP-002.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2: SCS + other intervention vs other intervention, Outcome 19: Medication use: morphine oral equivalent daily (mg). Medium‐term follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/media/CDSR/CD013756/image_n/nCD013756-CMP-002.19.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013756-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Active stimulation vs placebo (sham)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Active Stimulation versus placebo for chronic pain in adults</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Patient or population:</b> adults with chronic pain </p> <p><b>Settings:</b> secondary care </p> <p><b>Intervention/comparison:</b> SCS vs placebo (sham stimulation) </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Probable outcome with SNMD</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Probable outcome with sham</b> </p> </td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of participants</b> <b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign="top"> <p><b>Short‐term follow‐up (reported within the first month )</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity continuous outcomes. (VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity was 8.73 points lower (95%CI ‐15.67, ‐1.78) than in the control group. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean post‐intervention pain score in sham group. 55.8 (95%CI 43.3, 64.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>164 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not estimable, adverse events not reported by stimulation condition</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Medium term follow‐up (reported between 3 and 6 months)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes(VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Long term follow‐up (reported at 1 year or longer greater than 1 year)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Infection</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: Need for reoperation/reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>No evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>CI:</b> confidence interval; <b>SNMD:</b> Spinal neuromodulation<b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Lowcertainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1.</sup> downgraded twice for serious study limitations, once for imprecision, once for inconsistency and once for the potential for publication bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Active stimulation vs placebo (sham)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013756-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Active stimulation + other intervention vs other intervention alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Active stimulation + other intervention versus other intervention alone for chronic pain in adults (open label studies).</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Patient or population:</b> adults with chronic pain </p> <p><b>Settings:</b> secondary care </p> <p><b>Intervention/comparison:</b> SCS + other intervention (medical management or physical therapy) vs other intervention alone </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effects (Risk Ratio (RR) 95%CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of participants</b> <br/><b>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence</b> <br/><b>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Risk with SNMD + other interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Risk with other intervention alone</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Short‐term follow‐up (reported within the first month )</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity continuous outcomes. (VAS 0‐100, higher scores = worse pain)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 37.41 points lower (95% CI ‐46.39 to ‐28.42) than in the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean post‐intervention pain score in control group was 69.3 (95%CI 68‐72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 15.90 (95%CI 6.70, 37.74)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69.6%</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>249 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 65% more participants with SCS (95%CI 57, 74)</p> <p>NNTB 1.5 (95%CI 1.4, 1.8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Medium‐term follow‐up (reported between 4 and 8 months)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100, higher scores = worse pain)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 31.22 points lower (95% CI ‐47.34 to ‐15.10) than in the control group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean post‐intervention pain score in control group was 70.1 (95%CI 67, 73.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>635 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥50% pain relief.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 7.08 (95%CI 3.40, 14.71)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>597 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 43% more participants with SCS (95%CI 14, 73)</p> <p>NNTB 2.3 (95%CI 1.4, 7.1)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Adverse events:lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 3.02 (95%CI 0.52, 17.58)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>330 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝</p> <p>very low<sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 4% more participants with SCS (95%CI 4% fewer, 11% more)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events:infection</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 4.83 (95%CI 1.09, 21.40)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>548 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 4% more participants with SCS (95%CI 1, 7)</p> <p>NNTH 25 (95%CI 14, 100)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: need for reoperation/ reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 9.79 (95%CI 2.35, 40.76)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>548 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 11% more participants with SCS (95%CI 2, 21)</p> <p>NNTH 9 (95%CI 4.8, 50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 0.87 (95%CI 0.64, 1.30)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>278 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕ ⊕⊝⊝</p> <p>low<sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 5% fewer participants with SCS (95%CI 16% fewer, 6% more)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Long‐term follow‐up (reported at 1 year or longer greater than 1 year)</b><br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain intensity, continuous outcomes (VAS 0 ‐ 100, higher scores = worse pain) (5 years follow‐up) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the intervention groups was 7 points lower than in the control group (95% CI ‐‐24.76 to 10.76 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain intensity reduced from baseline in the control group by ‐10 (95%CI ‐18, 2) points.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain intensity. Proportion with ≥ 50% pain relief. (2‐year follow up)<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 15.15 (95%CI 2.11, 108.91)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>87 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 35% more participants with SCS (95%CI 20, 49)</p> <p>NNTB 2.9 (95%CI 2, 5)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: lead failure/ displacement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>RR 15.31 (95%CI 0.99, 237.16)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 55% more participants with SCS (95%CI 35, 75)</p> <p>NNTH 1.8 (95%CI 1.3, 2.9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: infection</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not estimable, data not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: need for reoperation/reimplantation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 25.81 (95%CI 1.69, 393.31)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>44 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 94% more participants with SCS (95%CI 80, 107)</p> <p>NNTH 1.05 (95%CI 0.93, 1.25)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events: other</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign=""> <p>RR 0.66 (95%CI 0.42, 1.05)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34.6%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p>very low<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Difference: 17% fewer participants with SCS (95%CI 37% fewer to 2% more)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>* Control group risk estimates come from pooled estimates of control groups.</p> <p><b>CI:</b> confidence interval; <b>SNMD:</b> Spinal neuromodulation<b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> downgraded once for study limitations, imprecision and inconsistency </p> <p><sup>2</sup> downgraded for twice for serious study limitations and once for imprecision </p> <p><sup>3</sup> downgraded once for study limitations and once for inconsistency </p> <p><sup>4</sup> downgraded once for study limitations and once for imprecision </p> <p><sup>5</sup> downgraded twice for serious study limitations, once for imprecision and once for inconsistency </p> <p><sup>6</sup> downgraded once for study limitations and twice for serious imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Active stimulation + other intervention vs other intervention alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013756-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS versus sham</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Period of measurement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Lead failure/ displacement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Infection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Need for reop</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other* AEs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Details</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0001" title="Al-KaisyA , PalmisaniS , McCammonS , SandersonKK , CaganilloR , TanY , et al.Spinal cord stimulation study evaluating role of higher frequencies (SCS frequency study) (10524). In: Neuromodulation. Vol. 19. 2016:e34. Al-KaisyA , PalmisaniS , PangD , SandersonK , WesleyS , TanY , et al.Prospective, randomized, sham-control, double blind, crossover trial of subthreshold spinal cord stimulation at various kilohertz frequencies in subjects suffering from failed back surgery syndrome (SCS Frequency Study). Neuromodulation2018;21(5):457‐65. ">Al‐Kaisy 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks cross‐over period + 17 days pre‐implementation trial period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (during pre‐implentation trial period)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 in pre‐implementation trial period, not defined.</p> <p>Pain at the IPG site 3 (1 required re‐operation)</p> <p>Skin heating during recharging 1</p> <p>Intercostal pain 1</p> <p>3 additional "minor lead migrations"</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0002" title="De RidderD , PlazierM , KamerlingN , MenovskyT , VannesteS .Burst spinal cord stimulation for limb and back pain. World Neurosurgery2013;80(5):642‐49 e1. ">De Ridder 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0004" title="EldabeS , DuarteR , GulveA , WilliamsH , GarnerF , BrookesM , et al.Analgesic efficacy of “Burst” and Tonic (500 Hz) spinalcord stimulation patterns: a randomized placebo-controlled crossover study. Neuromodulation2021;24:471-8. TariqA , EldabeS , MadzingaG , GulveA , WilliamsH , GarnerF , et al.Analgesic efficacy of “burst” and tonic(500 Hz) spinal cord stimulation patterns: arandomised placebo-controlled study. In: Neuromodulation. Vol. 23. 2020:e1-e325. ">Eldabe 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐week cross‐over period plus 6 months post study surveillance for SAEs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased pain 15</p> <p>Cramp in foot 2</p> <p>Pain over device 1</p> <p>Intermittent jolts of stimulation 2</p> <p>Loss of adaptive stimulator function 1</p> <p>Discomfort in neck 1</p> <p>Paraesthesia 1</p> <p>Bilateral foot pain 1</p> <p>Numbness in leg 1</p> <p>Left hip pain 1</p> <p>Uncomfortable sensations 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1‐ week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Device/ stim output issues 68,</p> <p>Itching rash 2,</p> <p>Axial paraesthesia 1,</p> <p>Headache 4, converted to standard stimulation 2, Discontinued stimulation 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0007" title="HellstromPM , LindG , LinderothB .Spinal cord stimulation in the irritable bowel syndrome-a randomized cross-over trial. In: United European Gastroenterology Journal. Vol. 1. 2013:A240. LindG , WinterJ , LinderothB , HellströmPM .Therapeutic value of spinal cord stimulation in irritable bowel syndrome: a randomized crossover pilot study. American Journal of Physiology2015;308(10):R887‐94. ">Lind 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2‐ week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Feeling of tiredness during stimulation periods 2,</p> <p>sensations of unsteady gait during stimulation probably related to paresthesia in the legs 2 </p> <p>Uncomfortably high‐intensity stimulation in her legs 1,</p> <p>pain at the implantation site of the stimulator 1, transient headache upon removal of the SCS system 1. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0008" title="PerruchoudC , EldabeS , BatterhamAM , MadzingaG , BrookesM , DurrerA , et al.Analgesic efficacy of high-frequency spinal cord stimulation: a randomized double-blind placebo-controlled study. Neuromodulation2013;16(4):363‐9. ">Perruchoud 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malaise that was attributed to a vasovagal attack at the programming session of one of the treatment periods. This patient subsequently withdrew consent to the study and was excluded. 1<br/>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0011" title="SchuS , BaraG , VesperJ .Burst or tonic stimulation' first results of a placebo controlled, doubled blinded, randomized study for the treatment of fbss patients. In: Pain Practice. Vol. 14. 2014:68. SchuS , SlottyPJ , BaraG , vonKnopM , EdgarD , VesperJ .A prospective, randomised, double-blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation2014;17(5):443‐50. VesperJ , SlottyPJ , SchuS .Burst or tonic stimulation? results of a placebo controlled, double blinded, randomized study for the treatment of FBSS patients-3y follow-up. In: Neuromodulation. Vol. 20. 2017:e170. ">Schu 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only SAEs measured and none reported.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0014" title="MalukiewiczA , SokalP .Comparison of tonic, burst and high frequency spinal cord stimulation in chronic pain syndromes: a double-blind, randomised, cross-over, placebo controlled trial. In: Stereotactic Functional Neurosurgery. Vol. 97. 2019:22. SokalP , MalukiewiczA , KieronskaS , MurawskaJ , GuzowskiC , RudasM , et al.Sub-perception and supra-perception spinal cord stimulation in chronic pain syndrome: a randomized, semi-double-blind, crossover, placebo-controlled trial. Journal of Clinical Medicine2020;9(9):31. ">Sokal 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2‐week pre‐trial implementation period, 8‐week cross‐over period, up to 17 months follow‐up </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Device/ electrodes removed due to inadequate pain relief 2</p> <p>Removal of IPG 3,</p> <p>Allergic reaction at implant site 1,</p> <p>Replacement due to battery issues 1</p> <p>Electrode replacement due to electrode dysfunction 1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0006" title="KriekN , GroenewegJ , StronksD , HuygenF .High frequency and burst spinal cord stimulations in patients with complex regional pain syndrome: a randomized placebo controlled trial. In: Pain Practice. Vol. 14. 2014:117. KriekN , GroenewegJG , StronksDL , deRidderD , HuygenFJ .Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: a multicentre, double-blind, randomized and placebo-controlled crossover trial. European Journal of Pain2017;21(3):507‐19. KriekN , GroenewegJG , StronksDL , HuygenFJ .Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial. BMC Musculoskeletal Disorders2015;16:222. ">Kriek 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐week cross‐over period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heavy feeling or pressure in their legs or feet 3</p> <p>Increased sensation of local stimulation around IPG 1</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><i>Footnotes:</i><b><i>AEs</i> </b><i>= adverse events;</i><b><i>IPG</i> </b><i>=  implanted pulse generator.</i><b><i>N</i> </b><i>I= No Information reported; *as defined and reported in original studies;</i><b><i>SAEs</i> </b><i>serious adverse events</i> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS versus sham</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013756-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS + other interventions vs other interventions alone</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N randomised to stimulation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N implanted with electrodes in SCS group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total N who received full device implantation in SCS group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Period of measurement</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Lead failure/ displacement</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Infection</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Need for reop</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other AEs*</b> </p> <p><b>(no. of events)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Other AE details</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Medium Term reporting</b> </p> </th> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0003" title="deVosC , Dijkstra-ScholtenC , MeierK , ZaalbergPB , VesperJ , LendersMW .Spinal cord stimulation in patients with diabetic neuropathic pain. In: Neuromodulation. Vol. 14. 2011:460. deVosC , MeierK , ZaalbergPB , NijhuisH , DuyvendakW , VesperJ , et l.Spinal cord stimulation in patients with painful diabetic neuropathy. In: Neuromodulation. Vol. 16. 2013:e44. deVosCC , MeierK , ZaalbergPB , NijhuisHJ , DuyvendakW , VesperJ , et al.Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain2014;155(11):2426-31. DuarteRV , AndronisL , LendersMW , deVosCC .Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of Life Research2016;25(7):1771‐7. ">de Vos 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 participant with coagulopathy, which complicated the implantation procedure and prolonged hospitalisation. </p> <p>2 pain due to IPG</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemler 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 dural puncture (1 with headache)</p> <p>Six of the 24 patients treated with spinal cord stimulation (25%) had a total of 11 other complications during the six months after implantation. Four patients had long‐term complications. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Back pain</p> <p>Device stimulation issues</p> <p>2 Device deployment issues</p> <p>1 Device Battery issue</p> <p>1 Implant site cellulitis</p> <p>1 Implant site pain</p> <p>2 Paraesthesia</p> <p>1 Pelvic pain</p> <p>1 Pulmonary oedema</p> <p>1 Urinary tract infection</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0012" title="ArgoffC , MekhailN , NasrC , TaylorR , CarawayD , GlinerB , et al.High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of neuropathic limb pain from painful diabetic neuropathy. In: Postgraduate Medicine. Vol. 130. 2018:9‐10. ArgoffC , MekhailN , NasrC , TaylorR , NeumannP , CarawayD , et al.A prospective, randomized, controlled trial of high frequency spinal cord stimulation for the treatment of neuropathic limb pain from painful diabetic neuropathy: the Senza-PDN protocol. In: Pain Practice. Vol. 18. 2018:31. MekhailNA , ArgoffCE , TaylorRS , NasrC , CarawayDL , GlinerBE , et al.High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: design of a multicenter, randomized controlled trial (SENZA-PDN). Trials2020;21(1):87. [DOI: 10.1186/s13063-019-4007-y]PetersenE , Investigators Senza-PDN.Neuromodulation for treatment of painful diabetic neuropathy: a multicentre randomised controlled trial. In: Diabetologia. Vol. 63. 2020:S94. PetersenE , StaussT , ScowcroftJ , BrooksE , WhiteJ , SillsS , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Postgraduate Medicine. Vol. 132. 2020:17-8. PetersenE , StaussT , ScowcroftJ , SillsS , WhiteJ , Amirdelfan K, et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Neuromodulation. Vol. 23. 2020:3: e31-32. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillS , AmirdelfanK , et al.Neuromodulation for treatment of painful diabetic neuropathy - A multicenter randomized controlled trial comparing 10 khz spinal cord stimulation to conventional medical management. In: Endocrine Practice. Vol. 26. 2020:159-60. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Journal of the Peripheral NervousSsystem. 551 edition. Vol. 25. 2020:4. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy-A Multicenter Randomized Controlled Trial. In: Neurology. Vol. 94. 2020:6. PetersenE , StaussT , ScowcroftJ , WhiteJ , SillsS , AmirdelfanK , et al.10 khz spinal cord stimulation for treatment of painful diabetic neuropathy-a multicenter randomized controlled trial. In: Pain Practice. Vol. 20. 2020:76. PetersenE , StaussT , WhiteJL , SillsSM , AmirdelfanK , GuirguisM , et al.Neuromodulation for treatment of painful diabetic neuropathy: a multicenter randomized controlled trial. In: Diabetes. Vol. 69. 2020. PetersenEA , StaussT , ScowcroftJ, WhiteJ , SillsS , AmirdelfaK , et al.10 kHz spinal cord stimulation for treatment of painful diabetic neuropathy - a multicenter randomized controlled trial. In: Neurosurgery. Vol. 67. 2020:177. PetersenEA , StaussTG , ScowcroftJA , BrooksES , WhiteJL , SillsSM , et al.Effect of high-frequency (10-kHz) spinal cord stimulation in patientswWith painful diabetic neuropathy: a randomized clinical trial. JAMA Neurology2021;78(6):687-98. [PMID: PMID: 33818600]">SENZA‐PDN</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 wound dehiscence</p> <p>1 impaired healing</p> <p>1 device extrusion</p> <p>1 incision site pain</p> <p>1 IPG site discomfort</p> <p>1 contact dermatitis</p> <p>1 urticaria</p> <p>1 radiculopathy</p> <p>1 uncomfortable stimulation</p> <p>1 Gastrooesophageal reflux</p> <p>1 myalgia</p> <p>1 arthralgia</p> <p>1 hyporeflexia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0013" title="SlangenR , FaberCG , Schaper NC , JoostenEA , vanDongenRT , KesselsAG , et al.A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painfuldDiabetic peripheralnNeuropathy. Journal of Pain2017;18(4):405-14. SlangenR , SchaperNC , FaberCG , JoostenEA , DirksenCD , vanDongenRT , et al.Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care2014;37(11):3016-24. ">Slangen 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 Dural puncture leading to headache. Subsequent large subdural haematoma leading to death. </p> <p>1 infection leading to device removal</p> <p>Participant did not fully recover and developed autonomic neuropathy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>Long term reporting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemler</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67****</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19, Change of amplitude with bodily movements.</p> <p>13 Paraesthesia over other body parts</p> <p>11 Pain/irritation from IPG</p> <p>7 More pain in other body parts</p> <p>4 Disturbed urination</p> <p>3 Movements or cramps resulting from elevated amplitude</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0009" title="EldabeS , BuchserE , KumarK , TaylorR .Function and quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S45. EldabeS , BuchserE , KumarK , TaylorR .Pain in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: European Journal of Pain. Vol. 13. 2009:S135‐. EldabeS , KumarK , BuchserE , TaylorRS .An analysis of the components of pain, function, and health-related quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. Neuromodulation2010;13(3):201‐9. KumarK , EldabeS , BuchserE , TaylorR .Changes in pain, function and quality of life in patients with failed back surgery syndrome treated with spinal cord stimulation or conventional medical management. In: Pain Practice. Vol. 9. 2009:85. KumarK , EldabeS , BuchserE , TaylorR .Function and health-related quality of life in failed back surgery syndrome patients following spinal cord stimulation and conventional medical management. In: Pain Medicine. Vol. 11. 2010:294‐5. KumarK , NorthR , TaylorR , SculpherM , Van Den AbeeleC , GehringM , et al.Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulation2005;8(4):213‐8. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain2007;132(1):179‐88. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , MoletJ , et al.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery2008;63(4):762‐70. MancaA , KumarK , TaylorRS , JacquesL , EldabeS , MeglioM , et al.Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain2008;12(8):1047‐58. MeglioM , CioniS , SabeneS .Spinal cord stimulation versus conventional medical management for failed back surgery syndrome: long-term results from the PROCESS study. In: European Journal of Neurology. Vol. 15. 2008:11, Abstract no: SC109. NorthRB .Spinal cord stimulation vesus conventional medical management: preliminary long-term results from the PROCESS study: a multi-center randomized controlled trial investigating the treatment of patients with failed back surgery syndrome. In: Neurology. Vol. 70. 2008:A162, Abstract no: PO3.147. ">PROCESS</a>*** </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> <p>(78 implanted after cross‐over from control group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 (+1 device migration)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 "Technique" issues**</p> <p>5 Pain at IPG site</p> <p>4 Fluid collection in neurostimulator pocket</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD013756-bbs2-0010" title="NorthR , DesaiM , VangeneugdenJ , RaftopoulosC , Van HavenberghT , Deruytter M et al.Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT). Neuromodulation2020;23(5):620-4. NorthRB , DeruytterMM , VangeneugdenJJM , RaftopoulosC , Van HavenberghT , DesaiMJ , et al.Perioperative infections and prolonged SCS trial duration (PROMISE study). In: Neuromodulation. Vol. 21. 2018:e11. RigoardP , BasuS , DesaiM , TaylorR , AnnemansL , TanY , et alR.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial. Pain2019;160(6):1410‐20. RigoardP , DesaiMJ , NorthRB , TaylorRS , AnnemansL , GreeningC , Tet al.Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study). Trials2013;14:376. [DOI: 10.1186/1745-6215-14-376]RigoardP , DesaiMJ , TaylorRS , AnnemansL , JohnsonMJ , TanY , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: an international multicenter randomized trial (PROMISE study). In: Pain Physician. Vol. 20. 2017:E614. RigoardP , NorthR , TaylorRS , AnnemansL , TanY , JohnsonMJ , et al.Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: 12-month results of an international multicenter randomized trial (PROMISE Study). In: Neuromodulation. Vol. 21. 2018:e155. ">PROMISE</a>*** </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> <p>(174 implanted overall after cross‐over from control group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 Device stimulation issues</p> <p>6 implant site pain</p> <p>5 Back pain</p> <p>4 Paraesthesia</p> <p>3 Device dislocation</p> <p>2 Device deployment issue</p> <p>2 Procedural pain</p> <p>2 Product ineffective</p> <p>2 Therapeutic response decreased</p> <p>2 Abdominal pain</p> <p>1 Burning sensation</p> <p>1 Dermatitis contact</p> <p>1 Device battery issue</p> <p>1 Extradural abscess</p> <p>1 Extradural haematoma</p> <p>1 Hypoaethesia</p> <p>1 Implant site cellulitis</p> <p>1 Implant site swelling</p> <p>1 Monoparesis</p> <p>1 Musculoskeletal pain</p> <p>1 Pelvic pain</p> <p>1 Postprocedural complication</p> <p>1 Pulmonary oedema</p> <p>1 Urinary tract infection</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><i>* Other AEs reported here if there is a high likelihood of being directly related to the device/ procedure.</i> </p> <p><i>** "Technique" issues (1) Cap not installed on IPG when only one lead was implanted: (2) suboptimal connection of extension to IPG led to intermittent stimulation; (3) anteriorly implanted electrode caused shocks; (4) lead cut during implant; (5) dural tear during implant</i> </p> <p>*** Numbers of events for these studies reflects those randomised to SCS and those who crossed over from the control group after 6 months. </p> <p>**** other device‐related AEs from <a href="./references#CD013756-bbs2-0005" title="KemlerMA , BarendseGA , vanKleefM , deVetHC , RijksCP , FurnéeCA , et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine2000;343(9):618‐24. KemlerMA , deVetHC , BarendseGA , vanden WildenbergFA , vanKleefM .Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. Journal of Neurosurgery2008;108(2):292‐8. KemlerMA , De VetHC , BarendseGA , Van Den WildenbergFA , Van KleefM .The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Annals of Neurology2004;55(1):13‐8. KemlerMA , Furnée CA .Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology2002;59(8):1203‐9. ">Kemler 2000</a> reported a 2 year follow‐up. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Procedure/device‐related adverse events from studies comparing SCS + other interventions vs other interventions alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/full#CD013756-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013756-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SCS vs sham</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pain Intensity: average post‐intervention. Short‐term follow up. Mean difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.73 [‐15.67, ‐1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Conventional SCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.88 [‐28.14, 12.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 High frequency SCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.31 [‐10.29, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Burst SCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.38 [‐30.09, 3.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Disability: short‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.48 [‐13.13, ‐1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Conventional</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐12.72, 2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Burst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.30 [‐18.48, ‐2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 HR‐QoL: short‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.30, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Conventional</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.60, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Burst</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.66, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 High frequency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.41, 0.55]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SCS vs sham</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013756-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SCS + other intervention vs other intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Pain intensity: average post‐intervention. Short‐term follow‐up. Mean Difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐37.41 [‐46.39, ‐28.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Pain: participants with ≥50% pain relief. Short‐term follow‐up. Risk Ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.90 [6.70, 37.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Pain intensity: average post‐intervention. Medium‐term follow‐up. Mean difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>635</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐31.22 [‐47.34, ‐15.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Pain: participants with ≥50% pain relief. Medium‐term follow‐up. Risk Ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>597</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.08 [3.40, 14.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Pain intensity: average post‐intervention. Long‐term follow‐up. Mean difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.00 [‐24.76, 10.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Pain: participants with ≥50% pain relief. Long‐term follow‐up. Risk Ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.15 [2.11, 108.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Adverse events: electrode/lead failure or displacement. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.04, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Adverse events: electrode/lead failure or displacement. Long‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.35, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Adverse events: infection. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.01, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Adverse events: need for repeated implantation procedures. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Adverse events: need for repeated implantation procedures. Long‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.80, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Adverse events: other. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.16, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 Adverse events: other. Long‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.37, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.14 Disability (Oswestry Disabiility Index). Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.93 [‐35.99, 4.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.15 Health‐Related Quality of Life. Short‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.00 [5.74, 28.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.16 Health‐Related Quality of Life. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.46, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.17 Health‐Related Quality of Life. Long‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.74, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.18 Medication use: participants using medication. Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.1 Participant using opioids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.58, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.2 Participants using NSAIDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.43, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.3 Participants using antidepressants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.46, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.4 Participants using anticonvulsants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.33, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.5 Participants using paracetamol (acetominophen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.23, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.19 Medication use: morphine oral equivalent daily (mg). Medium‐term follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SCS + other intervention vs other intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#CD013756-tbl-0006">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-1"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Pain Intensity: average post‐intervention. Short‐term follow up. Mean difference</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.1.1 Conventional SCS</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Kriek 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While the study was randomised there was no report of period effects being accounted for. The washout period employed was only for 2 days with no data provided to confirm the absence of carry‐over effects. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. Per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>4 participants (12%) discontinued during the stiudy and were excluded from the analysis. Of these 2 experienced lead dislocation and one an increase in pain. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No SAP Available but outcomes and analysis appear consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Sokal 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomisation was performed by drawing notes with the name of the modality or treatment arm (i.e., LF tonic, 1kHz, clustered tonic, sham) by an independent examiner. At the next meeting (after two weeks), the selection of notes with names of modalities was modified by the notes that were previously chosen." </p> <p>Comment: Method prone to bias and concealment processes not really clear. Also no clear accounting for period effects and no washout priod employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and effectively unblinded. High frequency and burst stimulation is likely subthreshold but blinding success was not formally evaluated. No information provided about deviations from intended interventions or on how the analysis was approached. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No post‐randomisation exclusions reported.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No published protocol or SAP. Registry documents suggest 1 year follow up which does not make sense in the context of this study. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias for mutliple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Tjepkema‐Cloostermans 2016</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No detail on methods used to randomise or conceal allocation. Period effects were dismissed based on a lack of statistical significance. No washout period was employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and therefore likely to be unblinded. Burst stimulation may be sub‐perceptual however no formal analysis of blinding was conducted. No information reported about deviations from intended interventions or how they were managed in the analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant withdrew post‐randomisation.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. Burst stimulation may be subperceptual however no formal analysis of blinding success was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Trial registry reports VAS is primary outcome but the published report demonstrates potential for selection "During all phases of the study, patients were requested to fill in a pain diary, including as VAS scores (on a scale of 0–100) forpain in their back, legs, and feet separately. The average VAS scores for pain during the last three days of each stimulation period (tonic at baseline, low amplitude burst, and high amplitude burst) were used to assess the pain score for that period, thereby the score of the most affected body part, defined as the body part with the highest VAS score at baseline during tonic stimulation, was used." </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.1.2 High frequency SCS</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Al‐Kaisy 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomised with allocation concealment. No washout was applied. While carryover effects were reported as not statistically significant there is potential for carryover effects and no reporting of baseline scores by phase. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While stimulation subperceptual there was no formal assessment of blinding. Battery recharginh issues may have impacted nlinding at 5882 Hz stimulation intensity. There were 20% post randomisation exclusions without specific detail oregarding suring which phase they occurred and a per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>20% post randomisation exclusions. Some of these are related to the intervention itself and thus likely related to the true value. Per protocol analysis employed. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Stimulation likely sub‐perceptual but no formal assessment of blinding. Stimulation at 5882 Hz associated with differences in battery recharging requirement which may have impacted blinding negatively. Outcome is subjective and self‐reported. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No statistical analysis plan available. Analysis intentions not reported in sufficient detail to enable assessment in published report. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on mutliple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Al‐Kaisy 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomised with allocation concealment. No washout was applied. While carryover effects were reported as not statistically significant there is potential for carryover effects and no reporting of baseline scores by phase. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While stimulation subperceptual there was no formal assessment of blinding. Battery recharginh issues may have impacted nlinding at 5882 Hz stimulation intensity. There were 20% post randomisation exclusions without specific detail oregarding suring which phase they occurred and a per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>20% post randomisation exclusions. Some of these are related to the intervention itself and thus likely related to the true value. Per protocol analysis employed. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Stimulation likely sub‐perceptual but no formal assessment of blinding. Stimulation at 5882 Hz associated with differences in battery recharging requirement which may have impacted blinding negatively. Outcome is subjective and self‐reported. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No statistical analysis plan available. Analysis intentions not reported in sufficient detail to enable assessment in published report. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on mutliple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Al‐Kaisy 2018</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-some col2" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomised with allocation concealment. No washout was applied. While carryover effects were reported as not statistically significant there is potential for carryover effects and no reporting of baseline scores by phase. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While stimulation subperceptual there was no formal assessment of blinding. Battery recharginh issues may have impacted nlinding at 5882 Hz stimulation intensity. There were 20% post randomisation exclusions without specific detail oregarding suring which phase they occurred and a per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>20% post randomisation exclusions. Some of these are related to the intervention itself and thus likely related to the true value. Per protocol analysis employed. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Stimulation likely sub‐perceptual but no formal assessment of blinding. Stimulation at 5882 Hz associated with differences in battery recharging requirement which may have impacted blinding negatively. Outcome is subjective and self‐reported. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No statistical analysis plan available. Analysis intentions not reported in sufficient detail to enable assessment in published report. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on mutliple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Kriek 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While the study was randomised there was no report of period effects being accounted for. The washout period employed was only for 2 days with no data provided to confirm the absence of carry‐over effects. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. Per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>4 participants (12%) discontinued during the stiudy and were excluded from the analysis. Of these 2 experienced lead dislocation and one an increase in pain. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No SAP Available but outcomes and analysis appear consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Perruchoud 2013</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col8" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information about methods used to randomise or conceal allocation. No washout period employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While steps were taken to blind participants and high‐frequency stimulation is likely sub‐perceptual, clinical personnel were not all blinded. No information provided about deviations from intended interventions. Per protocol analysis employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>5/38 (13%) excluded post randomisation. All appear to have had device issues. Per protocol analysis conducted. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Assessor blinded and a formal assessment suggests blinding was successful.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No protocol or statistical analysis plan available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains.</p> </td> </tr> <tr class="study-data"> <td> <p>Sokal 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomisation was performed by drawing notes with the name of the modality or treatment arm (i.e., LF tonic, 1kHz, clustered tonic, sham) by an independent examiner. At the next meeting (after two weeks), the selection of notes with names of modalities was modified by the notes that were previously chosen." </p> <p>Comment: Method prone to bias and concealment processes not really clear. Also no clear accounting for period effects and no washout priod employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and effectively unblinded. High frequency and burst stimulation is likely subthreshold but blinding success was not formally evaluated. No information provided about deviations from intended interventions or on how the analysis was approached. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No post‐randomisation exclusions reported.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No published protocol or SAP. Registry documents suggest 1 year follow up which does not make sense in the context of this study. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias for mutliple domains</p> </td> </tr> <tr> <td bgcolor="#ffffff" colspan="13"> <p><b>Subgroup 1.1.3 Burst SCS</b> </p> </td> </tr> <tr class="study-data"> <td> <p>Kriek 2017</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While the study was randomised there was no report of period effects being accounted for. The washout period employed was only for 2 days with no data provided to confirm the absence of carry‐over effects. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. Per protocol analysis was employed. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>4 participants (12%) discontinued during the stiudy and were excluded from the analysis. Of these 2 experienced lead dislocation and one an increase in pain. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No SAP Available but outcomes and analysis appear consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Schu 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col8" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While the study was randomised there was no report of period effects being accounted for and no washout period was employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and the resulting sensations prevent proper blinding compared to sham. Burst and High‐frequency stimulation may be subperceptual but no formal evaluation of blinding employed. No information provided regarding deviations from intended interventions. Intention to treat analysis was conducted. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No post randomisation exclusions.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Burst stimulation may be subperceptual but no formal evaluation of blinding employed.</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No registry record, protocol or SAP available,</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias or some concerns for multiple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Sokal 2020</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"Randomisation was performed by drawing notes with the name of the modality or treatment arm (i.e., LF tonic, 1kHz, clustered tonic, sham) by an independent examiner. At the next meeting (after two weeks), the selection of notes with names of modalities was modified by the notes that were previously chosen." </p> <p>Comment: Method prone to bias and concealment processes not really clear. Also no clear accounting for period effects and no washout priod employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and effectively unblinded. High frequency and burst stimulation is likely subthreshold but blinding success was not formally evaluated. No information provided about deviations from intended interventions or on how the analysis was approached. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No post‐randomisation exclusions reported.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. HF and burst stimulation may be subperceptual however no formal analysis of blinding was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No published protocol or SAP. Registry documents suggest 1 year follow up which does not make sense in the context of this study. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias for mutliple domains</p> </td> </tr> <tr class="study-data"> <td> <p>Tjepkema‐Cloostermans 2016</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-high col2" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No detail on methods used to randomise or conceal allocation. Period effects were dismissed based on a lack of statistical significance. No washout period was employed. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold and therefore likely to be unblinded. Burst stimulation may be sub‐perceptual however no formal analysis of blinding was conducted. No information reported about deviations from intended interventions or how they were managed in the analysis. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant withdrew post‐randomisation.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Conventional stimulation is suprathreshold. Burst stimulation may be subperceptual however no formal analysis of blinding success was conducted. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Trial registry reports VAS is primary outcome but the published report demonstrates potential for selection "During all phases of the study, patients were requested to fill in a pain diary, including as VAS scores (on a scale of 0–100) forpain in their back, legs, and feet separately. The average VAS scores for pain during the last three days of each stimulation period (tonic at baseline, low amplitude burst, and high amplitude burst) were used to assess the pain score for that period, thereby the score of the most affected body part, defined as the body part with the highest VAS score at baseline during tonic stimulation, was used." </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 1.1 Pain Intensity: average post‐intervention. Short‐term follow up. Mean difference</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-1">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-2"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Pain intensity: average post‐intervention. Short‐term follow‐up. Mean Difference</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data and balanced between groups (7.5% SCS group, 10% CMM group). Authors shared complete dataset which indicates no meaningful bias. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in PT management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant in PT only group lost to follow up at this time‐point</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial registry record, SAP or protocol available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. An ITT approach is reported, though there are a number of post‐randomisation exclusions. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Post randomisation exclusions took place prior to pre‐implantation trial period and were omitted from the analysis. In total at 1 month there are 16% of randomised participants excluded from the SCS group and 9% from the CMM group. It is possible that exclusions may be related to the value of the outcome. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While an SAP is available it is unclear whether it was finalised and unchanged ahead of the end of data collection. While authors shared data on request, they remained post‐randomisation exclusions and the N of participants analysed do not clearly match those in the CONSORT flow chart. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on mutliple domains</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.1 Pain intensity: average post‐intervention. Short‐term follow‐up. Mean Difference</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-2">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-3"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.2 Pain: participants with ≥50% pain relief. Short‐term follow‐up. Risk Ratio</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data (7.5% in SCS group and 0 in CMM group). Missing data treated as non‐responders. Authors shared complete dataset which indicates no meaningful bias. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. An ITT approach is reported, though there are a number of post‐randomisation exclusions. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Post randomisation exclusions took place prior to pre‐implantation trial period and were omitted from the analysis. In total at 1 month there are 16% of randomised participants excluded from the SCS group and 9% from the CMM group. While sensitivity analyses are presented they don't account for all exclusions and while statistical significance would likely be unchanged the effect size is likely to be affected.Missingness reasons could reflect intervention tolerability or treatment outcomes. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While an SAP is available it is unclear whether it was finalised and unchanged ahead of the end of data collection. While authors shared data on request, they remained post‐randomisation exclusions and the N of participants analysed do not clearly match those in the CONSORT flow chart. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.2 Pain: participants with ≥50% pain relief. Short‐term follow‐up. Risk Ratio</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-3">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-4"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.3 Pain intensity: average post‐intervention. Medium‐term follow‐up. Mean difference</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low and balanced levels of missing data (10% in each group). Authors shared complete dataset which indicates no meaningful bias. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess possible deviations in the PT management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Very low levels of missing data (1 participant) at this time‐point.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No registry record, protocol or SAP are available</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROCESS</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation with concealed allocation. Back pain higher in SCS group (SCS 54.5 (24.3: CMM 44.8 (23.2). Higher history of litigation in CMM group (17% VS 10% IN SCS) but likely compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data at this time‐point (SCS 4%, CMM 8%).</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting and analysis consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROMISE</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. Difference in percentage of participants unable to work: SCS+OMM=58.2%, OMM=43.5% but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>16% discontinuations in the SCS group and 3% in OMM group. It is not clear how many of these continued to provide data and how many were missing. While BOCF was used to impute missing data, proportion of missing data is imbalanced across groups. ITT analysis appears conservative. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting and analysis consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. An ITT approach is reported, though there are a number of post‐randomisation exclusions. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Post randomisation exclusions took place prior to pre‐implantation trial period and were omitted from the analysis. In total at 6 months there are 16% of randomised participants excluded from the SCS group and 9% from the CMM. While sensitivity analyses are presented they don't account for all exclusions and the effect size is likely to be affected. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While an SAP is available it is unclear whether it was finalised and unchanged ahead of the end of data collection. While authors shared data on request, they remained post‐randomisation exclusions and the N of participants analysed do not clearly match those in the CONSORT flow chart. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.3 Pain intensity: average post‐intervention. Medium‐term follow‐up. Mean difference</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-4">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-5"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.4 Pain: participants with ≥50% pain relief. Medium‐term follow‐up. Risk Ratio</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>PROCESS</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation with concealed allocation. Back pain higher in SCS group (SCS 54.5 (24.3: CMM 44.8 (23.2). Higher history of litigation in CMM group (17% VS 10% IN SCS) but likely compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data at this time‐point (SCS 4%, CMM 8%).</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting and analysis consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. An ITT approach is reported, though there are a number of post‐randomisation exclusions. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Post randomisation exclusions took place prior to pre‐implantation trial period and were omitted from the analysis. In total at 6 months there are 15% of randomised participants excluded from the SCS group and 9% from the CMM group. Reasons for missingness include refusal to be implanted with device and adverse events. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While an SAP is available it is unclear whether it was finalised and unchanged ahead of the end of data collection. While authors shared data on request, they remained post‐randomisation exclusions and the N of participants analysed do not clearly match those in the CONSORT flow chart. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on multiple domains</p> </td> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low and balanced levels of missing data (10% in each group). Missing data treated as non‐responders. Authors shared the complete dataset which indicates no meaningful bias. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Slangen 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data (14% SCS group, 7% OMM group). Missing data treated as non‐responders. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No published protocol or SAP available for the study to outline the intentioned for analysis. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROMISE</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col6" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. Difference in percentage of participants unable to work: SCS+OMM=58.2%, OMM=43.5% but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>16% discontinuations in the SCS group and 3% in OMM group. It is not clear how many of these continued to provide data and how many were missing. However the classification of participants with missing values as non‐responders reduces the risk of inflating the effect size. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting and analysis consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.4 Pain: participants with ≥50% pain relief. Medium‐term follow‐up. Risk Ratio</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-5">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-6"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.5 Pain intensity: average post‐intervention. Long‐term follow‐up. Mean difference</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study. 4/36 (11%) randomised to PT received a spinal cord stimulator by 5 years and were excluded. 1/18 (5.5%) in SCS group was excluded after 6 months due to failure to implant lead in epidural space despite use of a special lead. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>14% missing data in SCS group; 28% missing data in PT group. 14% missing data in SCS group; 28% missing data in PT group. LOCF imputation may introduce a bias. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No registry record, protocol or SAP available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.5 Pain intensity: average post‐intervention. Long‐term follow‐up. Mean difference</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-6">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-7"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.6 Pain: participants with ≥50% pain relief. Long‐term follow‐up. Risk Ratio</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>PROCESS</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation with concealed allocation. Back pain higher in SCS group (SCS 54.5 (24.3: CMM 44.8 (23.2). Higher history of litigation in CMM group (17% VS 10% IN SCS) but likely compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study. By 12 months 28 (58%) in the CMM group had crossed to SCS. 5 (9.6%) in SCS group had crossed to CMM. No information about CMM delivered in either group. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Missing data at this time point (SCS 5/52 (9%), CMM 7/48 14.5%). Analysis based on available data excluding loss to follow up. Analysis based on available data excluding loss to follow up. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study of a complex, invasive intervention with a subjective self‐reported outcome (Pain VAS). </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reported analysis aligns with that in published protocol and reported for this time‐point.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of biason multiple domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.6 Pain: participants with ≥50% pain relief. Long‐term follow‐up. Risk Ratio</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-7">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-8"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.7 Adverse events: electrode/lead failure or displacement. Medium‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. Any potential deviations in medical management unlikely to impact the incidence of device related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Balanced levels of missing data (10% per group). Study authors shared data for all participants. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> <p>"The safety and tolerability of SCS therapy over time was evaluated using information on treatment‐emergent adverse events, device complications, and premature withdrawal<br/>from the trial." Authors clarified all device‐related AEs on request. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial protocol or statistical analysis plan available, though no clear suggestion of selective reporting. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information to suggest there were or were not deviations from the intended intervention that arose because of the experimental context. No information on the details of the physical therapy delivered. Any potential deviations in PT management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant reported LTFU in the PT only group.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial protocol or statistical analysis plan available, though no clear suggestion of selective reporting. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial protocol or statistical analysis plan available, though no clear suggestion of selective reporting. </p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. ITT analysis used. Any potential deviations in medical management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>AEs based on full cohort as randomised with low levels of missing data. 4 LTFU and1 withdrew consent in SCS group (4%), 4 LTFU and 2 withdrew consent in CMM group (6%). </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data reported as per pre‐specification in protocol and SAP</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias due to possible bias in the measurement of the outcome</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.7 Adverse events: electrode/lead failure or displacement. Medium‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-8">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-9"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.8 Adverse events: electrode/lead failure or displacement. Long‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the PT management across groups. Any potential deviations in PT management unlikely to impact the incidence of device related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>At 5 year follow up, 14% LTFU in SCS group and 28% LTFU in PT group. It is possible that LTFU was related to adverse events. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No triap protocol or SAP available</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.8 Adverse events: electrode/lead failure or displacement. Long‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-9">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-10"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.9 Adverse events: infection. Medium‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information to assess deviations from intended intervention that arose because of experimental context, including no information about medical care received in each group. Any potential deviations in medical management unlikely to impact the incidence of device related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Balanced levels of missing data (10% per group). Study authors shared data for all participants. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>"The safety and tolerability of SCS therapy over time was evaluated using information on treatment‐emergent adverse events, device complications, and premature withdrawal<br/>from the trial." </p> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial protocol or statistical analysis plan available, though no clear suggestion of selective reporting. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on potential bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information to suggest there were or were not deviations from the intended intervention that arose because of the experimental context. No information on the details of the physical therapy delivered. Any potential deviations in PT management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant lost to follow up at this point.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance, which may impact on the reported values. </p> <p>"Finally, we documented complications of spinal cord stimulation."</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No registry record, protocol or SAP available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROMISE</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. Difference in percentage of participants unable to work: SCS+OMM=58.2%, OMM=43.5% but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No information to assess deviations from intended intervention that arose because of experimental context, including no information about medical care received in each group. Any potential deviations in medical management unlikely to impact the incidence of device ‐adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data in each group (6% in SCS group and 3% in OMM)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> <p>"An independent clinical events committee adjudicated AEs."</p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting of results for this outcome appears complete and unselective.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. Any potential deviations in medical management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>AEs based on full cohort as randomised with low levels of missing data. 4 LTFU and1 withdrew consent in SCS group (4%), 4 LTFU and 2 withdrew consent in CMM group (6%). </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data reported as per pre‐specification in protocol and SAP</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.9 Adverse events: infection. Medium‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-10">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-11"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.10 Adverse events: need for repeated implantation procedures. Medium‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. Any potential deviations in medical management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Balanced levels of missing data (10% per group). Study authors shared data for all participants. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> <p>"The safety and tolerability of SCS therapy over time was evaluated using information on treatment‐emergent adverse events, device complications, and premature withdrawal<br/>from the trial." </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the PT management across groups. Any potential deviations in PT management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Only 1 participant lost to follow up at this timepoint.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No registry record, protocol or SAP is available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROMISE</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. Difference in percentage of participants unable to work: SCS+OMM=58.2%, OMM=43.5% but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. Any potential deviations in medical management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data in each group (6% in SCS group and 3% in OMM)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Protocol consistent with published report</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>SENZA‐PDN</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. No apparent baseline imbalance.</p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open‐label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. An ITT approach is reported. Any potential deviations in medical management unlikely to impact the incidence of device‐related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>4 LTFU and 1 withdrew consent in SCS group (4%), 4 LTFU and 2 withdrew consent in CMM group (6%). Safety cohort is all randomised with low levels of missing data. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Data reported as per pre‐specification in protocol and SAP and data clarified by authors on request. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on bias in the measurement of the outcome.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.10 Adverse events: need for repeated implantation procedures. Medium‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-11">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-12"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.11 Adverse events: need for repeated implantation procedures. Long‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>Kemler 2000</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col4" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col12" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation. Allocation concealed. Minor imbalance of gender (61%F in SCS group and 83%F in PT group) but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the PT management across groups. Any potential deviations in PT management unlikely to impact the incidence of device related adverse events. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>5/36 (14%) LTFU in SCS group and 5/18 (28%) in PT group at 5 year follow up.</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>No trial protocol or SAP available.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.11 Adverse events: need for repeated implantation procedures. Long‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-12">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-13"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.12 Adverse events: other. Medium‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>de Vos 2014</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col10" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. No apparent baseline imbalance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Some concerns related to bias due to deviations from intended interventions, in the measurement of the outcome and selection of the reported result </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Balanced levels of missing data (10% per group). Study authors shared data for all participants. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>While no protocol or full SAP is available sharing of the full dataset by the study authors indicates no evidence of selectivity. </p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> <tr class="study-data"> <td> <p>PROMISE</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-some col4" colspan="2"><img alt="Some concerns" src="/cochrane-theme/images/some_concerns.png" title="Some concerns"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col6" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Randomisation block stratified by centre. Allocation concealed. Difference in percentage of participants unable to work: SCS+OMM=58.2%, OMM=43.5% but compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Open label study without blinding of participants and personnel and no information provided to assess deviations in the medical management across groups. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Low levels of missing data in each group (6% in SCS group and 3% in OMM)</p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reporting and analysis consistent with published protocol.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias based on possible bias in the measurement of the outcome.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.12 Adverse events: other. Medium‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-13">Navigate to table in review</a></div> </div> <div class="table riskOfBias2"> <table data-id="riskOfBias2Table-14"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.13 Adverse events: other. Long‐term follow‐up</span></div> <tr> <th align="center" class="headercell" colspan="13" rowspan="1" scope="col" valign=""> <p><b>Bias</b></p> </th> </tr> <tr> <th class="headercell"> <p><b>Study</b></p> </th> <th class="rob-col-trigger" colspan="2" data-index="0"> <p><b>Randomisation process</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="1"> <p><b>Deviations from intended interventions</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="2"> <p><b>Missing outcome data</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="3"> <p><b>Measurement of the outcome</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="4"> <p><b>Selection of the reported results</b> </p> </th> <th class="rob-col-trigger" colspan="2" data-index="5"> <p><b>Overall</b> </p> </th> </tr> <tr class="study-data"> <td> <p>PROCESS</p> </td> <td bgcolor="#ffffff" class="rob-trigger rob-low col2" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col4" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col6" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col8" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-low col10" colspan="2"><img alt="Low risk of bias" src="/cochrane-theme/images/low.png" title="Low risk of bias"/></td> <td bgcolor="#ffffff" class="rob-trigger rob-high col12" colspan="2"><img alt="High risk of bias" src="/cochrane-theme/images/high.png" title="High risk of bias"/></td> </tr> <tr class="indicator-row col3"> <td colspan="1"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Computer generated randomisation with concealed allocation. Back pain higher in SCS group (SCS 54.5 (24.3: CMM 44.8 (23.2). Higher history of litigation in CMM group (17% VS 10% IN SCS) but likely compatible with chance. </p> </td> </tr> <tr class="indicator-row col5"> <td colspan="3"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>By 12 months 28 (58%) in the CMM group had crossed to SCS. 5 (9.6%) in SCS group had crossed to CMM. No information about CMM delivered in either group. </p> </td> </tr> <tr class="indicator-row col7"> <td colspan="5"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Missing data at this time point (SCS 6/52 (11.5%, CMM 7/48 14.5%). Analysis based on available data. Missingness of data may depend on true value. </p> </td> </tr> <tr class="indicator-row col9"> <td colspan="7"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Limited information on how AEs were classified and the approach taken to surveillance which may impact on the reported values. </p> </td> </tr> <tr class="indicator-row col11"> <td colspan="9"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>Reported analysis aligns with that in published protocol and reported for this time‐point.</p> </td> </tr> <tr class="indicator-row col13"> <td colspan="11"></td> <td class="indicator" colspan="2"></td> </tr> <tr class="support"> <td></td> <td colspan="12"> <p>High risk of bias on multiple domains.</p> </td> </tr> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label"></span><span class="table-title">Risk of bias for analysis 2.13 Adverse events: other. Long‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013756.pub2/references#riskOfBias2Table-14">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013756.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013756-note-0018">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013756-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013756-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD013756-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013756-note-0013">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013756-note-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD013756-note-0011">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD013756-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013756-note-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013756-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013756\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013756\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013756\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013756\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013756\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tIsQXAzh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013756.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013756.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013756.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013756.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013756.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724567913"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013756.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724567917"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013756.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e65f8ea9af44a',t:'MTc0MDcyNDU2OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 